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CHAPTER 1 
 
INTRODUCTION  
 
1.1 The central dogma 
The proper flow of genetic information is crucial to all life. Every living thing contains 
an initial set of instructions for its assembly in its genome. Long deoxyribonucleic acid 
(DNA) polymers encode functional components that work together to guide the 
construction of macromolecules, organelles, cells, tissues, and ultimately whole 
organisms. Distinct integral processes are responsible for decoding the information within 
DNA and creating usable materials. DNA contains four monomeric nucleotide 
constituents that make up its code: Adenosine (A), Thymine (T), Guanosine (G), and 
Cytosine (C). A single strand of 
DNA contains many nucleotides 
linked together via phosphodiester 
bonds. The order in which 
nucleotides are linked together is 
referred to as a DNA sequence. 
DNA is typically double stranded; a 
single strand is bound to another 
opposite strand with what is termed 
a “complementary” sequence. 
Adenosines in one DNA strand bind 
to Thymines in the opposite strand, 
and Guanines pair with Cytosines 
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(Fig. 1.1). Ribonucleic acid (RNA) 
polymerases read the information 
contained in one strand of double 
stranded DNA, termed the coding 
strand, and generate a single 
stranded RNA copy of the DNA in a 
process known as transcription. The 
resulting RNA transcript is nearly 
identical to the DNA coding strand 
with a few exceptions: RNA is single 
stranded, a hydroxyl group replaces 
a hydrogen at the 2’ position of the 
sugar ring within each nucleotide, and the Thymine nucleotide in DNA is replaced by 
Uracil (U) in RNA (Fig. 1.2). Many RNA molecules become functional themselves and 
serve necessary structural and enzymatic roles. One major class of transcripts is 
messenger RNAs (mRNAs), which code for proteins. The code within mRNAs exists as 
sequences of trinucleotide units (codons) that specify a particular polypeptide sequence. 
Beginning with an AUG start codon, every succeeding three nucleotides “in frame” 
determine one of twenty amino acids to incorporate. Corresponding amino acids are 
added sequentially until a stop codon (UGA, UAA, and UAG) signifies the end of the code. 
The ribosome, a complex composed of many RNAs and proteins itself, interprets the 
message in mRNA and physically links each amino acid together in the polypeptide chain. 
Protein synthesis in this 
manner is known as 
translation (Fig. 1.3).   The 
myriad proteins produced 
by the ribosome go on to 
serve many cellular 
functions.  
Certainly, different 
organisms contain varying 
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sets of protein-coding DNA genes that underlie biodiversity. However, not all genes within 
an organism are expressed (turned on) at all times and in all tissues. Changes in the 
level, timing, and site of gene expression results in major differences both within species 
(e.g. “identical” twins) and between closely related species (e.g. Chimpanzees and 
humans). Thus, tight control of the processes of transcription (DNA → RNA) and 
translation (RNA → protein) is essential to the development and homeostasis of an 
organism. This dissertation will focus on the regulation of gene expression at the post-
transcriptional level (RNA → protein).  Hallmarks of such regulation include modifying the 
rates of mRNA destruction, which removes mRNA to prevent its expression, and the 
inhibition of translation, which blocks protein synthesis but may leave an mRNA message 
intact for future use. Relevant to the work presented here, strategies employed in 
eukaryotic cells will be discussed.   
1.2 Eukaryotic mRNA regulation 
1.2.1 mRNA transcription and processing 
The life cycle of a eukaryotic mRNA begins as 
it is transcribed from DNA by RNA polymerase II 
(RNAP II) (Wade and Struhl 2008). Nucleotide 
polymers like DNA and RNA are synthesized in a 
5’ to 3’ manner, corresponding to the numbered 
nomenclature of the carbon atoms at each 
terminus of the nucleotide chain (Fig 1.4). Since 
polymerases use nucleotide triphosphates as 
substrates for chain elongation, the first nucleotide in a growing mRNA chain will contain 
an exposed 5’ triphosphate. While the mRNA is being transcribed, this 5’ end is protected 
through a process known as capping (Perales and Bentley 2009) (Fig 1.5). The capping 
process is exclusive to eukaryotes. During capping, the triphosphate is trimmed to a 
diphosphate, and a guanosine triphosphate nucleotide is added via a unique 5’ to 5’ 
linkage. Additionally, this newly formed Guanosine cap is methylated, further 
distinguishing the mRNA 5’ end. This distinct structure protects the mRNA from enzymes 
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that would otherwise recognize and 
destroy the free 5’ phosphates. The cap 
also promotes later events in the 
maturation of the mRNA. 
Mature eukaryotic mRNAs contain a 
code for a single protein that will be 
translated by the ribosome, the coding 
sequence (CDS), and 5’ and 3’ flanking 
sequences which are not translated 
(untranslated regions - UTRs). Many 
premature mRNAs are made up of both 
exons, sequence retained in the final 
mRNA, and introns, sequence that is 
removed. The process of intron elimination is known as splicing and occurs co-
transcriptionally (Perales and Bentley 2009) (Fig 1.6). The 3’ termini of the mRNA is 
determined by a cleavage event. An mRNA signal sequence (AAUAAA) is encoded at the 
intended end of a transcript. Upon being transcribed, the signal is recognized by the 
cleavage and 
polyadenylation specificity 
factor (CPSF). This leads 
to an endonucleolytic (i.e. 
cuts between nucleotides) 
cleavage of the growing 
mRNA about 25-30 
nucleotides downstream 
of the signal (Mandel et al. 2008; Perales and Bentley 2009) (Fig 1.7). Coupled to 
cleavage, a poly-Adenosine polymerase (PAP) then adds numerous Adenosine 
nucleotides onto to the 3’ end. The binding of nuclear poly-Adenosine binding proteins 
(PABP) helps to ensure proper poly-adenylation (Kuhn et al. 2009). Like the 5’ cap, this 
3’ poly-Adenosine (poly(A)) tail is also protective and is important in the mRNA’s fate. 
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1.2.2 mRNA export and 
translation initiation 
A mature capped 
and poly-adenylated 
mRNA molecule must be 
transported from the 
eukaryotic nucleus into 
the cytoplasm before 
translation can occur. 
The nuclear Cap-binding Complex (CBC) recognizes the 5’ cap and directs mRNA to the 
nuclear pore complex (NPC) where it is exported into the cytoplasm (Lewis and Izaurralde 
1997; Stutz and Izaurralde 2003). After clearing the NPC, nuclear factors which recognize 
the 5’ cap and 3’ poly(A) tail are replaced by cytoplasmic protein complexes that serve to 
promote mRNA translation. The cap is bound by the eukaryotic Initiation Factor 4E 
(eIF4E), while the poly(A) tail is coated with cytoplasmic poly(A) binding proteins (PABP) 
(Gebauer and Hentze 2004). Another protein, eukaryotic Initiation Factor 4G (eIF4G), 
bridges eIF4E and pAbp through direct interactions with each. Together, this links the 5’ 
and 3’ ends of an mRNA and forms the eukaryotic 
Initiation Factor 4F (eIF4F) complex (Fig 1.8). 
Formation of eIF4F promotes the assembly of 
more initiation components at the 5’ end, 
including an initiator methionine transfer RNA 
(tRNA), eukaryotic Initiation Factors 2, 3, and 5 
(eIF2, eIF3, and eIF5), and the 40S ribosomal 
subunit (Aitken and Lorsch 2012). This complex 
scans from the 5’ end until it reaches an AUG 
start codon within the mRNA, signifying the beginning of a CDS. In the correct context, 
this AUG will promote the incorporation of the 60S ribosomal subunit and signal the 
transition from initiation into elongation. 
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1.2.3 Translation elongation and termination 
Elongation of translation proceeds within the A, P, and E sites of the 80S (60S + 40S) 
ribosome. The A site acts as in entry for aminoacylated tRNAs, tRNAs “charged” with a 
single amino acid. The anticodon stem of a tRNA molecule specifies which mRNA codon 
it will recognize in the A site through base-pairing interactions. Along with other structural 
features, the anticodon stem may also determine what amino acid a charged tRNA will 
contain (Pang et al. 2014). In this way, each mRNA codon determines each amino acid 
in the polypeptide chain assembled during translation. The AUG start codon is recognized 
by an initiator tRNA charged with the amino acid methionine, but this tRNA is unique as 
it is present in the 40S ribosome scanning complex and begins occupying the P site (the 
location of Peptidyl transfer). After the start, each subsequent tRNA must be recruited to 
the ribosome according to the mRNA codon residing in the A site. Eukaryotic Elongation 
Factor 1 A (eEF1A) is responsible for bringing charged tRNAs to the A site. The protein 
eEF1A exists in a guanosine triphosphate (GTP) bound or guanosine diphosphate (GDP) 
bound state. The GTP-bound form 
readily associates with charged 
tRNAs and thus is important for A site 
recruitment. However, the charged 
tRNA cannot donate its amino acid to 
an elongating polypeptide while it 
remains associated with eEF1A. 
When a correct codon-anticodon pair 
assembles in the A site, the GTP 
bound to eEF1A is hydrolyzed to 
GDP. This causes dissociation of 
eEF1A, allowing the charged tRNA in 
the A site to participate in peptide 
elongation. Ribosomal RNA (rRNA) 
catalyzes the peptidyl transfer 
reaction. The amino acid in the P site 
links with the amino acid in the A site 
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via peptide bond formation and leaves the tRNA in the P site uncharged, depositing the 
elongating polypeptide chain onto the A site tRNA. Using the energy from hydrolysis of a 
bound GTP to GDP, the eukaryotic Elongation Factor 2 (eEF2) translocates the 
polypeptide bound tRNA from the A site to the P site and the uncharged tRNA from the P 
site to the E site (Dever and Green 2012). The uncharged tRNA then Exits the E site and 
the P site peptidyl-tRNA is ready for another round of addition (Fig 1.9).  
The termination of translation also involves manipulation of the ribosome A and P 
sites (Dever and Green 2012). Elongation proceeds until an mRNA stop codon occupies 
the A site. No normal tRNA can decode the stop codon. Instead, eukaryotic Release 
Factor 1 (eRF1) binds to the stop codon in the A site. In another GTP hydrolysis 
dependent interaction, eRF1 and eukaryotic Release Factor 3 (eRF3) promote 
polypeptide release from the P site tRNA, liberating the nascent protein from the ribosome 
(Fig 1.10). PABP proteins can contribute to translation termination through direct 
interactions with eRF3 (Hoshino et al. 1999; Osawa et al. 2012). After termination, the 
ATP-Binding Cassette subfamily E member 1 (ABCE1) protein couples ATP hydrolysis 
to the dissociation of the remaining 
80S ribosome into its 40S and 60S 
constituents, which can then be 
recycled into initiation complexes.  
1.2.4 mRNA turnover 
Gene expression can be 
modulated by controlling the rate of 
translation or modulating the level of 
mRNA. The level of mRNA can be 
controlled through its synthesis during 
transcription and also by managing 
the rate of mRNA destruction. Decay 
of mRNA proceeds in a highly 
regulated stepwise fashion. The 5’ cap 
and 3’ poly(A) tail serve as protection 
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from decay factors, thus the first steps in mRNA destruction involves removal of these 
modifications. Proteins known as deadenylases catalyze enzymatic removal of the 
poly(A) tail; deadenylases remove adenosines from the 3’ end, eventually leaving an 
mRNA with a short oligo(A) 3’ end. Two major eukaryotic deadenylase complexes exist, 
the CCR4-NOT complex and the PAN complex (Wahle and Winkler 2013). Some reports 
propose that the PAN complex is responsible for initial deadenylation, while CCR4-NOT 
is necessary for complete deadenylation (Yamashita et al. 2005). Other data suggests 
that each complex may target separate groups of mRNAs (Sun et al. 2013). Both 
complexes can be recruited directly or indirectly through association with PABP 
(Ezzeddine et al. 2007; Siddiqui et al. 2007). Regardless of the mechanism of 
deadenylation, an mRNA lacking a tail becomes a better substrate for both the exosome, 
a complex which degrades RNA nonspecifically from the 3’ end, and the decapping 
complex (Tharun and Parker 2001). The Like Sm (Lsm) 1-7 complex recognizes short 
tailed mRNAs and interacts with the decapping complex proteins 1 and 2 (Dcp1 and 
Dcp2) to facilitate their activity. The enzyme Dcp2 cleaves the 5’ cap from the mRNA, 
exposing the 5’ end of the transcript. Once an mRNA is decapped, it is susceptible to 
rapid 5’-3’ decay by the exoribonuclease 1 (XRN1) protein (Garneau et al. 2007) (Fig 
1.11). Beyond the ultimate 
degradation of an mRNA, 
loss of these modifications is 
immediately coupled to 
translational output. Loss of 
the poly(A) tail excludes 
PABP from an mRNA, 
precluding the formation of 
the closed loop and its 
stimulation of translation. 
Loss of the cap prevents 
recognition by eIF4E and 
subsequent assembly of the 
40S ribosomal scanning 
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complex. Consequently, in addition to reorganizing initiation, elongation, and termination 
factors, many examples of mRNA regulation rely on directly modifying or interfering with 
recognition of the cap and poly(A) tail.  
1.2.5 Cis and trans mRNA regulatory elements 
Beyond the CDS that determines the identity of synthesized protein, an mRNA 
molecule also contains sequences which determine its relative processing, its localization 
in space, the efficiency of its translation, and its ultimate lifespan. Nucleotide sequences 
within an mRNA that guide these outcomes are considered to be cis regulatory elements. 
Some cis elements form secondary and tertiary structures, giving form to the mRNA for 
specific purpose. Other cis sequences or structures serve to recruit so-called trans 
factors, which are accessory proteins or other molecules that mediate an mRNA 
regulatory outcome. Many trans factors are specific to a particular cis element, while 
others recognize features common to all mRNAs (e.g. the cap, poly(A) tail). Introns and 
UTRs are common sites of cis regulatory elements. RNA binding proteins (RBPs) are a 
large class of proteins which exert regulatory activity on cis elements within mRNAs. 
1.2.6 The importance of RNA binding proteins 
RBPs make up a large portion of translated proteins. To date, greater than 1500 
RBPs have been identified in mammalian cells and many are important to critical 
processes (Gerstberger et al. 2014). During splicing, RBP recognition of cis elements in 
both introns and exons can serve to inhibit or promote inclusion or exclusion of specific 
exons (Chen and Manley 2009). This alternative splicing contributes to the protein 
diversity within an organism by generating multiple proteins with potentially different 
function from the same gene. A stem loop structural element in the mRNAs coding for 
histones, the proteins responsible for the organization of DNA into chromosomes, serves 
as an alternative processing element. These histone stem loops are bound by the Stem 
Loop Binding Protein (SLBP) instead of CPSF, leading to cleavage at the 3’UTR that does 
not result in polyadenylation (Dominski and Marzluff 2007). The specific processing of 
histone mRNAs ensures their expression is properly timed and controlled. The Iron 
Response Element (IRE) is a cis regulatory element that acts in opposite fashion 
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depending on its location within an mRNA (Anderson et al. 2012). IRE-binding protein 1 
(IRP1) is an RBP that recognizes the IRE sequence. When cellular iron is high, IRP1 
dissociates from the 5’UTR of ferritin mRNA, allowing ribosome scanning and increased 
translation of ferritin protein, which in turn stores the excess iron. If iron is low, IRP1 bound 
to the 3’UTR of transferrin receptor mRNA blocks 3’ degradation, stabilizing this message 
and increasing the level of transferrin receptor. In this way, IRP mediates the response to 
iron levels in the cell. 
Dysregulation of RBPs is directly linked to human disease. For example, in patients 
presenting symptoms of myotonic dystrophy types 1 and 2 (DM1 and DM2), a 
trinucleotide and tetranucleotide repeat expansion (CTG and CCTG) occurs in the DNA 
sequences of the mytonic dystrophy protein kinase (DMPK) and the cellular nucleic acid-
binding protein (CNBP), respectively (Ranum and Cooper 2006). Due to these 
expansions, the DMPK mRNA 3’UTR and the first intron of the CNBP mRNA contain long 
CUG containing structures which form foci within nuclei. The CUG elements serve as a 
sponge for the muscleblind like 1 (MBNL1) RBP that normally acts in splicing. The MBNL1 
aggregation on the CUG elements leads to a loss of function and ultimately contributes 
to the disease. RBPs may contribute to the proliferation of cancer as well. In human 
cancer cell lines, alternative cleavage and polyadenylation results in many mRNAs 
bearing significantly shortened 3’UTRs (Mayr and Bartel 2009). Shortened mRNAs 
coding for oncogenes (genes that contribute to cancer progression) were seen to be 
highly expressed, as RBPs and other trans factors that target the 3’UTR for regulation 
could no longer bind. 
1.2.7 The 3’UTR: a hotspot for post-transcriptional regulation 
The 3’UTR is a common target for the regulation of mRNA stability and translation. A 
well-studied example is that of adenosine and uridine rich elements (AREs) present in the 
mRNA 3’UTR of many inflammation genes (Beisang and Bohjanen 2012). These 
elements are recognized by ARE binding proteins (ARE-BPs). Multiple ARE-BPs exist, 
and their effects on bound mRNAs can differ. Some ARE-BPs promote mRNA instability, 
accelerating decay, while other ARE-BPs are protective. While ARE-BPs engage 3’UTR 
sites with minor sequence specificity, other factors have evolved to bind more distinct 
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mRNA targets. The large family of small RNAs known as microRNAs (miRNAs) use base 
complementarity with mRNA 3’UTRs to recruit RNA induced silencing complexes (RISCs) 
(Huntzinger and Izaurralde 2011). A miRNA RISC engaged with an mRNA target evicts 
PABP from the poly(A) tail to inhibit translation and recruits both PAN and CCR4-NOT 
deadenylase complexes to initiate its destruction (Fabian et al. 2009; Zekri et al. 2013) 
(Fig 1.12).  There are many instances where an RBP structure can specify recognition of 
a unique 3’UTR sequence. For instance, the RBP Musashi 1 (MSI1) binds to the 
sequence (G/A)U1-3AGU in 
mRNA 3’UTRs and results in 
repression of protein expression 
(Kawahara et al. 2008). An MSI1 
interaction with PABP interferes 
with eIF4F assembly and thus 
inhibits translation. The work 
presented in this dissertation will 
focus on the protein Pumilio 
(Pum), a member of the larger 
family of RBPs known as PUFs 
(Pumilio and Fem-3 binding 
factor), and its partner Nanos (Nos), a zinc finger protein implicated in Pum function. PUFs 
bind sequence specific cis elements, mainly in 3’UTRs, to coordinate localization, 
translation, and destruction of mRNAs (Miller and Olivas 2011). The function of Pum and 
Nos is not unlike that of ARE-BPs, miRNAs, or MSI1; however, the mechanistic details of 
regulation remain to be elucidated. 
1.3 The PUF family of proteins 
1.3.1 Drosophila Pumilio and Caenorhabditis elegans Fem-3 binding factor 
The founding member of the PUF family of RBPs, Pum, was identified in Drosophila 
melanogaster (fruit fly) in 1987 (Nusslein-Volhard et al. 1987). The fly embryo is unique; 
early stages of development occur in a shared bulk cytoplasm known as a syncytium 
where the placement of mRNAs and proteins determine what and where structures 
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ultimately form. A number of genes are expressed from the female parent fly genome and 
are transmitted into the egg cell, so-called maternal effect genes. Maternal effect genes 
control multiple events in the early development of the fly embryo, including maturation 
of the germline stem cells and anterior-posterior axis determination. Female flies that do 
not express wild type Pum produce embryos lacking abdominal segments, a result of 
impaired posterior definition. This effect was linked to Pum-mediated regulation of an 
anterior determinant gene Hunchback 
(Hb) (Tautz 1988). The function of Pum 
in the posterior was also dependent on 
the protein Nos (Irish et al. 1989). This 
Nos and Pum regulation is dependent 
on regions of the Hb mRNA 3’UTR, 
initially termed the Nos Response 
Elements (NRE) (Wharton and Struhl 
1991) (Fig 1.13). It was later clarified that Pum was essential for Hb regulation; Pum is an 
RBP that binds directly to the Hb NREs (Barker et al. 1992; Murata and Wharton 1995). 
The model that emerged involved Pum binding to the NRE and recruitment of Nos to 
inhibit Hb translation and trigger deadenylation (Wreden et al. 1997; Sonoda and Wharton 
1999). The Hb RNA is certainly not the sole target of Pum. Based on RNA 
immunoprecipitation experiments from fly embryos and adult flies, Pum associates with 
nearly 1000 mRNAs in the transcriptome (Gerber et al. 2006). These observations of Pum 
were the basis for proceeding studies of PUF proteins, including this dissertation. 
In 1997, a protein similar to Pum was discovered in Caenorhabditis elegans 
(nematode) (Zhang et al. 1997). C.elegans are hermaphrodite worms that produce both 
sperm and oocytes from their germ cells (Zanetti and Puoti 2013). Repression of the fem-
3 gene is necessary for germ cells to switch from spermatogenesis to oogenesis. A fem-
3 mutant with persistent expression of the FEM-3 protein produces only sperm, while a 
loss of FEM-3 function results in worms that only produce oocytes. The protein 
responsible for this regulation was named fem-3 Binding Factor (FBF) (Zhang et al. 1997). 
Like Pum, Fem-3 Binding Factor (FBF) is an RBP that recognizes a cis element in a 
3’UTR. FBF binds to an element similar to an NRE within the fem-3 mRNA and also acts 
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to inhibit translation. It was found that a specific region of the FBF protein bearing 8 
repeated amino acid sequence elements contained the RNA binding activity. 
Coincidentally, a similar repeated sequence was identified in the C-terminal region of Pum 
that also contained RNA binding activity (Zamore et al. 1997). A subsequent search for 
homologous proteins in other organisms found other instances of the 8 repeat structure 
throughout eukaryotes including two proteins in humans (Zamore et al. 1997; Zhang et 
al. 1997). These proteins became known collectively as PUF proteins for their founding 
members Pum and FBF.     
1.3.2 PUFs across eukaryotes 
The PUF RNA binding domain is present in many integral proteins throughout 
eukaryotes. The first protein identified bearing a Pum like region was YGL023, now known 
as Puf4p (Barker et al. 1992). The budding yeast Saccharomyces cerevisiae is a 
eukaryotic single celled organism that does not maintain two sexes for reproduction. 
However, yeast can exchange genetic information with cells of the opposite “mating type”. 
Each cell can switch between the “a” or “α” mating type through a genetic rearrangement 
catalyzed by the HO endonuclease protein (Haber 2012). Expression of HO is tightly 
controlled at the transcriptional and post-transcriptional level. Puf4p binds the HO mRNA 
3’UTR and recruits the CCR4-NOT deadenylase complex to negatively regulate 
expression (Hook et al. 2007). Through an adjacent binding site, another yeast PUF 
protein, Puf5p, recruits eIF4E interacting protein 1 (EAP1) to promote 5’ decapping and 
accelerate mRNA decay (Blewett and Goldstrohm 2012). 
In Xenopus laevis (frog) a pumilio homolog (XPum) was found to regulate an 
important mediator of oocyte maturation, Cyclin B1 (CycB1) (Nakahata et al. 2001). 
Before maturation, many mRNAs including CycB1 exist in a “masked” state of limited 
expression, lacking a long poly(A) tail. When ready, cytoplasmic polyadenylation 
elements (CPE) in the 3’UTR are bound by the CPE binding protein (CPEB), signaling 
polyadenylation of the transcript and subsequent translation. XPum binds an NRE like 
sequence in the CycB 3’UTR and interacts with CPEB to further repress CycB. In fact, 
XPum can counteract CPEB mediated polyadenylation, instead retaining a short tail on 
CycB (Nakahata et al. 2003). Conserved PUFs in other organisms also mediate germline 
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regulation akin to XPum: FBF in C. elegans, Pumilio in flies (discussed in detail in 1.4.2), 
and PUM1 and PUM2 in mice and humans (Jaruzelska et al. 2003; Chen et al. 2012). 
PUF proteins are also necessary for neuronal regulation from flies to mammals. The 
Pumilio2 protein localizes to stress granules in rat hippocampal neurons and is thought 
to regulate local translation through repression of eEF1A and eIF4E mRNAs (Vessey et 
al. 2006). Human PUM2 is responsible for the formation of similar granules in human 
HeLa cells. The presence of Pumilio2 in rat hippocampal neurons has large effects on 
neuronal morphology. Depletion of Pumilio2 protein results in an increase in dendritic 
extensions and excitatory synapses, while over-expression of Pumilio2 significantly 
reduces dendritic development, dendritic spine number, and excitatory synapses (Vessey 
et al. 2010). A similar relationship is observed between the expression of Pumilio2 and 
visual cortical pyramidal neuron excitability in mice. Depletion of Pumilio2 relieves 
repression of mRNA encoding sodium channel voltage-gated type VIII alpha (Scn8a), a 
channel responsible for maintaining membrane potential (Driscoll et al. 2013). Again, the 
loss of Pumilio2 leads to hyper-excitable synapses while its overexpression results in a 
loss of synaptic firing. Beyond the nervous system, > 2000 mRNA transcripts associate 
with human PUM1 and PUM2 in HeLa cells, underscoring the myriad potential pathways 
in which PUFs could participate (Galgano et al. 2008). PUFs across eukaryotes control 
many diverse important functions, yet they do so through a conserved mechanism of 
sequence recognition made clear by the elucidation of the PUF RNA binding domain’s 
structure. 
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1.3.3 PUF structure 
The definition of the PUF 
family of proteins relied on the 
homology across eukaryotes in the 
eight repeated elements in the Pum 
and FBF RNA binding domains (Fig 
1.14) (Barker et al. 1992; Zamore et 
al. 1997; Zhang et al. 1997). The first 
X-ray diffraction mediated crystal 
structure of the conserved Pum RNA 
binding domain revealed the 
coordination of these three helical 
repeats as a crescent shaped 
molecule with a concave RNA-
binding surface and an opposite surface for binding to protein partners (Edwards et al. 
2001). The crystal structure of human PUM1 was solved at the same time and revealed 
that the same structure is conserved (Wang et al. 2001). The first RNA elements 
Drosophila Pum was thought to bind was the two Hb NREs, which each contain a so-
called Box A and Box B element thought to be necessary for Pum binding (Wharton and 
Struhl 1991) (Fig. 1.13). It had been unknown what specific nucleotides were engaged by 
the RNA binding face of PUF proteins, but this was elucidated when the structure of 
human PUM1 bound to RNA was solved (Wang et al. 2002). Surprisingly, PUM1 bound 
directly to an eight nucleotide sequence including only a portion of Box B. PUM1 was 
crystallized bound to UGUAUAUA from NRE1 and UGUACAUA from NRE2 (Fig 1.15). 
Each PUF repeat of the PUM1 RNA binding domain binds a single nucleotide in the RNA. 
Three amino acids within each repeat confer nucleotide specificity; two amino acids form 
hydrogen bonds with the Watson-Crick face of the base, while a third amino acid 
contributes stacking interactions between each base (Fig 1.16). PUF proteins rarely 
deviate from this mode of binding. Some PUFs can recognize G in the fourth position 
(FBF-like) or accommodate extra nucleotides within the binding site through base flipping 
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(FBF2, Puf4p, Puf3p), but each of eight 
repeats will always bind one nucleotide 
in a binding site specified by their  
amino acid triad (Miller et al. 2008; 
Wang et al. 2009; Zhu et al. 2009). 
When fly Pum is immunoprecipitated 
from fly embryos or adult flies, the most 
enriched RNA motif associated with 
Pum is UGUAHAUA, where H is any 
nucleotide except G (Gerber et al. 
2006). This minimal 8 nucleotide 
binding site will be referred to as the Pum response element (PRE).  
1.4 Targets and mechanisms of Pumilio 
1.4.1 Hunchback and embryonic body patterning 
The first PUF target identified was Drosophila Hunchback (Hb), a transcription 
factor whose activity is necessary for proper anterior segmentation of the fly embryo 
(Lehmann and Nusslein-Volhard 1987). Transcriptional activation of zygotic Hb is 
dependent on the anterior localized Bicoid (Bcd) protein. However, the zygotic genome 
is silenced in the early stages of embryogenesis; the zygote does not produce new 
mRNAs. The mRNAs that exist during this time are deposited into the embryo by the 
mother fly, and all gene expression must be regulated at the post-transcriptional level. Hb 
protein presents as a gradient emanating from the anterior pole of the embryo even at 
these early stages of development, underlying a maternal source of Hb mRNA (Tautz and 
Pfeifle 1989). The maternal Hb mRNA exists throughout the embryo, thus its translation 
must be specifically inhibited in the posterior. The Hb mRNA contains two PREs in its 
3’UTR that result in Pum dependent regulation. Pum expression is not limited to the 
posterior; however, Pum repression of Hb persists only in this region. Instead, the Nos 
protein is the spatial determinant of Hb regulation. Nos is expressed as a gradient 
beginning at the posterior pole and extending into the embryo (Barker et al. 1992). The 
combination of Pum and Nos in the posterior of the embryo results in translational 
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silencing of Hb mRNA and loss of the Hb poly(A) tail (Tautz 1988; Irish et al. 1989; Murata 
and Wharton 1995; Wreden et al. 1997; Sonoda and Wharton 1999). Pum and Nos could 
also effectively regulate mRNAs lacking a poly(A) tail, but could not regulate mRNAs 
lacking the normal 5’ cap (Chagnovich and Lehmann 2001). Another protein partner, 
Brain Tumor (Brat), was also recruited to Hb through an RNA dependent interaction with 
Pum and Nos and contributed to Hb repression (Sonoda and Wharton 2001). Brat 
interacts with the 4E homologous protein (4EHP) to compete for recognition of the cap by 
eIF4E, blocking translation (Cho et al. 2006). This accessory repression is important for 
abdominal segmentation as it refines the Hb protein gradient; brat mutant embryos have 
similar segmentation defects to pum and nos embryos (Sonoda and Wharton 2001). 
These findings contributed to a model of Pum repression wherein Pum binds the PRE 
through its RNA binding domain and recruits Nos and Brat for deadenylation and 
translational inhibition (Fig 1.17). More recently, Brat has been identified as maintaining 
its own RNA binding activity which is enhanced by Pum (Loedige et al. 2014). The Brat 
binding site resides in Box A of the NRE sequence, explaining the necessity for both Box 
A and Box B in Pum dependent regulation of Hb mRNA.   
 
 
 
 
 
 
 
1.4.2 Cyclin B and germline stem cell maintenance 
In addition to controlling abdominal segmentation in the early developing embryo, 
Pum and Nos are also important for maintenance of the developing Drosophila germline 
through regulation of another PRE containing mRNA of the Cyclin B (CycB) gene. CycB 
regulates progression of the cell cycle into mitosis and its destruction is necessary for 
entry into anaphase (Fung and Poon 2005). Thus, blocking the expression of CycB 
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prevents cell proliferation. In the developing fly embryo, CycB mRNA becomes localized 
at high levels in the posterior pole, eventually becoming incorporated into the germline 
precursor pole cells. The pole cells form before the rest of the syncytial embryo 
cellularizes (Asaoka-Taguchi et al. 1999). Translation of CycB protein is limited until 
gastrulation, after the pole cells physically migrate to what will become the fly ovaries. 
The localization and translational regulation of the CycB mRNA can be attributed to 
elements in its 3’UTR that resemble the Box A and Box B of the Hb NRE (Dalby and 
Glover 1993).  
Pum protein is present throughout the embryo during development, but high levels 
of Nos protein are specifically retained within the pole cells (Wang et al. 1994).  Pole cells 
without maternal Nos expression fail to migrate to the midgut region during development, 
resulting in flies with underpopulated and inviable germlines (Forbes and Lehmann 1998). 
Both pum and nos mutants are impaired for pole cell migration and experience premature 
expression of CycB, resulting in precocious entry into mitosis (Asaoka-Taguchi et al. 
1999). Because Nos and Pum are also necessary for maintaining asymmetric cell division 
in these primordial germ cells as well as mature germline stem cells, this early proliferation 
event results in terminal differentiation (Gilboa and Lehmann 2004; Wang and Lin 2004). 
The regulation of CycB translation is normally dependent on a weak PRE 
(UGUAAUUUAUA), but Pum’s requirement for binding can be precluded by tethering Nos 
directly to the CycB mRNA (Kadyrova et al. 2007). From yeast 2-hybrid data, Nos was 
found to interact with the protein CCR4-NOT transcription complex subunit 4 (CNOT4) 
homolog, Cnot4. From this evidence, it was proposed that Pum binds the PRE of CycB 
solely to recruit Nos and the CCR4-NOT deadenylase complex (through Cnot4) to 
promote translational inhibition (Kadyrova et al. 2007). However, Cnot4 is not a 
constitutive member of the CCR4-NOT complex in Drosophila (Temme et al. 2010). 
Instead, CNOT4 may play a role in ubiquitin mediated protein decay (Sun et al. 2015).  
1.4.3 Paralytic and neurological function 
Pum protein also controls important neurological processes in the fly including 
motor function, neuronal morphology, and long-term memory (Schweers et al. 2002; 
Dubnau et al. 2003; Ye et al. 2004). At the neuromuscular junction (nmj), where a synapse 
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separates a motor neuron from muscle fiber, proper ion concentrations are necessary for 
signal transmission. Ion currents control how voltage-gated Calcium (Ca2+) channels 
respond to nerve impulses, 
the amount of Ca2+ taken up 
by the motor neuron, and 
ultimately the level of neuro-
transmitter released into the 
synapse (Fig 1.18) (Frank 
2014). The combined length 
and amplitude of these 
effects make up neuronal 
“excitability”. Repeated 
stimulation of a motor neuron 
results in long-term 
facilitation (LTF): extended 
release of neurotransmitters 
that promotes an equivalent response in the muscle (Jan and Jan 1978). The time it takes 
the NMJ to achieve a state of LTF is proportional to neuronal excitability. The motor 
neurons of mutant pum larva reach LTF faster than their wild type counterparts and adult 
pum flies suffer from motor defects (Schweers et al. 2002). Conversely, larva that over-
express Pum cannot reach LTF. This dependence on Pum is directly correlated with 
changing levels of the PRE containing mRNA for Paralytic (Para), a sodium (Na+) channel 
protein (Mee et al. 2004). Interestingly, the functional PRE (UGUAAAUA) necessary for 
Pum regulation resides in the Para CDS (Muraro et al. 2008). While Nos is necessary for 
all Pum regulation of Para, Brat is only required in certain motor neurons. 
1.5 Nanos and its homologs  
1.5.1 Drosophila Nanos 
In each identified case of Pum regulation in Drosophila (Hb, CycB, and Para), Nos 
is necessary for the PRE dependent activity. Nos is proposed to recruit translational 
inhibitors (Brat and 4EHP) as well as decay factors (CCR4-NOT), but how it determines 
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which strategy to utilize or what other factors may be necessary remain unknown. Nos is 
the defining member of a family of Zinc Finger (ZnF) proteins, containing conserved 
tandem ZnF domains at its C-terminus (Fig 1.19). Each ZnF coordinates one Zinc ion 
using a combination of three cysteines and one histidine (Curtis et al. 1997). A portion of 
Nos containing the ZnF region and a C-terminal extension is suggested to bind RNA non- 
specifically in vitro (Curtis et al. 1997). However, expression of Nos proteins with 
mutations that abrogate zinc binding by either ZnF (C315Y, C354Y) or truncations of the 
N-terminus or C-terminus cannot rescue nos defects of abdominal segmentation in the 
embryo (Curtis et al. 1997). Mutations in Pum that block Nos recruitment have been 
identified, but how Nos interacts with Pum is unclear (Edwards et al. 2001). 
1.5.2 The conservation of Nanos proteins 
Nanos homologues exist in many eukaryotes, but are absent in yeast. The only 
feature conserved throughout 
NANOS proteins is the tandem 
ZnF regions. A structure of Danio 
rerio (zebrafish) Nanos3 tandem 
ZnF illustrates coordination of Zinc 
by key conserved residues and 
this construct can recapitulate 
nonspecific RNA binding, albeit at 
high µM concentrations (Fig. 1.20)  
(Hashimoto et al. 2010). Outside of 
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the ZnF, a conserved element in the N-terminus of X. laevis Nanos1 was identified which 
could repress mRNAs independently of a poly(A) tail or a 5’ cap (Lai et al. 2011). 
Curiously, this region is absent from Drosophila Nos. Structural evidence suggests that 
this conserved region acts as a NOT1 interacting motif (NIM) in human NANOS1, 
NANOS2, and NANOS3 (Bhandari et al. 2014). While this may support a CCR4-NOT 
mechanism of Nos mediated repression, it was also observed that this region mediated 
deadenylation independent translational repression. Because the NIM is absent in 
Drosophila Nos, it is not clear whether the recruitment of NOT1 is integral to Pum and 
Nos cooperative repression. 
1.5.3 Interactions between NANOS and PUF proteins 
The direct association of Nos and Pum has been observed in an RNA dependent 
manner through the yeast 3-hybrid system and at high µM concentrations using pull-down 
assays in vitro (Sonoda and Wharton 1999; Edwards et al. 2001). These interactions 
depended on a region between repeats 7 and 8 of the Pum RNA binding domain. 
Additionally, one piece of evidence suggests that a C-terminal motif (ITMEDAI) in Nos, 
which is not conserved in other NANOS proteins, is necessary for this interaction with 
Pum (Sonoda and Wharton 1999). In contrast, the ZnF region of human NANOS1 is 
reported to interact with the human PUM2 RNA binding domain between repeats 7 and 8 
(Jaruzelska et al. 2003). Xenopus pumilio1 and nanos1 also interact, however the details 
of their binding are unknown (Nakahata et al. 2001). Co-expression of human PUM2 and 
NANOS3 results in repression of the E2F transcription factor 3 mRNA, but their individual 
contributions were not investigated (Miles et al. 2012). It is unclear whether the PUM2-
NANOS3 interaction is direct or indirect. In short, the understanding of how PUF and 
NANOS homologues interact, if their interaction is truly conserved, remains incomplete. 
1.6 Conclusions 
The activity of PUF proteins represents a microcosm of important post-
transcriptional regulation. The control of mRNA decay and translation are integral to 
proper gene expression. Pum, the founding PUF, mediates multiple important biological 
processes (embryogenesis, germline stem cell maintenance, neurological function) and 
does so via multiple mechanisms (CCR4-NOT mediated deadenylation, Brat mediated 
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translational inhibition). When research for this dissertation began, there was no direct 
functional evaluation of these models outside of the whole fly. Some direct interactions 
with suggested partners had been demonstrated, but the details of interaction with even 
the necessary partner Nos were not robustly verified. I set out to critically investigate the 
models and mechanisms of Pum regulation using a Drosophila cell based model. Cell 
lines provide a living system in which expression of every gene can be measured via 
multiple means, increased through transfection, and depleted by double stranded RNA 
interference (dsRNAi). The question this research addresses can be simplified to, “What 
is necessary for Pumilio repression?” 
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CHAPTER 2 
 
REPRESSION AND REGULATORY DOMAINS OF PUMILIO 
Portions of the work presented in this chapter were originally published as:  
 
“Drosophila Pumilio Protein Contains Multiple Autonomous Repression Domains That 
Regulate mRNAs Independently of Nanos and Brain Tumor”  
 
Molecular and Cellular Biology January 2012. Vol. 32 No. 2: 527-540  
Authors: Chase A. Weidmann and Aaron C. Goldstrohm 
2.1 Abstract 
Drosophila Pumilio (Pum) is an RNA binding protein (RBP) that potently represses 
specific mRNAs. In developing embryos, Pum regulates a key morphogen, Hunchback 
(Hb), in collaboration with the cofactor Nanos (Nos). To investigate repression by Pum 
and Nos, we created cell-based assays and find that Pum inhibits translation and 
enhances mRNA decay independent of Nos. Nos robustly stimulates repression through 
interactions with the Pum RNA binding domain (RBD). We programmed Pum to recognize 
a new binding site, which garners repression of new target mRNAs. We show that 
cofactors Brain Tumor (Brat) and eIF4E Homologous Protein (4E-HP) are not obligatory 
for Pum and Nos activity. The conserved RBD of Pum was thought to be sufficient for its 
function. Instead, we demonstrate that three unique domains in the amino-terminus (N-
terminus) of Pum possess the major repressive activity and can function autonomously. 
The N-termini of insect and vertebrate PUFs are related and we show that corresponding 
regions of human PUM1 and PUM2 have repressive activity. Other PUF proteins lack 
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these repression domains. Our findings suggest that PUF proteins have evolved new 
regulatory functions through protein sequences appended to their conserved PUF repeat 
RBDs. 
2.2 Introduction 
Precise regulation is required for expression of the appropriate quantity of proteins 
at the proper time and location. Post-transcriptional regulation of messenger RNAs 
(mRNAs) is an integral control point mediated by cis-acting sequences and trans-acting 
regulators (Gebauer and Hentze 2004). PUF (Pumilio and Fem-3 binding factor) proteins 
are a family of mRNA regulators defined by a conserved RBD (Wickens et al. 2002). PUFs 
exert their function by selectively binding to single-stranded RNA sequences with high 
affinity and specificity (Zamore et al. 1997; Zhang et al. 1997; Wang et al. 2002; Lu et al. 
2009). Drosophila Pum, the focus of this study, binds the consensus sequence 5’-
UGUANAUA (Murata and Wharton 1995; Zamore et al. 1997; Wharton et al. 1998; Gerber 
et al. 2006).  
Pum controls diverse processes including stem cell proliferation (Lin and Spradling 
1997; Forbes and Lehmann 1998; Asaoka-Taguchi et al. 1999; Parisi and Lin 2000), 
motor neuron function, and memory formation (Schweers et al. 2002; Dubnau et al. 2003; 
Mee et al. 2004; Menon et al. 2004). Pum was initially identified by its requirement for 
embryonic development. Mutations in Pum disrupt abdominal segmentation (Lehmann 
and Nusslein-Volhard 1987b). Early embryonic development is regulated through intricate 
expression patterns of maternally derived mRNA transcripts while the genome is 
transcriptionally silent (Wickens et al. 2000). During this stage, Pum regulates the mRNA 
encoding Hb (Lehmann and Nusslein-Volhard 1987a; Tautz 1988; Barker et al. 1992). 
For proper development, Hb protein must be restricted to the embryonic anterior, yet the 
mRNA is distributed throughout the embryo (Tautz 1988; Tautz and Pfeifle 1989). The 
zinc finger (ZnF) protein Nos spatially restricts Hb expression (Nusslein-Volhard et al. 
1987; Lehmann and Nusslein-Volhard 1991; Wharton and Struhl 1991). A gradient of Nos 
emanates from the posterior pole, opposing the Hb gradient (Wang and Lehmann 1991). 
Two RNA sequences located in the 3’ UTR of Hb mRNA, Nos Response Elements 
(NREs), are necessary for repression of Hb (Wharton and Struhl 1991). The NREs are, 
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in fact, binding sites for Pum, which is evenly dispersed throughout the embryo (Barker 
et al. 1992; Macdonald 1992; Murata and Wharton 1995). In the posterior, Nos partners 
with Pum on the NREs to form a ternary Nos-Pum-NRE complex that represses Hb 
(Sonoda and Wharton 1999). 
Pum repression correlates with shortening of the 3’ poly-Adenosine (poly(A)) tail 
of target mRNAs (i.e. deadenylation) (Wharton and Struhl 1991; Wreden et al. 1997; 
Chagnovich and Lehmann 2001; Gamberi et al. 2002). Yeast and C. elegans PUFs also 
enhance deadenylation (Olivas and Parker 2000; Jackson et al. 2004; Goldstrohm et al. 
2006; Goldstrohm et al. 2007; Hook et al. 2007; Suh et al. 2009). However, multiple lines 
of evidence indicate that additional repression mechanisms exist. Pum inhibits mRNAs 
that lack a poly(A) tail, implicating a poly(A) independent mechanism (Chagnovich and 
Lehmann 2001). Pum repression was shown to be dependent on the 5’ 7-methyl 
guanosine cap (Chagnovich and Lehmann 2001); however, in the Drosophila eye, Pum 
inhibited a reporter whose translation was driven by an internal ribosome entry site, 
suggesting a cap independent mechanism (Wharton et al. 1998). Therefore, Pum likely 
uses multiple means to repress mRNAs, though the precise mechanism(s) remain 
unknown. 
To inhibit Hb, Pum is thought to recruit co-repressors. Assembly of the Pum-Nos 
complex on the Hb NRE recruits the Brat protein (Sonoda and Wharton 2001). Like Pum 
and Nos, Brat promotes formation of the correct Hb gradient and abdominal segments 
(Sonoda and Wharton 2001). A lack of Brat shifts the Hb gradient and limits segmentation. 
A similar phenotype is produced by mutations in 4EHP, which partners with Brat (Cho et 
al. 2006). 4EHP competes with eIF4E for binding to the 5’ cap structure and inhibits 
translation (Cho et al. 2005). Inactivation of 4EHP, or mutations that abrogate its 
recruitment, shifts the Hb gradient towards the posterior and reduce abdominal 
segmentation, though the effect is not fully penetrant (Cho et al. 2006). Therefore, 
recruitment of 4EHP by Brat is proposed to interfere with cap-dependent translation to 
refine the Hb protein gradient (Cho et al. 2006). 
Nos may be an obligatory cofactor for Pum repression. Supporting this notion, Nos 
is necessary for Pum repression of Hb, Cyclin B (CycB), and Paralytic in the embryonic 
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posterior, primordial germ cells, and larval neurons, respectively (Wharton and Struhl 
1991; Kadyrova et al. 2007; Muraro et al. 2008). One study suggested that the main 
function of Pum is to recruit Nos (Kadyrova et al. 2007). Orthologs of Nos serve as 
cofactors for PUFs in C. elegans and Xenopus (Kraemer et al. 1999; Nakahata et al. 
2001). However, PUFs in yeast repress though no Nos ortholog is present. Evidence in 
Drosophila also hints that Nos might not be essential in all contexts. For instance, Pum 
regulates Bicoid (Bcd) and CycB in the anterior of the embryo, where Nos is not detected 
(Gamberi et al. 2002; Vardy and Orr-Weaver 2007). Therefore, the universal necessity of 
Nos in Pum repression remains questionable. 
The carboxy-terminal (C-terminal) RBD of Pum binds Nos and Brat, which in turn 
recruits 4EHP (Sonoda and Wharton 1999; Sonoda and Wharton 2001; Edwards et al. 
2003; Cho et al. 2006). Because over-expression of the Pum RBD partially rescued 
embryonic segmentation defects in Pum mutant embryos, this region was thought to be 
sufficient for function (Wharton et al. 1998). Biochemical studies focused on the 336 
amino acid RBD because it is amenable to purification, whereas full length Pum (1533 
amino acid) has been recalcitrant (Zamore et al. 1997; Zamore et al. 1999). The functions 
of regions outside the RBD are obscure, though some evidence hints at their importance 
(Barker et al. 1992; Wharton et al. 1998), (Menon et al. 2004; Muraro et al. 2008). Analysis 
of the molecular functions of these sequences has awaited development of new 
approaches to measure their activities. 
In the research presented here, we develop assays that measure repression by 
Pum and Nos. We uncover two modes of Pum-mediated repression: one that is 
dependent on Nos and another that is not. We examine the roles of co-repressors Brat 
and 4EHP and find that they are dispensable for either mode. Furthermore, we 
engineered a new Pum protein with altered RNA binding specificity to direct repression 
of a new target mRNA. A key discovery was that full length Pum mediates robust 
repression, whereas the RBD displays weak activity. The major repressive activity of Pum 
resides within three unique repression domains in the protein’s N-terminus. We show that 
equivalent regions of human PUFs also exhibit repressive activity. 
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2.3 Results 
2.3.1 A cell-based reporter assay recapitulates canonical Pum repression 
To dissect repression by 
Pum and Nos, we used the D.mel-
2 cell line (ATCC® #CRL-1963™), 
derived from Drosophila embryo 
Schneider 2 (S2) cells (Schneider 
1972). We created a plasmid that 
expresses a reporter mRNA 
encoding Renilla luciferase, a 
bioluminescent enzyme derived from sea pansy, and containing efficient cleavage and 
poly-adenylation signals within a minimal 3’UTR. To study regulation by Pum and Nos, 
one or three NRE sequences (Wharton and Struhl 1991) were inserted into the 3’UTR to 
create Rn1xNRE and Rn3xNRE, respectively (Fig. 2.1). As a control, the NRE sequences 
were mutated by changing the U1G2U3 trinucleotide, crucial for Pum binding, to ACA in 
Rn3xNREmut (Fig. 2.1). Reporter plasmids were individually transfected into D.mel-2 
cells. As an internal control, a plasmid expressing a luciferase protein derived from 
fireflies was co-transfected (FF control, Fig. 2.1). To measure protein expression, the 
enzymatic activities of Renilla and firefly luciferases were assayed. Transfection efficiency 
of each sample was normalized by calculating a relative response ratio of Renilla activity 
divided by Firefly activity. Relative 
response ratios and standard errors 
for all experiments are reported in 
Tables 2.1 – 2.17. We observed that 
Renilla expression from reporters 
with three NREs was slightly reduced 
when compared to those lacking 
NREs, suggesting putative Pum 
repression (Fig. 2.2). However, the 
3xNRE reporter was slightly elevated 
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when compared to reporters with 
mutant NREs, complicating 
interpretation (Fig. 2.2). RNAi 
mediated depletion of endogenous 
Pum caused a 1.8 fold increase in 
Rn3xNRE expression, but did not 
affect Rn3xNREmut (Fig. 2.3), 
indicating that endogenous Pum 
inhibits the mRNA with Pum binding 
sites. In the same experiment, 
attempts to deplete Nos through double stranded RNA (dsRNA) mediated interference 
had no effect (Fig. 2.3).  
A possible explanation for the minimal difference between 3xNRE and 3xNREmut 
expression is that a key regulator - Pum or Nos - may be limiting. Therefore, we measured 
expression of Pum and Nos in D.mel-2 cells. Reverse transcription followed by 
quantitative polymerase chain reaction (qRT-PCR) revealed that D.mel-2 cells express 
Pum mRNA (cycle threshold (Ct) of 27.0); however, Nos mRNA was not detected. A 
constitutively expressed ribosomal subunit Rpl32 was detected at Ct of 24.2 (Fig. 2.4). 
Nos mRNA was detectable when cells were transfected with a Nos expression plasmid, 
demonstrating that the qRT-PCR assay is valid (Fig. 2.4). Nos, Pum, and Rpl32 were not 
detected in control reactions lacking template (No Template Control, NTC, Fig. 2.4) or 
reverse transcriptase (data not shown). These results demonstrate that D.mel-2 cells 
express Pum but not detectable 
amounts of Nos, supported by 
microarray analysis of mRNA 
expression in S2 cells (Cherbas 
et al. 2011). 
The effect of Nos was 
tested by transfecting 
increasing amounts of a Nos 
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expression plasmid into D.mel-2 
cells along with the Rn3xNRE 
reporter (Fig. 2.5, raw data are 
reported in Fig. 2.6). As a control, 
equivalent samples were prepared 
using an inactive Nos mutant wherein the cysteine at position 354 of the ZnF was changed 
to a tyrosine (C354Y). Loss of zinc binding at this site is reported to impede nonspecific 
RNA binding by Nos (Curtis et al. 1997). Western blotting confirmed expression of both 
wild type and mutant Nos proteins (Fig. 2.5). To measure Nos mediated repression, 
luciferase activities were measured. Next, a normalized response ratio was determined 
for each amount of transfected Nos, relative to the equivalent amount of Nos C354Y. Nos 
inhibited expression of the Rn3xNRE reporter mRNA in a dose dependent manner (Fig. 
2.5). Transfection of 100ng of Nos expression plasmid caused 85.6% repression of 
Renilla expression (Fig. 2.5). 
Titration of Nos expression 
plasmid over a 2000-fold 
range demonstrated that Nos 
repression plateaus at 10 ng 
and continues to repress 
greater than 80% up to 200ng 
with no observed squelching 
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effect (Fig. 2.7). Therefore, this assay recapitulates the ability of Nos to cause repression 
of NRE-bearing target mRNA.  
2.3.2 Nos dependent and independent Pum repression 
2.3.2.1 Nos inhibits protein expression and reduces levels of target mRNAs 
Nos targets mRNAs through direct interactions with its partner, Pum, and the NRE 
(Sonoda and Wharton 1999). To address the necessity of the NRE for Nos-directed 
regulation, the effect of Nos on varying Renilla reporters was tested (Fig. 2.1). Reporters 
were transfected into cells with plasmid expressing either wild type or mutant Nos C354Y. 
Each sample was split into three portions: luciferase activity assays were performed on 
one, qRT-PCR was performed on RNA from another, and western blots were performed 
on the final portion (Fig. 2.8). Wild type but not mutant Nos repressed luciferase 
expression from both Rn1xNRE (76% repression) and Rn3xNRE (85% repression) 
reporters, whereas the mutant Rn3xNREmut reporter was not repressed (Fig. 2.8). 
Repression of mRNA level corresponded to the observed change in luciferase protein. 
Rn1xNRE and Rn3xNRE mRNAs were reduced by 72% and 79%, respectively, whereas 
the Rn3xNREmut mRNA was not 
affected (Fig. 2.8). Western blot 
analysis confirmed expression of 
wild type and mutant Nos proteins 
(Fig. 2.8). These data show that the 
NRE is necessary for Nos-directed 
regulation, in agreement with data 
from embryos (Wharton and Struhl 
1991), and that Nos potently 
decreases reporter protein and 
mRNA levels. 
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2.3.2.2 Depletion of Pum and Nos, but not Brat or 4EHP, abrogates Nos-
dependent repression 
Pum and Nos assemble on the NRE 
and are thought to recruit Brat and 4EHP to 
inhibit translation (Sonoda and Wharton 2001; 
Cho et al. 2006). We sought to examine the 
role of each co-repressor in Nos mediated 
repression. Using qRT-PCR, we confirmed 
expression of endogenous Brat and 4EHP 
mRNAs in D.mel-2 cells with specific Ct 
values of 23.3 and 24.2, respectively. We 
then depleted each protein by RNA 
interference using specific double-
stranded RNAs (dsRNAs). As a 
negative control, cells were treated 
with dsRNA corresponding to the 
bacterial LacZ gene. Rn3xNRE 
reporter and Nos expression plasmids 
were subsequently transfected into 
these dsRNA-treated cells. As before, 
Nos dependent repression was 
calculated relative to mutant Nos 
C354Y. Depletion of exogenously expressed Nos or endogenously expressed Pum 
almost completely abolished repression, whereas non-targeting LacZ dsRNA had no 
effect (Fig. 2.9). These results demonstrate that Pum is essential for Nos dependent 
repression of the NRE containing mRNA and validate the RNAi efficacy. Surprisingly, 
depletion of Brat or 4EHP had no effect on Nos-directed repression (Fig. 2.10). This result 
was corroborated using two different dsRNAs that targeted separate regions of the Brat 
or 4EHP coding sequences (Fig. 2.10). We confirmed depletion of each mRNA by qRT-
PCR. Exogenously expressed Nos mRNA was depleted by up to 95% by treatment with 
Nos dsRNA (data not shown). Across multiple experiments, specific dsRNAs depleted 
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Pum mRNA by up to 67%, Brat mRNA by up to 
80%, and 4EHP mRNA by up to 84% (data not 
shown). To further verify the RNAi efficacy, we 
tested the ability to deplete Brat or 4EHP proteins 
by over-expressing fluorescently labeled HaloTag 
(HT) fusions of Brat or 4EHP (Fig. 2.11). Both 
dsRNAs for Brat or 4EHP completely ablated 
expression (98-99% depletion) of HT-Brat and HT-
4EHP, respectively, as measured by fluorescence 
detection (Fig. 2.11). As an internal control, 
HaloTag was also over-expressed and was not depleted by the dsRNAs (Fig. 2.11). We 
conclude that Nos and Pum collaborate to repress. Moreover, Nos dependent repression 
remains effective when Brat and 4EHP are significantly depleted. 
2.3.2.3 Pum represses mRNAs independent of Nos 
The observation that Pum 
represses mRNAs in the anterior of the 
developing embryo, where Nos is not 
detected, suggests that Nos may not be 
absolutely required (Gamberi et al. 2002; 
Vardy and Orr-Weaver 2007). While 
depletion of endogenous Pum in D.mel-2 
cells increased RnLuc3xNRE 
expression, RNAi of Nos had no effect 
(Fig. 2.3). Since Nos is undetectable in 
D.mel-2 cells, this indicates that Pum can 
repress independently of Nos (Fig. 2.4). 
We tested the ability of Pum to repress NRE containing reporters by transfecting a Pum 
expression plasmid, which caused dose-dependent repression of Rn3xNRE (Fig. 2.12, 
raw data are reported in Fig. 2.13). At the highest expression level, Pum repressed 
expression by 66% (Fig. 2.12). A broader titration range of Pum is shown in Figure 2.14. 
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Repression increased as the dosage of 
Pum increased, with no indication of 
squelching (Fig. 2.14). The assay is very 
responsive to modest increases in Pum. 
Over-expression at maximum repression, 
measured by qRT-PCR, was 1.34 fold 
above endogenous Pum (Fig. 2.15). Pum repression values were calculated relative to 
equivalent amounts of an inactive mutant Pum (Pum mutR7) that is incapable of binding 
to RNA by way of alanine substitutions in the RNA recognition amino acids in the seventh 
PUF repeat (Fig. 2.12). Both wild type and mutant Pum proteins were expressed (Fig. 
2.12) and increased in response to the mass of transfected expression plasmid (Fig. 
2.16). The data indicate that Pum can indeed repress in a Nos independent fashion.  
2.3.2.4 Pum reduces protein and mRNA levels in NRE-dependent manner 
To verify that Nos independent Pum repression is mediated by the NRE, we 
examined the effect of Pum on reporter protein and mRNA levels using Rn1xNRE, 
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Rn3xNRE, and control Rn3xNREmut reporters. 
Pum potently decreased NRE-containing reporter 
mRNA levels and caused a corresponding 
reduction in Renilla luciferase protein activity (Fig. 
2.17). Rn1xNRE and Rn3xNRE mRNAs were 
reduced 63% and 76%, respectively (Fig. 2.17). 
Luciferase expression was repressed by 47% for 
Rn1xNRE and 68% for Rn3xNRE (Fig. 2.17). 
Mutation of the NRE alleviates repression entirely 
(3xNREmut, Fig. 2.17). These results 
demonstrate that Pum over-expression elicits Nos 
independent repression of NRE containing reporters by reducing protein and mRNA 
expression. 
2.3.2.5 Nos and Brat are not necessary for Pum mediated repression 
We further interrogated the potential involvement of Nos and Brat in Pum 
repression. Although Nos expression was undetectable in D.mel-2 cells, we wished to 
use multiple strategies to eliminate the possibility that trace amounts of Nos, below the 
limit of detection, might be sufficient to aid Pum repression. First, we utilized Pum mutants 
that are inactive for interaction with either Nos or Brat. 
Mutation of F1367S in Pum blocks interaction with Nos 
(Edwards et al. 2001; Edwards et al. 2003). The G1330D 
mutation in Pum, originally identified as the pum680 allele 
that eliminates abdominal segmentation (Lehmann and 
Nusslein-Volhard 1987b; Wharton et al. 1998), binds the 
NRE but is unable to recruit Brat into the Pum-Nos-NRE 
complex (Edwards et al. 2001; Sonoda and Wharton 
2001). We tested the ability of these mutants to repress 
Rn3xNRE reporter relative to wild type Pum and mutant 
Pum mutR7. Neither F1367S nor G1330D affected Pum 
repression (Fig. 2.18).  
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As an additional means of assessing 
participation of Nos and Brat in Pum repression, 
cells were treated with corresponding dsRNAs to 
induce RNA interference, and the resulting impact 
on repression by over-expressed Pum was 
measured. As a positive control, RNAi depletion of 
Pum completely alleviated repression (Fig. 2.19). 
Treatment with LacZ dsRNA had no effect on Pum 
repression (Fig. 2.19). RNAi of Nos, Brat, or 
simultaneous knockdown of Nos and Brat had 
negligible effects on Pum repression (Fig. 2.19). 
Therefore, using three approaches, we have shown 
that Pum can repress by a mechanism that is independent of Nos and Brat: 1) Pum 
represses in a Nos-deficient cells, 2) Mutations in Pum that inhibit Nos and Brat ternary 
complex formation do not affect repression, and 3) Depletion of Nos, Brat, or both does 
not alleviate Pum repression. These findings provide strong evidence indicative of a 
previously uncharacterized regulatory function of Pum, which we now explore. 
2.3.3 Pum contains multiple repression and regulatory domains 
2.3.3.1 The N-terminus of Pum is necessary for optimal repression 
To characterize the domains of Pum that are necessary for repression, we 
examined the activities of the RBD and full length Pum. The RBD is composed of eight 
PUF repeats located at the C-terminus of Pum protein (amino acids 1091-1426) (Fig. 
2.20) and is necessary and sufficient for high affinity binding to the NRE RNA and 
interaction with co-repressors Nos and Brat (Zamore et al. 1997; Wharton et al. 1998; 
Sonoda and Wharton 1999; Zamore et al. 1999; Edwards et al. 2001; Sonoda and 
Wharton 2001; Edwards et al. 2003). Outside of the RBD, no domains or motifs have 
been documented. 
However, within the 
large N-terminal region 
of Pum (aa1-1090), we 
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identified two regions conserved in PUF proteins from insects to vertebrates, designated 
Pum Conserved Motifs “a” and “b”, (PCMa and PCMb, Fig. 2.20). 
Repression by the Pum RBD was measured 
relative to an RNA binding defective mutant RBD 
mutR7. The RBD repressed the Rn3xNRE reporter 
by 8-15% (Fig. 2.21). While repression increased 
slightly over a gradient of transfected RBD, the 
maximum level of repression did not exceed 15% 
(Fig. 2.21). Under identical conditions, the full length 
Pum protein repressed by 57% while the RBD 
repressed by 11% (Fig. 2.22). This difference 
cannot be attributed to poor protein expression of 
the RBD; western blotting revealed that the RBD 
expressed to a higher level than full length Pum 
(Fig. 2.22). We scrutinized repression by Pum and the RBD over a 250 fold range of 
transfected plasmids (Fig. 2.14). At each transfected amount, full length Pum repressed 
greater than the RBD.  Repression by the RBD never exceeded 15%; whereas repression 
by full length Pum continued increasing up to 61% at the maximum amount of transfected 
plasmid (Fig. 2.14). The RBD mRNA was maximally over-expressed by 3.31 fold and full 
length Pum by 1.34 fold, relative to endogenous Pum mRNA (Fig. 2.15). Comparison of 
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conditions where mRNAs and proteins were over-expressed at similar levels (e.g. 400ng 
Pum and 80ng RBD), shows that Pum repressed 49% while the RBD only repressed 11% 
(Fig. 2.16 and 2.23). Therefore, differential repression does not result from disparate 
expression levels. These results indicate that the N-terminal 1090 amino acids of Pum 
contain the major repressive activity, illuminating a previously unknown function.  
2.3.3.2 Programming Pum RNA binding specificity confers repression of a new 
target mRNA 
We engineered a Pum protein with altered RNA binding specificity that recognizes 
a new binding site, allowing examination of exogenously introduced Pum mutants without 
potential interference by the endogenous protein. Previous studies deciphered an RNA 
binding code for PUF repeats (Wang et al. 2002; Cheong and Hall 2006; Lu et al. 2009). 
Three amino acids of each PUF repeat recognize one nucleotide (Wang et al. 2002). The 
third base of the Pum binding site is a uracil (U1G2U3), which interacts with amino acids 
N1306, Y1307, and Q1310 of the sixth PUF repeat. The two flanking amino acids, N1306 
and Q1310, make hydrogen bonds with U3 while Y1307 mediates base stacking 
interactions between U3 and the following nucleotide base, A4 (Wang et al. 2002). By 
changing the RNA recognition amino 
acids of repeat 6 (N1306S and Q1310E), 
we programmed the mutant Pum R6SYE 
to bind an NRE sequence with U1G2G3 
trinucleotide, instead of U1G2U3, in the 
Rn3xNRE UGG reporter. 
We tested the ability of wild type 
Pum to repress the Rn3xNRE and 
Rn3xNRE UGG reporter mRNAs.  As 
expected, Pum repressed the wild type 
NRE reporter by 58% but only slightly 
affected the Rn3xNRE UGG reporter by 
12% (Fig. 2.24). We then measured the 
activity of Pum R6SYE, which minimally 
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repressed the wild type NRE by 15% (Rn3xNRE, Fig. 2.24). In contrast, Pum R6SYE 
dramatically repressed the Rn3xNRE UGG reporter by 63%. This result demonstrates 
that PUF proteins can be programmed to repress new target mRNAs. 
We then used Pum R6SYE to examine the activity of the RBD relative to full length 
protein. We considered that repression by the exogenous Pum RBD tested in Figure 2.21 
and 2.22 might be antagonized by endogenous Pum. This concern could be eliminated 
by the altered specificity approach. First, we confirmed that the wild type Pum RBD 
repressed the Rn3xNRE reporter by 11% but was incapable of repressing the Rn3xNRE 
UGG reporter (Fig. 2.24). Next, repression by RBD R6SYE was examined. RBD R6SYE 
repressed the UGG reporter weakly (5%) but had no effect on the reporter bearing wild 
type NREs (Fig. 2.24). Expression of Pum RBD and derivatives was confirmed by western 
blot (Fig. 2.24). These results reaffirm that repression by the RBD is substantially deficient 
relative to full length Pum. 
2.3.3.3 The RBD is sufficient for Nos stimulation of repression 
The effectiveness of Pum R6SYE created the opportunity to further examine Nos 
dependent repression. We hypothesized that inefficient repression by the RBD might be 
caused by the lack of Nos in D.mel-2 
cells. Because Nos enhances repression 
by endogenous Pum of the wild type NRE 
reporter (Fig. 2.5), we circumvented this 
issue using the altered specificity 
approach. Using the Rn3xNRE UGG 
reporter, the ability of Pum RBD R6SYE 
to respond to Nos was tested. While Nos 
and the RBD R6SYE mutant have low 
activity when tested individually (Fig. 
2.25, 8% and 11% repression, 
respectively), when expressed together, 
they synergize to repress by 34% (Fig. 
2.25). To confirm that Nos dependent 
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repression is mediated by interaction with the RBD, we tested the ability of Nos to affect 
the RBD R6SYE mutant, F1367S, which disrupts the Pum-Nos interaction (Edwards et 
al. 2001). RBD R6SYE F1367S with Nos repressed by 17% — less than the additive 
repression of the Nos and RBD R6SYE controls combined (Fig. 2.25); therefore, Nos 
cannot synergize with the Pum RBD in the absence of a direct protein interaction. Using 
a RBD R6SYE with the G1330D mutation, we tested the requirement of interaction with 
Brat (Sonoda and Wharton 2001). Nos stimulated repression by RBD R6SYE G1330D to 
38% (Fig. 2.25). We confirmed expression of Nos and RBD R6SYE proteins by western 
blot (Fig. 2.25). We conclude that repression by the RBD is enhanced by interaction with 
Nos, but enhancement does not require binding to Brat. 
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2.3.3.4 The N-terminal portion of Pum contains the major repression activity 
Full length Pum exhibits greater repression than the RBD, indicating that the major 
repression domain resides outside of the PUF repeats. To separate Pum repression and 
RNA binding activities, we utilized a tethered-function approach. Pum, or portions thereof, 
were fused to the MS2 coat protein (MS2), which binds a specific RNA stem-loop. A 
Renilla luciferase reporter was constructed with two MS2 binding sites in a minimal 3’UTR 
(Fig. 2.26, RnMS2). If the test protein represses when tethered by MS2, then reporter 
expression will be reduced. As a control, Firefly luciferase was co-expressed. Luciferase 
activities were normalized by dividing Renilla signals by those of Firefly to calculate 
relative response ratios. Values generated using test proteins were compared to control 
MS2 protein. 
When tethered, full length Pum repressed 
by 60% (Fig. 2.27), a magnitude similar to that 
observed for repression of Rn3xNRE (Fig. 2.12). 
The N-terminal two-thirds of Pum (N, amino 
acids 1-1090) repressed by 50% whereas the C-
terminal RBD (C, aa1091-1533) repressed by 
22% (Fig. 2.27). Repression is dependent on 
tethering because, when not fused to MS2, full 
length Pum and RBD had no effect on RnMS2 
(data not shown). Consistent with results in 
Figure 3, the C-terminal RBD represses 
inefficiently. Therefore, the N-terminal 1090 
amino acids contain the major repressive activity 
of Pum.  
2.3.3.5 Multiple domains within the Pum N-terminus have autonomous repression 
activity 
We further dissected repression by the Pum N-terminus using the tethered-
function assay. Internal deletions did not cause loss of repression, thus we reasoned that 
the N-terminus harbors multiple repression domains (Fig. 2.28). Six segments of Pum 
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were then separately fused to MS2 including amino acids 
1-378 (Region 1), 379-547 (PCMa, Region A), 548-776 
(Region 2), 777-847 (PCMb, Region B), 848-1090 
(Region 3), and 1091-1533 (Region C) (Fig. 2.26). When 
tethered, three segments repressed more efficiently than 
the N-terminus: region 1, 48% repression; region 2, 76% 
repression; and region 3, 68% repression (Fig. 2.29). 
PCMb did not repress while PCMa and region C 
repressed to lesser degree (24% and 26% repression) 
(Fig. 2.29). Therefore, multiple domains of Pum can 
independently 
repress an mRNA. We termed Regions 1, 2, and 
3 Repression Domains (RDs) for their ability to 
stimulate robust repression when tethered. 
2.3.3.6 Conserved motifs modify the activity 
of an autonomous Pum repression domain 
The role of PCMa and PCMb remained 
unclear. We reasoned that these domains may 
regulate Pum function. To investigate this idea, 
we created tethered constructs with one or both 
conserved motifs connected to a Pum repression domain (RD2, aa548-776) (Fig. 2.30). 
By itself, RD2 had maximal activity (Fig. 
2.30, 69% repression). When PCMa was 
fused to RD2 (A2, aa379-776), the activity 
remained robust (Fig. 2.30, 56% 
repression). Strikingly, when PCMb was 
fused to RD2 (2B, aa548-847), activity was 
completely lost (Fig. 2.30, 1% repression). 
In agreement with Fig. 2.29, PCMa and 
PCMb exhibited weak or no repression on 
their own (Fig. 2.30). When PCMb was 
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fused to RD3 (B3, aa777-1090), activity was also severely 
reduced (Fig. 2.31, 12% repression). Western blots 
confirmed protein expression (Fig. 2.30, 2.31). The data 
show that PCMb inhibits repression domains in Region 2 
and Region 3.  
We measured the activity of a segment containing 
PCMa, RD2, and PCMb; this construct (A2B, aa379-847) 
repressed the mRNA by 50% (Fig. 2.30). A similar 
restoration of repression is observed when PCMa is fused 
to a construct containing PCMb and RD3 (2B3, aa777-
1090 + aa379-547) (Fig. 2.32). Deletion of PCMa from the 
tethered N-terminus also leads to a small but significant 
decrease in repression (Fig. 2.29).  We speculate 
that PCMa may antagonize the negative 
regulatory function of PCMb, perhaps via auto-
inhibitory interactions.  
2.3.3.7 The N-terminal Pum repression 
domains reduce protein and mRNA levels 
Full length Pum reduces protein 
expression and mRNA levels with comparable 
efficiency (Fig. 2.8). We next tested the ability of 
individual Pum RDs to do the same. Using the tethered-
function approach, we measured the effect of the N-
terminus and C-terminus on luciferase protein and 
mRNA expression. Reduction of protein levels 
correlated with reduction of mRNA levels for both the full 
length protein (Fig. 2.33, Pum, 45% protein and 32% 
mRNA) and the C-terminus (Fig. 2.33, Region C, 10% 
protein and 6% mRNA). The N-terminus caused a 
substantially greater effect on protein expression than 
50 
 
mRNA (Region N, 32% protein and 9% mRNA, 
Fig. 2.33). When each N-terminal repression 
domain was tested, similar differences were 
observed for RD1 (42% vs 18%), RD2 (72% vs 
42%), and RD3 (62% vs 45%) (Fig. 2.34). This 
suggests that the N-terminal repression 
domains inhibit translation to a greater extent 
than they enhance mRNA degradation. 
2.3.3.8 N-terminal repression domains are 
conserved in human PUF proteins 
We hypothesized that the N-terminal repression domains of Pum may be 
conserved by other PUF proteins. Insect and vertebrate PUF proteins share a similar 
architecture including a highly conserved C-terminal RBD (>80% identical, Fig. 2.35) and 
N-terminal domains 
(Fig. 2.35) including 
PCMa and PCMb 
motifs (Fig. 2.35). We 
compared repression 
by the N-termini of 
human PUM1 (Hs 
PUM1-N; aa1-827) and 
PUM2 (Hs PUM2-N; 
aa1-704) to that of 
Drosophila Pum (Dm 
Pum-N) using the tethered-function assay (Fig. 2.36). All three proteins were expressed, 
as confirmed by western blotting (Fig. 2.36). Human PUM1-N and PUM2-N repressed 
RnMS2 reporter by 47% and 36%, respectively, comparable to the 35% repression 
caused by the N-terminus of Pum (Fig. 2.36). Next, we tested whether the regions of 
human PUM1 corresponding to Pum repression domains possessed autonomous 
repressive activity. When tethered, region 1 of human PUM1 (Hs PUM1-1; aa1-150) 
lacked repressive function (Fig. 2.37). However, PUM1 region 2 (HsPUM1-2, aa309-459) 
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and region 3 (HsPUM1-3, aa589-827) repressed 48% and 82%, respectively (Fig. 2.37). 
These results show that the N-termini of human PUFs contain potent repressive domains, 
indicating a conserved regulatory function.  
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2.4 Discussion 
Pum and Nos control important functions including development (Lehmann and 
Nusslein-Volhard 1987b; Lehmann and Nusslein-Volhard 1991; Wang and Lehmann 
1991), stem cell proliferation (Lin and Spradling 1997; Forbes and Lehmann 1998; 
Asaoka-Taguchi et al. 1999; Parisi and Lin 2000) and learning (Dubnau et al. 2003). 
Previous analyses of Pum and Nos function were restricted to mutant or transgenic 
Drosophila. The experiments presented in this work build upon these studies to elucidate 
the mechanism of regulation. We developed a reporter assay that recapitulates Nos 
dependent repression. Nos mRNA is not detectable in D.mel-2 cells (Fig. 2.4) (Cherbas 
et al. 2011), but exogenous expression of Nos confers potent repression of an mRNA 
bearing Hb NREs (Fig. 2.5 and 2.8). Pum is essential for Nos repression (Fig. 2.9) 
(Lehmann and Nusslein-Volhard 1991; Barker et al. 1992). Therefore, Nos activates Pum. 
Acting together, Nos and Pum inhibit protein expression and cause a corresponding 
decrease in mRNA level (Fig. 2.8). The data are consistent with Nos and Pum 
collaborating to repress Hb mRNA in the Drosophila embryo (Lehmann and Nusslein-
Volhard 1987b; Tautz 1988; Lehmann and Nusslein-Volhard 1991; Wharton and Struhl 
1991; Barker et al. 1992; Murata and Wharton 1995; Sonoda and Wharton 1999). 
Pum also represses independently of Nos (Fig. 2.12). Without Nos, endogenous 
Pum in D.mel-2 cells minimally represses the NRE-bearing reporter (Fig. 2.3); however, 
efficient repression was elicited by increasing the concentration of Pum (Fig. 2.12, Fig. 
2.14). A likely explanation is that the amount of endogenous Pum is insufficient to 
efficiently repress. Like Nos dependent repression, Pum potently decreased reporter 
protein and mRNA levels (Fig. 2.17). Several facts support the conclusion that Nos was 
not necessary for repression by Pum. First, Nos is not detectable in D.mel-2 cells. Also, 
RNAi of Nos did not affect Pum repression (Fig. 2.19). Furthermore, a mutation that blocks 
Nos binding to Pum (F1367S) did not alleviate repression (Fig. 2.18). Nos independent 
Pum repression is supported by observations that Pum regulates Bcd and CycB mRNAs 
in the anterior of Drosophila embryos, where Nos is below the limit of detection (Gamberi 
et al. 2002; Vardy and Orr-Weaver 2007). 
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The finding that Pum represses independently of Nos raises the question: what is 
the function of Nos? One logical answer is that Nos strengthens Pum repression. The 
observation that Nos activates endogenous Pum supports a model wherein Nos 
enhances the RNA binding activity of Pum. Indeed, the association of Nos with the RBD 
of Pum is sufficient for enhancement (Fig. 2.25). Previous work strengthens this 
hypothesis: Nos and Pum interact with each other and both associate with the NRE RNA 
through a network of protein-protein and protein-RNA interactions that may cooperate to 
enhance binding (Sonoda and Wharton 1999; Sonoda and Wharton 2001). The necessity 
of Nos could be obviated by increasing the level of Pum (Fig. 2.12), likely resulting from 
increased occupancy of the NRE reporter. Another hypothesis is that binding of Nos to 
Pum might displace a negative regulatory factor, resulting in activation of endogenous 
Pum. Nos may also collaborate with Pum to recruit co-repressors. The Nos-Pum-NRE 
complex is thought to recruit Brat and 4EHP to refine regulation of the Hb gradient 
(Sonoda and Wharton 2001; Cho et al. 2006). However, RNAi depletion of Brat and 4EHP 
did not abrogate Nos dependent repression (Fig. 2.10). We interpret this as evidence that 
Nos and Pum repress mRNAs through additional mechanisms (see below), with the 
caveat that residual Brat and 4EHP might be sufficient to support Nos dependent 
repression. As an alternative model, Nos and Pum may collaborate to recruit the Ccr4-
Not deadenylase complex through interactions with Not4 and Pop2 subunits, respectively 
(Kadyrova et al. 2007; Goldstrohm and Wickens 2008). These models are further 
addressed in Chapters 3 and 4. 
Potent Pum repression in the absence of Nos indicates that Pum independently 
inhibits protein expression and/or enhances mRNA decay. Involvement of known co-
repressors, Brat and 4EHP, is improbable because recruitment of these proteins depends 
on Nos (Sonoda and Wharton 2001; Cho et al. 2006). Furthermore, a mutant Pum 
(G1330D) that cannot bind Brat is fully active for Nos independent repression (Fig. 2.18). 
In addition, depletion of Brat by RNAi did not affect Pum repression (Fig. 2.19). These 
findings reveal that mechanisms other than Brat-4EHP mediated inhibition of 5’ cap 
dependent translation are utilized by Pum. Previous studies concluded that Brat, and 
therefore 4EHP, are dispensable for Pum repression in certain contexts. For instance, 
Pum repression of CycB in embryonic pole cells does not require Brat (Sonoda and 
56 
 
Wharton 2001; Kadyrova et al. 2007). Furthermore, while Brat is necessary for Pum 
repression in motor neurons, it is not essential in other neurons (Muraro et al. 2008). 
Finally, the G1330D mutant Pum, which is deficient for recruitment of Brat, is functional 
for regulation of dendritic morphology in sensory neurons (Ye et al. 2004). We do not 
dismiss the importance of Brat and 4EHP in embryonic development. Instead, these 
findings illustrate that while Brat and 4EHP facilitate repression of Hb in the embryo, in 
other contexts, Pum represses by other means. 
We identified Pum domains that mediate Nos independent repression. The Pum 
RBD has modest repressive activity compared to the full length protein (Fig. 2.14, 2.22, 
2.24), indicating that regions outside of the RBD must confer repressive activity. Previous 
analysis of the ability of Pum transgenes to rescue abdominal segmentation defects in a 
pum mutant embryo support this conclusion. Whereas over-expression of the Pum RBD 
partially rescued segmentation defects, the full length Pum fully restored proper 
embryonic development (Barker et al. 1992; Wharton et al. 1998). Indeed, we discovered 
three repression domains within the N-terminal two-thirds of Pum that provide the major 
repressive activity (Fig. 2.29). These unique RDs (i.e. aa1-378, 548-776, and 848-1090) 
do not share sequence homology. Each functions autonomously when tethered to mRNA 
(Fig. 2.29). Because all known Pum cofactors (i.e. Nos, Brat, 4EHP, and Pop2) interact 
with the RBD (Sonoda and Wharton 1999; Sonoda and Wharton 2001; Cho et al. 2006; 
Kadyrova et al. 2007), the N-terminal repression domains likely function through novel 
mechanism(s). While full length Pum affects both mRNA and protein levels almost equally 
(Fig. 2.8, 2.17), the individual repression domains affect protein expression more than 
mRNA levels (Fig. 2.33 and 2.34). This suggests translational inhibition may be their 
predominant function. 
The repressive function of the Pum N-terminus may be evolutionarily conserved. 
Sequence alignments indicated that the N-terminus of vertebrate PUMs, including human 
PUM1 and PUM2, are related to the Pum N-terminus (Fig. 2.35). When tethered, the N-
terminal portions of human PUM1 and PUM2 repressed, providing evidence that human 
PUFs are repressors (Fig. 2.36). Two regions in human PUM1 are autonomous 
repression domains (Fig. 2.37). These regions are small (Region 2, 152 amino acids and 
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Region 3, 240 amino acids), share 19% and 15% identity with Pum, and do not contain 
previously identified motifs. We propose that they may contact novel co-repressors, which 
remain to be identified. 
We compared the Pum N-terminus to other PUF proteins; no detectable 
relationship could be found with six S. cerevisiae PUFs or twelve C. elegans PUFs. 
Instead, these PUFs have evolved unique sequences, appended to their RBDs, whose 
function remains unknown. We also searched the non-redundant protein sequence 
database (www.ncbi.nlm.nih.gov) using the BLAST algorithm (Altschul et al. 1990) to 
identify protein sequences similar to the Pum N-terminus: no proteins, other than PUF 
family members, share homology. The broad implication is that members of the PUF 
family have evolved unique domains, appended to the evolutionarily conserved PUF 
repeat RNA binding module, which may confer unique regulatory activities to individual 
PUFs. Consistent with this idea, specific PUFs have been shown to affect translation, 
mRNA degradation, mRNA localization, and for one PUF, activation of target mRNAs 
(Olivas and Parker 2000; Tadauchi et al. 2001; Gu et al. 2004; Goldstrohm et al. 2006; 
Garcia-Rodriguez et al. 2007; Saint-Georges et al. 2008; Kaye et al. 2009; Chritton and 
Wickens 2010; Quenault et al. 2011). 
We identified two sequence motifs in the N-terminus of Pum, designated PCMa 
and PCMb, which are conserved between insect (e.g. Drosophila) and vertebrates (e.g. 
humans) (Fig. 2.35). PCMb encompasses a motif in Xenopus PUM2 proposed to interfere 
with cap-dependent translation (Cao et al. 2010). However, when tethered, PCMb does 
not repress (Fig. 2.29), nor does deletion of PCMb diminish Pum repression (Fig. 2.28). 
In addition, mutation of a PCMb tryptophan residue (W783) proposed to contact the 5’ 
cap (Cao et al. 2010) had no effect (data not shown). Therefore, we find no evidence that 
the putative cap binding motif of PCMb is important for Pum repression. Instead, PCMb 
negatively affects RD2 (aa548-776) and RD3 (aa848-1090) (Fig. 2.31). While PCMa had 
weak repressive activity on its own, it could counteract the inhibitory effect of PCMb (Fig. 
2.30) and deletion of PCMa caused a minor but significant drop in repression (Fig. 2.28). 
The precise roles of PCMa and PCMb remain to be determined; we speculate that they 
may have auto-regulatory functions. 
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We successfully programmed Pum to repress a new target mRNA. By changing 
the RNA recognition amino acids in the sixth PUF repeat of Pum from NYQ to SYE, the 
specificity was altered from uridine to guanosine, thereby conferring repression to an 
mRNA with an altered binding site (3xNRE UGG, Fig. 2.24). This experiment provides the 
proof-of-principle that PUF proteins with programmed RNA binding specificity can be 
engineered to repress new mRNAs. While programmed Pum fully represses its new 
target, a similarly programmed RBD lacks substantial activity (Fig. 2.24), further 
emphasizing the importance of the N-terminal repression domains. This finding has 
important implications for future engineering of PUFs. The Pum RBD provides a protein 
module with low intrinsic regulatory activity that can be programmed to bind new RNA 
sequences. Functional domains – either repression or activation domains - can be 
attached to this module to create novel RNA regulators. Consistent with this idea, a recent 
study reported that addition of splicing effector domains and a nuclear localization signal 
transformed a PUF RBD into a splicing regulator (Wang et al. 2009). 
An important question for future research is: how do the Pum repression domains 
function? A probable hypothesis is that the repression domains inhibit the translation 
machinery. Alternatively, the repression domains may activate enzymes that degrade 
mRNAs.  In future experiments, we seek to identify co-repressor(s) that interact with these 
domains. Also worth consideration is why Pum possesses multiple repression domains. 
These domains may recruit the same co-repressor, either acting redundantly or 
collaboratively. Alternatively, each repression domain could bind to a different co-
repressor, perhaps affecting different steps in the gene expression pathway (e.g. 
translation initiation or mRNA degradation). In this case, their individual repressive 
activities would collaborate to increase the efficiency of repression. Addressing these 
crucial questions will help reveal how Pum regulates mRNAs to control diverse biological 
functions.  
2.5 Materials and Methods 
Plasmids. To create pAc5.1 FF control, Firefly luciferase was PCR amplified from 
pGL4.13 (Promega) and inserted into plasmid pAc5.1/V5-His A (Invitrogen). Reporter 
plasmids were created by inserting the Renilla luciferase open reading frame with a 
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minimal 3’UTR into pAc5.1. This 3’UTR contains a multiple cloning site and cleavage and 
poly-adenylation signal from psiCHECK1 (Promega). To create the reporters, 
oligonucleotides encoding wild type NREs (Rn1xNRE and Rn3xNRE) or mutant NREs 
(Rn3xNREmut) were inserted into Xho1 and Not1 sites in multiple cloning site of pAc5.1 
Renilla luciferase. The NRE sequences, derived from Drosophila hunchback 
(NM_169234), are as follows (Pum site underlined, mutations bold):  
NRE (5’-UUGUUGUCGAAAAUUGUACAUAAGCCAA)  
NRE mutant (5’-UUCAUCACGAAAAUACAACAUAAGCCAA) 
NRE UGG (5’-UUGGUGGCGAAAAUUGGACAUAAGCCAA).   
The RnMS2 reporter plasmid for the tethered-function assays was created by 
inserting oligonucleotides containing two MS2 binding sites into the Xho1 and Not1 sites 
in the 3’UTR of pAc5.1 Renilla luciferase. The sequence of the tandem MS2 binding sites 
is: 5’AAAACATGAGGATCACCCATGTCTGCAGGTCGACTCTAGAAAACATGAG 
GATCACCCATGTC (stem-loops are underlined). Drosophila Pumilio (NP_731315.1) and 
the Pumilio RBD (aa 1091-1426) were amplified by RT-PCR from oligo-dT primed cDNA 
from S2 cells and inserted into pIZ/V5-His vector (Invitrogen). Nanos (NP_476658.1) was 
cloned from whole fly cDNA and also inserted into the pIZ/V5-His vector. Mutations in 
Pumilio and the RBD were created by Quickchange site-directed mutagenesis 
(Stratagene). RNA binding defective Pumilio and RBD were created by mutating amino 
acids S1342A, N1343A, E1346A of the seventh PUF repeat. Pumilio R6SYE mutants 
were created by mutating N1306S and Q1310E of the sixth PUF repeat. The Pumilio and 
RBD mutants F1367S or G1330D were also created by site-directed mutagenesis. To 
create defective Nanos mutant, amino acid C354Y was mutated by site-directed 
mutagenesis. For the tethered-function expression vectors, DNA encoding MS2 coat 
protein was amplified from the pLexA N55K three-hybrid vector and fused in-frame to the 
N-terminus of Pumilio. Control plasmid pIZ MS2 was created by inserting MS2 coding 
sequence into the pIZ plasmid. The control pIZ-HT plasmid was created by inserting the 
HaloTag (Promega) ORF into pIZ plasmid. Brat (NP_476945.1) or 4EHP (NP_788729.1) 
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coding sequences were amplified from S2 cell cDNA and inserted into pIZ-HT to create 
HT-Brat and HT-4EHP. 
Cell culture.  D.mel-2 cells (Invitrogen) were cultured in Sf-900™ III serum-free media 
(Invitrogen) with 5mL/L Penicillin-Streptomycin using standard cell culture techniques. 
Cells were grown at 28°C. 
Transfections. D.mel-2 cells were transfected with plasmid DNA using Effectene (Qiagen) 
according to manufacturer’s specifications. Unless otherwise noted, standard transfection 
conditions of 2.2mL per well of a 6-well plate are as follows:  1.6mL D.mel-2 cells 
(1.5x106cells/mL), 600µl Sf900™ III media, 10ng of Renilla reporter plasmid DNA, 5ng 
firefly control plasmid DNA, and Effectene. For transfection of Pumilio expression vectors, 
400ng of DNA was used unless otherwise noted in the figures. For Nanos expression, 
10ng was the standard amount, unless otherwise noted. Cells were harvested for dual 
luciferase assay, western blotting, TMR labeling and fluorescence detection, and qRT-
PCR after two days of growth following transfection. Where necessary, total DNA 
transfected in each sample was held constant by balancing transfection with empty pIZ 
vector. 
RNA interference. Double stranded RNAs corresponding to each target gene were 
generated by in vitro transcription from DNA templates. The templates were created by 
PCR amplification of regions of 250-600bp of open reading frame from either plasmid 
vectors or cDNA from D.mel-2 cells. Both forward and reverse PCR primers had T7 
promoters appended. Oligos used are listed below with T7 sequence underlined and gene 
specific sequence in bold: 
LacZ control 
Forward Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGTGACGTCTCGTTGCTGCATAAAC   
Reverse Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGGGCGTTAAAGTTGTTCTGCTTCATC 
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Pumilio 
Forward Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGGTCAAGGATCAGAATGGCAATCATGT   
Reverse Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGCTTCTCCAACTTGGCATTGATGTGC 
Nanos 
Forward Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGCATTCCACTCGCCACCCACTGG   
Reverse Primer:  
5’-
dGGATCCTAATACGACTCACTATAGGGCTAAACCTTCATCTGTTGCTTGTAGTAAC 
Brain Tumor - 1 
Forward Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGCAGATCTTCGACAAGGAGGGACG   
Reverse Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGCATACCCACTGGCGCCAGTTGG 
Brain Tumor - 2 
Forward Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGCAACGAGCTGAACGAGACGCACC   
Reverse Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGGGTGTGACTGTTGGTGGTGGCC 
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4EHP - 1 
Forward Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGCGATGCTCGGGGAGCAGTTCC   
Reverse Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGCAATGGGCCTTTATTAATTGAAACATA 
4EHP - 2 
Forward Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGGCAGTACGAGACGAAAAACTGGCC   
Reverse Primer:  
5’-dGGATCCTAATACGACTCACTATAGGGCGACCATGTGCAGCGACTTGC 
From each PCR template, dsRNA was transcribed in vitro with T7 RiboMAX Large 
Scale RNA Production System (Promega), treated with TURBO DNase (Ambion) for 3 
hours, and purified using the SV Total RNA Isolation System (Promega). For knockdown 
of each gene’s expression, 6µg of dsRNA per well of a 6-well plate was added to cells 10 
minutes before transfection of reporters and expression vectors. 
Luciferase Assays. Luciferase assays were performed two days post-transfection. To do 
so, 100µl of transfected D.mel-2 cells were plated into three or four wells of a 96-well 
plate. Firefly and Renilla luciferase expression was measured using the Dual-Glo 
Luciferase Assay (Promega) according to the manufacturer’s specifications and the 
GloMax Multi+ Detection System (Promega) Luminometer. The measured relative light 
units (RLU) were used to calculate a relative response ratio (RRR) using the equation 
RRR = Renilla RLU/Firefly RLU. Response ratios are displayed normalized to mutant 
controls (set to 100). A percent repression value was then calculated as Percent 
Repression = 100x(1-RRRvariable/RRRmutant). For Nanos-stimulated repression, RRRmutant 
corresponds to the Nanos C354Y mutant. For Pumilio repression, Pumilio mutR7 
(S1342A, N1343A, E1346A) was used as the mutant control. For RNAi treated samples, 
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percent repression was calculated for each sample relative to the negative control Pum 
mutR7 treated with LacZ control dsRNA using the equation Percent Repression = 100x(1-
RRRvariable/RRRcontrol). To measure activation of the Pumilio RBD R6SYE by Nanos, the 
RRRmutant control was measured from cells expressing RBD mutR7. Displayed response 
ratios and percent repression in the tethered-function assay was determined relative to 
the control samples expressing MS2CP from the pIZ MS2CP plasmid, using the equation 
Percent Repression = 100x(1-RRRvariable/RRRMS2CP). To measure experimental error, we 
calculated standard error of the mean (SEM) from triplicate or quadruplicate samples in 
each experiment. The reported SEMs are from technical replicates and are representative 
of multiple biological replicates performed at different times from different cell populations. 
Data were analyzed using Microsoft Excel. A graph of Pumilio repression relative to fold 
over-expression was created using the GraphPad Prism software. 
Western blotting. For western blotting analysis, 1mL aliquots were taken from the same 
transfected D.mel-2 samples used for dual luciferase expression analysis.  Two days 
post-transfection, cells were centrifuged at 1000xg for 3 minutes and pellets were lysed 
for one hour on ice in lysis buffer (0.5% Igepal CA-630 (USB), 50mM Tris-HCl pH 8.0, 
0.5mM EDTA, 2mM MgCl2, 150mM NaCl, 20nM PMSF, 1µg/mL Aprotinin, 1µg/mL 
Pepstatin, 1µg/mL Leupeptin). Lysates were cleared by centrifugation at 16,000xg for two 
minutes, and supernatants were saved as whole cell protein extracts.  Extracts were 
separated via SDS polyacrylamide (12%) gel electrophoresis (Tris-Glycine running 
buffer) and proteins were transferred onto Immobilon-FL PVDF membranes (Millipore). 
Membranes were blocked in blocking buffer (PBS, 5% milk, 0.01% Tween 20), probed 
with V5-antibody (Invitrogen), washed in buffer, probed with HRP-conjugated goat anti-
mouse IgG (Thermo Scientific), washed again, covered in ECL Western Blotting Reagent 
(Pierce), and imaged (luminescence) on autoradiography film. 
Fluorescent labeling and visualization of HaloTag protein constructs. Protein extracts 
from HaloTag expression cells were harvested as above and mixed with HaloTag TMR 
Ligand (900nM final) for 30 minutes on ice in the dark.  After labeling, extracts were 
separated via SDS polyacrylamide (4-20%) gel electrophoresis (Tris-Glycine running 
buffer) and protein fluorescence (532 Ex/580 Em) was measured with a Typhoon Trio+ 
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Imager (GE Healthcare). Relative fluorescence was quantified using ImageQuant TL 
software (GE Healthcare).  
RNA isolation and cDNA preparation. For isolation of RNA, 1mL of transfected D.mel-2 
cells was centrifuged at 1000xg for 3 minutes, washed twice in PBS, and lysed with 
QIAzol reagent (Qiagen) according to the manufacturer’s specifications.  Upon ethanol 
precipitation and resuspension, whole cell RNA was treated with TURBO DNase 
(Ambion) for 3 hours. For isolates prepared from the tethered-function assay, RNA was 
purified from cell pellets using Maxwell LEV simplyRNA Cells (Promega). RNAs were 
primed with random hexamers (IDT) for synthesis of cDNAs using the GoScript Reverse 
Transcriptase (Promega). The final concentration of RNA in RT reactions was 60ng/µl.  
Quantitative PCR. To measure endogenous mRNA levels, quantitative PCR was 
performed on 5µl of cDNA product in a 50µl reaction using 100nM of specific primers and 
GoTaq qPCR Master Mix (Promega). To measure Firefly and Renilla luciferase mRNAs, 
multiplexed qPCR was performed in 25µl reactions with 200nM fluorescent primers 
(Biosearch Technologies) and Plexor® Master Mix (Promega).  Reactions were 
performed with a C1000 thermal cycler equipped with the CFX96 Real-Time System (Bio-
Rad). Standard control reactions were performed without reverse transcriptase or without 
RNA template. For GoTaq reactions, cycling conditions were performed using the 
following sequence of steps: 1) 95°C for 3 min, 2) 95°C for 10 sec, 3) 65°C for 30 sec, 4) 
72°C for 40 sec, with steps 2–4 repeated for 40 cycles.  For Plexor reactions: 1) 95°C for 
2 min, 2) 95°C for 5 sec, 3) 60°C for 35 sec, with steps 2–3 repeated for 40 cycles.  In the 
case of Figure 2.4, GoTaq qRT-PCR was performed for 30 cycles and products were 
visualized by 0.8% agarose gel electrophoresis. Each qPCR reaction was analyzed via a 
thermal melting curve and gave a single peak with the expected melting temperature. 
Amplification efficiencies of each primer set were optimized. Plexor primers were 
optimized at 100% for the Plexor qPCR protocol, while all other primers had efficiencies 
between 90-110% with 65°C elongation steps. 
Cycle thresholds (Ct) were measured using CFX Manager software (Bio-Rad) for 
GoTaq reactions, while the raw data were imported into Plexor Analysis Desktop 
(Promega) for Plexor® reactions. Differences in mRNA levels were calculated using the 
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ΔΔCt method. For analysis of RNAi depletion of endogenous mRNAs (i.e. Pumilio, Nanos, 
Brain Tumor, and 4EHP), Ct values were measured and normalized to the internal control 
Rpl32 mRNA for each sample using the equation: ΔCt target RNAi = Ct target – Ct control. A 
normalized ΔCt control RNAi was also calculated for each mRNA in the LacZ dsRNA treated 
samples. To measure relative changes in each mRNA level, ΔΔCt was calculated for each 
gene as ΔΔCt = ΔCt target RNAi – ΔCt control RNAi. The fold change in mRNA level was then 
calculated as 2-ΔΔCt.  For the measurement of reporter mRNA levels, the same method 
was used but the normalizations were calculated relative to the internal control Firefly 
mRNA (FF control). The ΔCt for each sample was calculated as ΔCt = Ct Renilla – Ct firefly. 
To measure changes in reporter mRNA levels induced by Pumilio or Nanos, ΔΔCt was 
calculated as ΔCt WT – ΔCt mutant where “mutant” refers to samples expressing RNA binding 
defective Pumilio (mutR7) or Nanos (C354Y), as indicated in the figure legends. The fold 
change was then calculated from 2-ΔΔCt. Relative changes in reporter ratios were 
represented as normalized to the mutant controls (set to 100). Percent repression values 
were derived using the equation: Percent Repression = 100x(1-fold change). 
 
qPCR primer sequences. 
Firefly Luciferase Reporter 
Forward Primer: 5’-dGATCCTCAACGTGCAAAAGAAGC       
Reverse Primer: 5’-d FAM-isoC-TCACGAAGGTGTACATGCTTTGG     
Renilla Luciferase Reporter 
Forward Primer: 5’-d CAL Fluor Orange 560-isoC-CGCAACTACAACGCCTACCTTC 
Reverse Primer: 5’-dCCCTCGACAATAGCGTTGGAAAA 
Rpl32 
Forward Primer: 5’-dGCCCAAGGGTATCGACAACAG         
Reverse Primer: 5’-dGCACGTTGTGCACCAGGAAC 
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Pumilio 
Forward Primer: 5’-dGCCTGATGACCGATGTCTTTGG 
Reverse Primer: 5’-dCGATTTCCTGCTGCTGCTCC 
Nanos 
Forward Primer: 5’-dCTGGCTCGATGCAGGATGTG 
Reverse Primer: 5’-dGTCTGCAGCTGGGCAGGATT 
Brain Tumor 
Forward Primer: 5’-dCAACTACAGACGGGCATTCAGG        
Reverse Primer: 5’-dGCCCGAATGTAACCAAAGGTG 
4EHP 
Forward Primer – 5’-dCCAGCGTGCAGCAGTGGTGG 
Reverse Primer – 5’-dCAAACGTTCTCCCAGGCCCG 
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CHAPTER 3 
 
MECHANISMS OF mRNA REPRESSION BY THE PUF RNA 
BINDING DOMAIN 
Portions of the work presented in this chapter were originally published as:  
 
“The RNA binding domain of Pum antagonizes poly-adenosine binding protein and 
accelerates deadenylation”  
 
RNA August 2014. 20: 1298-1319 
Authors: Chase A. Weidmann, Nathan A. Raynard (Figures 3.6, 3.27, and 3.28), Nathan 
H. Blewett (Figures 3.15 and 3.17), Jamie Van Etten (Figure 3.3), and Aaron C. 
Goldstrohm 
3.1 Abstract 
Pumilio and Fem-3 Binding Factor (PUF) proteins are potent repressors that serve 
important roles in stem cell maintenance, neurological processes, and embryonic 
development. These functions are driven by PUF protein recognition of specific binding 
sites within the 3’ untranslated regions (UTRs) of target mRNAs. In this study, we 
investigated mechanisms of repression by the founding PUF, Drosophila Pumilio (Pum), 
and its human orthologs. Here we evaluated a previously proposed model wherein the 
Pum RNA Binding Domain (RBD) binds Argonaute which in turn blocks the translational 
activity of the eukaryotic elongation factor 1A (eEF1A). Surprisingly, we found that 
Argonautes are not necessary for repression elicited by Drosophila and human PUFs in 
cells. A second model proposed that the RBD of Pum represses by recruiting 
deadenylases to shorten the mRNA’s poly-adenosine (poly(A)) tail.  Indeed, the RBD 
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binds to the Pop2 deadenylase and accelerates deadenylation; however, this activity is 
not crucial for regulation. Rather, we determined that the poly(A) is necessary for 
repression by the RBD. Our results reveal that poly(A) dependent repression by the RBD 
requires the poly(A) binding protein, pAbp. Furthermore, we show that repression by the 
human PUM2 RBD requires the pAbp ortholog, PABPC1. Pum associates with pAbp but 
does not disrupt association of pAbp with the mRNA. Taken together, our data support a 
model wherein the Pum RBD antagonizes the ability of pAbp to promote translation. Thus 
the conserved function of the PUF RBD is to bind specific mRNAs, antagonize pAbp 
function and promote deadenylation. 
3.2 Introduction 
Protein expression is controlled at multiple levels including translation and mRNA 
stability (Garneau et al. 2007; Jackson et al. 2010; Schwanhausser et al. 2011). For 
example, the efficiency of mRNA translation is promoted by the 5’ 7-methyl guanosine 
cap and the 3’ poly(A) tail, which are respectively recognized by the eukaryotic initiation 
factor 4F complex, eIF4F, and the poly(A) binding protein, pAbp (Jackson et al. 2010). 
Enzymatic removal of the poly(A) tail (i.e. deadenylation) and 5’ cap (i.e. decapping)  can 
antagonize translation and initiate mRNA degradation  (Goldstrohm and Wickens 2008; 
Li and Kiledjian 2010).  
Translation and mRNA stability are controlled by interaction of trans-acting 
regulators with cis-acting RNA elements. A prototypical example of these regulators is 
the PUF family of proteins, named after founding members Drosophila melanogaster Pum 
and Caenorhabditis elegans Fem-3 Binding Factor (FBF) (Wickens et al. 2002). PUFs 
are present in all eukaryotes and share a conserved RNA binding domain (RBD) 
composed of eight repeated motifs. The RBD binds with high affinity and specificity to 8-
10 nucleotide regulatory sequences that are predominantly found in 3’UTRs of mRNAs 
(Zamore et al. 1997; Zamore et al. 1999; Wang et al. 2002; Lu et al. 2009). PUF binding 
sites are prevalent in the transcriptome and hundreds of mRNAs copurify with individual 
PUFs (Gerber et al. 2004; Gerber et al. 2006; Galgano et al. 2008; Morris et al. 2008; 
Hafner et al. 2010). As a consequence, the impact of PUFs on gene expression is likely 
substantial. Analysis of the biological functions of PUFs supports this idea: they control 
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diverse functions including development, fertility, cell proliferation, and neurological 
processes (Lehmann and Nusslein-Volhard 1987; Lin and Spradling 1997; Zhang et al. 
1997; Forbes and Lehmann 1998; Asaoka-Taguchi et al. 1999; Crittenden et al. 2002; 
Dubnau et al. 2003; Mee et al. 2004; Ye et al. 2004). 
PUF proteins repress target mRNA expression by inhibiting translation and/or 
inducing mRNA degradation (Miller and Olivas 2011), but the mechanisms and cofactors 
involved remain to be fully elucidated.  Results discussed in Chapter 2 revealed that 
human and Drosophila PUFs possess multiple domains that contribute to repression 
(Weidmann and Goldstrohm 2012). For all PUFs studied to date, the conserved RBD 
contributes to repression; therefore, we focused on dissecting the mechanism of 
repression by the RBDs of Drosophila Pum and human PUFs, PUM1 and PUM2. To do 
so, we used recently developed assays that specifically measure their ability to repress 
target mRNAs (Van Etten et al. 2012; Weidmann and Goldstrohm 2012).  
Multiple mechanisms have been proposed to account for repression by the RBD. 
Initially, the repressive activity of the Pum RBD was thought to depend on two partners, 
Nanos and Brain Tumor; however, our results revealed that they are not essential for Pum 
mediated repression (Weidmann and Goldstrohm 2012). Early research in multiple 
organisms found that PUF repression correlated with shortening of the poly(A) tail of 
target mRNAs (Ahringer et al. 1992; Wreden et al. 1997; Olivas and Parker 2000; 
Chagnovich and Lehmann 2001). Subsequently, the RBD of PUFs from S. cerevisiae, 
Drosophila, C. elegans, and human were shown to bind orthologs of Pop2, a deadenylase 
enzyme that shortens the poly(A) tail of mRNAs in a 3’ to 5’ direction, indicating a 
conserved role for the RBD in deadenylase recruitment to target mRNAs (Goldstrohm et 
al. 2006; Kadyrova et al. 2007; Suh et al. 2009; Van Etten et al. 2012). In addition, Pop2 
forms a heterodimer with another deadenylase, Ccr4, as a part of the Ccr4-Not 
deadenylase complex (Goldstrohm and Wickens 2008). These facts support a model in 
which the PUF RBD represses mRNAs by recruiting deadenylases to enhance the rate 
of poly(A) tail shortening. Consistent with this model, functional data from yeast and 
humans demonstrate that deadenylases contribute to the efficiency of PUF repression 
(Goldstrohm et al. 2006; Goldstrohm et al. 2007; Hook et al. 2007; Van Etten et al. 2012). 
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Because the poly(A) tail plays a pivotal role in translation through the action of pAbp (Kuhn 
and Wahle 2004; Jackson et al. 2010), PUF enhanced shortening of the poly(A) tail could 
reduce synthesis of the encoded protein and/or promote mRNA decay. In the research 
presented here, we measured the impact of deadenylases, the poly(A) tail, and pAbp in 
the mechanism of repression by Pum. 
A recent study proposed, based on biochemical data, that PUF RBDs can inhibit 
translation by blocking polypeptide elongation (Friend et al. 2012). The RBD of the C. 
elegans PUF, FBF, was found to bind the CSR-1 protein, one of 27 nematode Argonaute 
orthologs (Wedeles et al. 2013). Together, FBF and CSR-1 were reported to interact with 
the translation elongation factor, eEF1A, and inhibit its GTPase activity, which is essential 
for translation. This mechanism may apply to the RBD of human PUMs as well (Friend et 
al. 2012). Like FBF, PUM2 bound to Argonaute orthologs and eEF1A and specific 
mutations of conserved phenylalanine and threonine residues were reported to disrupt 
PUM2 binding to eEF1A and Argonautes, respectively. In vitro translation assays using a 
rabbit reticulocyte extract provided functional evidence that the PUM2 RBD inhibits 
translation. Wild-type PUM2 RBD impeded translation whereas PUM2 RBD mutants, 
defective for binding to eEF1A or Argonautes, had no repressive effect. Given that the 
amino acids that mediate interaction with eEF1A and Argonautes are conserved in the 
RBDs of PUFs, this could be a conserved mechanism (Friend et al. 2012). In this report, 
we examine the role of Argonaute proteins in PUF repression in vivo. 
In the present study, we scrutinized the mechanisms that underlie repression 
mediated by the RBDs of Drosophila and human PUFs. Our results indicate that the PUF-
Argonaute interactions are not required for PUF mediated repression of protein 
expression. Instead, we find repression by the Pum RBD is completely dependent on the 
poly(A) tail. The RBD promotes deadenylation, dependent on the Pop2 and Ccr4 
deadenylase enzymes, and interacts with Pop2. However, while blocking deadenylation 
stabilizes the mRNA, it does not prevent repression of protein synthesis. We find that the 
crucial mechanism of RBD mediated repression depends on the poly(A) binding protein, 
pAbp. Consistent with these observations, the Pum RBD associates with pAbp. Together 
our data support a mechanism wherein the Pum RBD targets pAbp to interfere with its 
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ability to promote translation. The RBD does not displace pAbp from the mRNA, but 
instead antagonizes its ability to promote translation. Upon triggering repression of protein 
synthesis, deadenylation occurs as a subsequent effect. Finally, our data reveal that the 
additional Pum repression domains inhibit protein expression by a pAbp and poly(A) 
independent mechanism. 
3.3 Results 
3.3.1 PUFs and Argonautes 
3.3.1.1 Mutations in the Argonaute and eEF1A binding motifs do not alter PUF 
Repression 
We first tested the requirement of a PUF-Argonaute-eEF1A interaction using a 
mutational approach and cell-based reporter assays that we previously developed to 
measure PUF repression by Drosophila and human PUFs (Van Etten et al. 2012; 
Weidmann and Goldstrohm 2012). A PUF responsive reporter gene was created by 
inserting three copies of the Pum Response Element (PRE) into the 3’UTR of a Renilla 
luciferase gene to create RnLuc 3xPRE. Mutations within the RBD of C. elegans FBF and 
human PUM2 have been identified that abolish binding to Argonaute and eEF1A but do 
not affect RNA binding, as measured by in vitro binding assays (Friend et al. 2012). 
Alignment of C. elegans, 
human, Drosophila, and 
S. cerevisiae PUFs 
revealed that a threonine 
residue required for 
Argonaute-binding and 
the phenylalanine 
residue required for 
eEF1A-binding are 
conserved throughout 
PUFs (Fig. 3.1) (Friend 
et al. 2012). Interestingly, the Argonaute binding threonine is conserved in S. cerevisiae 
PUFs, though Argonautes are not present in this species (Meister 2013). Conservation of 
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these residues in Drosophila and 
human PUFs indicated that our 
functional assay could be used to 
assess their roles in repression. We 
created mutant versions of human 
PUM1 and PUM2 that correspond 
to the previously identified 
mutations that disrupt binding to 
Argonautes (T874E of PUM1; 
T752E of PUM2) or eEF1A (F990R 
of PUM1; F866R of PUM2) and tested their ability to repress the Renilla luciferase 
reporter in human cells (Friend et al. 2012). Because endogenous PUM1 and PUM2 in 
HEK293 cells repress the RnLuc 3xPRE reporter, we modified the PRE sequences (Fig. 
3.2, RnLuc 3xPRE UGG) so that only exogenously introduced PUF proteins with altered 
RNA binding specificity (Fig. 3.2, PUM1 R6as or PUM2 R6as) can regulate the reporter, 
as previously described (Van Etten et al. 2012). When expressed in human cells, the 
altered specificity PUM1 and PUM2 
repressed the RnLuc 3xPRE UGG 
reporter by 62% and 64%, 
respectively, relative to the negative 
control, Halotag (Fig. 3.3). When 
mutations in the Argonaute or eEF1A 
binding sites were introduced into the 
altered specificity PUFs (PUM1 
T874E or F990R; PUM2 T752E or 
F866R), their capacity for repression 
was not compromised (Fig. 3.3), 
indicating that these binding 
interfaces are not required for 
repression by human PUMs in living 
cells.  
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We next assessed the 
role of Argonaute and eEF1A 
binding residues in repression 
by Drosophila Pum. The level of 
endogenous Pum in Drosophila 
D.mel-2 cells is insufficient to 
efficiently repress RnLuc 
3xPRE (Fig. 3.4); yet, moderate 
over-expression of Pum causes 
repression (Van Etten et al. 
2012; Weidmann and 
Goldstrohm 2012). This system provides an excellent means of studying Pum structure 
and function. Full-length Drosophila Pum (Fig. 3.4, Pum FL) potently repressed the PRE-
bearing reporter, whereas the Pum RBD repressed to a lesser degree (Weidmann and 
Goldstrohm 2012). Mutations that inactivate Pum RNA binding activity (Fig. 3.4, Pum 
mutR7), or change the PRE, completely blocked repression (Weidmann and Goldstrohm 
2012). Using this approach, we tested the 
activity of Pum with mutations in the predicted 
Argonaute (T1137E) and eEF1A (F1251R) 
binding residues by measuring repression of 
RnLuc 3xPRE (Fig. 3.4). Full-length Pum 
T1137E retained the repression activity of 
wild-type Pum (Fig. 3.5, Pum FL WT at 73% 
repression vs. Pum FL T1137E at 74% 
repression) and Pum F1251R repressed at 
slightly below wild-type level (Fig. 3.5, Pum FL 
F1251R, 61% repression). We considered that 
the repressive activity of Pum’s RBD might be 
obscured by additional repression domains 
that we previously identified in the amino-
terminus of the protein (Weidmann and 
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Goldstrohm 2012). Therefore, we tested the effect of these mutations on the activity of 
the RBD (Fig. 3.4). Wild-type Pum RBD, RBD T1137E, and RBD F1251R all repressed 
between 30% and 34% (Fig. 3.5). We conclude that these conserved residues are not 
necessary for repression by full length Pum or the conserved RBD.  
3.3.1.2 Argonaute associates with human and Drosophila PUFs 
The lack of detectable functional impact of mutation of the Argonaute binding 
residues of Drosophila and human PUFs compelled us to assess whether the mutations 
did indeed prevent this association. HEK293 cells were transfected with FLAG-tagged 
AGO1 and Halotag fusions of either wild- type or the T752E mutant PUM2. AGO1 was 
selected because it was reported to bind strongly (Friend et al., 2012). Halotag alone was 
used as a negative control and a Halotag fusion of CNOT6L, a deadenylase known to 
associate with Argonaute, served as a positive control (Fabian et al. 2009). Complexes 
were purified using a FLAG antibody from RNase-treated cell extracts. PUM2 and 
CNOT6L co-immunoprecipitated with FLAG-AGO1 but were not detected in the mock 
eluates (Fig. 3.6, compare lanes 14 and 16 to lanes 10 and 12). These findings are 
consistent with biochemical data of Friend et al (2012) but, surprisingly, we detect robust 
association between the PUM2 T752E mutant and AGO1 (Fig. 3.6, lane 15).  
We also 
assessed binding of 
Drosophila Pum to 
Argonaute and the 
effect of the equivalent 
T1137E mutation. V5 
epitope-tagged Pum 
RBD, fused to Halotag, 
was purified from 
RNase-treated D.mel-2 
cell extracts that co-
expressed FLAG-
tagged Ago2 and the negative control protein, myc-tagged Lsm11. After washing, bound 
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complexes were eluted by cleavage of 
the Halotag-Pum RBD fusion with TEV 
protease. Ago2 co-eluted with Pum RBD 
whereas Lsm11 did not (Fig. 3.7, lane 5). 
This was true for Drosophila Ago2, but 
no interaction between Pum and Ago1 
was detected (data not shown). This 
result provides evidence that Drosophila 
Pum, like C. elegans FBF and human 
PUM2, associates with Argonaute. 
However, the Pum T1137E mutation did 
not disrupt binding of Pum to Ago2 (Fig. 
3.7, lane 6). Further, an alanine 
substitution, T1137A, also possessed 
wild-type repression activity and bound 
Ago2 (data not shown). In summary, our data show that mutations reported to abrogate 
PUF interaction with Argonaute do not effect repression or Argonaute association. 
3.3.1.3 The repression and Argonaute binding 
activities of the Pumilio RNA binding domain can 
be separated 
 Because mutation of the residues purported to 
mediate PUF binding to Argonaute did not in fact 
prevent the interaction, we sought an alternative way 
to assess the functional relevance to Pum repression. 
The tethered function assay provided an ideal means 
to dissect the regions of the RBD necessary for 
Argonaute binding and repression (Coller and 
Wickens 2002). In this assay, regions of Pum were 
fused to the phage protein MS2 which binds specific 
RNA stem-loop structures in the 3’UTR of a Renilla 
reporter gene (Fig. 3.8, RnLuc MS2). The regions of 
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the RBD necessary for association 
with Ago2 and for repression of 
RnLuc MS2 were mapped via a 
series of truncations with C-terminal 
V5 epitope tags (Fig. 3.8). These 
proteins were expressed in D.mel-2 
cells with FLAG-tagged Ago2. Anti-
FLAG immunoprecipitations were 
then performed from RNase-treated 
cell extracts. The RBD and a C-
terminal truncation (ΔC) both copurified with FLAG-Ago2 (Fig. 3.9, lanes 6 and 7), but the 
ΔR1-2, ΔR4-5, ΔR7-8 deletions of the PUF repeats prevented the RBD-Ago2 interaction 
(Fig. 3.9, lanes 8-10), indicating that multiple PUF repeats are necessary to contact Ago2. 
Having identified Pum truncations that no longer bind Ago2, we next tested their 
repressive activity in the tethered function assay (Fig. 3.10). We found that the RBD, ΔC 
and ΔR7-8 each repressed the RnLuc MS2 reporter; however, neither ΔR4-5 nor the 
ΔR1-2 were active (Fig. 3.10). 
Expression of each protein was verified 
by western blotting (Fig. 3.9, lanes 1-5). 
Most significantly, the tethered region 
lacking PUF repeats 7 and 8 (ΔR7-8) 
was active for repression though it did 
not bind Ago2 (Fig. 3.9 and 3.10). 
Based on this analysis, we can 
conclude that the interaction between 
Pum and Ago2 is dispensable for 
repression by the RBD. 
3.3.1.4 Depletion of Argonaute proteins does not hinder PUF repression in cells 
We further tested the requirement for Argonautes in repression by Pum by 
depleting Argonautes using RNA interference (RNAi). Efficient RNAi was demonstrated 
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by the depletion of over-expressed Ago1 and Ago2 
proteins (Fig. 3.11). We also confirmed RNAi 
depletion of endogenous Argonautes by quantitative 
Reverse Transcriptase coupled with Polymerase 
Chain Reaction (qRT-PCR); Ago1 and Ago2 mRNA 
levels were depleted by up to 70% and 86%, 
respectively (Fig. 3.12). In cells treated with non-
targeting control dsRNA (NTC), Pum FL repressed 
RnLuc 3xPRE mRNA by 70% and the 
Pum RBD repressed by 24% (Fig. 
3.12, NTC), consistent with our 
previous findings (Weidmann and 
Goldstrohm 2012). Depletion of either 
Argonaute, Ago1 or Ago2, did not 
affect repression by Pum FL or the 
Pum RBD (Fig. 3.12, Ago 1, Ago2) nor 
did simultaneous knockdown of both 
Ago1 and Ago2 (Fig. 3.12, 
Ago1/Ago2). Therefore, depletion of 
Argonautes does not affect Pum 
repression in cells.  
We also measured the effect of 
Argonaute depletion on the repressive activity of the human PUM1 in D.mel-2 cells. PUM1 
achieved 53% repression in cells treated with the non-targeting control dsRNA (Fig. 3.13), 
consistent with our previous observation (Van Etten et al. 2012). Efficient depletion of 
Ago1, Ago2, or both did not alleviate PUM1 mediated repression (Fig. 3.13). Thus, like 
Drosophila Pum, human PUM1 is able to efficiently repress a PRE-containing mRNA 
when Argonautes are depleted. It is notable that, because eEF1A is an essential 
translation factor, it was not feasible to test its role in PUF repression using RNAi; 
however, because the eEF1A interaction with the RBD was Argonaute-dependent (Friend 
et al. 2012) and Argonaute is not necessary, this point is likely inconsequential.   
83 
 
Finally, we measured the effect of 
Argonaute depletion on the regulation of an 
mRNA bearing the 3’UTR from a natural Pum 
target. Well-characterized targets of Pum, such 
as the mRNA encoding the morphogen 
Hunchback, are not expressed in D.mel-2 cells; 
therefore, we appended the 3’UTR of the 
Hunchback mRNA to a Renilla luciferase 
reporter (Fig. 3.14, RnLuc Hb 3’UTR). To 
assess the effect of endogenous Pum and 
Argonaute on RnLuc Hb 3’UTR expression, 
we performed RNAi with non-targeting control 
dsRNA, or dsRNA targeting Pum, or dsRNA 
targeting both Ago1 and Ago2. When Pum was 
depleted, the RnLuc Hb 3’UTR reporter 
expression increased by about 2-fold (Fig. 
3.14). In contrast, no effect on RnLuc Hb 
3’UTR expression was detected when Argonautes were depleted (Fig. 3.14). We 
conclude that endogenous Pum represses the Hb 3’UTR reporter, but Argonautes are not 
required for this effect.  
3.3.2 Mechanisms of repression by the PUF RNA binding domain 
3.3.2.1 The RBD of Pum enhances deadenylation dependent on the Pop2 and 
Ccr4 deadenylases 
The data reported above demonstrate that interaction with Argonautes is not 
necessary for RBD mediated repression. Consequently, alternative mechanisms(s) must 
account for the observed PUF mediated repression in vivo. In several model systems 
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PUF repression correlates with shortening of the poly(A) tail of target mRNAs; therefore, 
we next measured the effect of the Pum RBD on deadenylation (Ahringer et al. 1992; 
Wreden et al. 1997; Olivas and Parker 2000; Chagnovich and Lehmann 2001; Gamberi 
et al. 2002; Goldstrohm et al. 2006). We investigated the ability of the wild-type and mutR7 
Pum RBD to affect poly(A) tail length of the RnLuc 3xPRE reporter using a transcriptional 
shutoff strategy (Fig. 3.15). RNA samples were collected at specific time points following 
inhibition of synthesis with Actinomycin D. To measure poly(A) tail length, the 3’ end of 
the RnLuc 3xPRE mRNA was liberated by RNase H cleavage with a specific antisense 
DNA oligonucleotide and detected by northern blotting. Inclusion of a poly-thymidine 
oligonucleotide in a control reaction removed the poly(A) tail, serving as a marker (Fig. 
3.15, dT). 
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At the initial time point, a heterogeneous population of poly(A) tails were present, 
including new mRNAs with long poly(A) tails of up to 250 nucleotides in addition to 
intermediates at various stages of deadenylation (Fig. 3.15, time = 0). Over the two hour 
time course, we observed that deadenylation of RnLuc 3xPRE progressed relatively 
slowly in the presence of RBD mutR7 (Fig. 3.15). In contrast, when the wild-type Pum 
RBD was present, the poly(A) tail of RnLuc 3xPRE was more rapidly shortened, with the 
majority of RnLuc 3xPRE mRNA having almost no poly(A) tail after two hours (Fig. 3.15). 
In the last three time points (1, 1.5, 2 hours), deadenylated RnLuc 3xPRE intermediate 
accumulated (Fig. 3.15, Pum RBD). As an internal control, the levels of non-adenylated 
7SL RNA were unchanged over the time course that samples were collected (Fig. 3.15, 
7SL). These results demonstrate that the RBD of Pum is sufficient to accelerate 
deadenylation of the reporter mRNA. 
In yeast, PUF mediated deadenylation depends on Pop2-Ccr4 deadenylase 
heterodimer, wherein the PUF directly interacts with the Pop2 subunit (Goldstrohm et al. 
2006; Goldstrohm et al. 2007; Hook et al. 2007). This interaction is thought to be a 
conserved feature of PUF repression, because orthologs of PUFs and Pop2 from C. 
elegans and humans have been reported to bind each other (Goldstrohm et al. 2006; Suh 
et al. 2009; Van Etten et al. 2012). Furthermore, in vitro evidence indicates that Drosophila 
Pum binds to Pop2 (Kadyrova et al. 2007). We first asked whether RNAi depletion of 
Pop2 and Ccr4 (Drosophila Twin) would affect Pum RBD promoted deadenylation of the 
RnLuc 3xPRE mRNA. We confirmed depletion 
of epitope-tagged Pop2 and Ccr4 by western 
blotting (Fig. 3.16). Next, northern blotting was 
performed to measure the effect of 
deadenylase depletion on the poly(A) tail of 
RnLuc 3xPRE mRNA. In cells treated with 
non-targeting control RNAi, the reporter was 
deadenylated (Fig. 3.17, NTC); however, 
depletion of Pop2 and Ccr4 prevented the 
ability of Pum RBD to accelerate 
deadenylation (Fig. 3.17, Pop2 + Ccr4). In fact, 
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deadenylation was completely blocked: the 
RnLuc 3xPRE mRNA was stabilized with a 
long poly(A) tail throughout the three hour 
time course. These data indicate that the 
Pop2-Ccr4 deadenylase complex is 
necessary for Pum RBD mediated 
deadenylation of RnLuc 3xPRE. 
Given the observations that 
deadenylation of the Pum reporter mRNA 
depends on Pop2-Ccr4 deadenylase, we wished to confirm that Pum binds to the Pop2 
subunit of the deadenylase complex. To do so, the Pum RBD was fused to Halotag and 
the V5 epitope (HT-RBD-V5) and co-expressed in D.mel-2 cells with myc-tagged Pop2. 
As a negative control, Pop2 was also co-expressed with Halotag-V5 alone (HT-V5). 
Expression of HT-V5, HT- RBD-
V5 and the myc-Pop2 protein was 
confirmed in the cell extracts (Fig. 
3.18, Inputs). Halotag proteins 
were affinity purified from RNase 
treated extracts and the bound 
proteins were eluted with TEV 
protease and detected by western 
blotting. Pop2 substantially co-
eluted with the Pum RBD (Fig. 
3.18, HT-Pum RBD-V5), but was 
not detected in the Halotag control 
eluate (Fig. 3.18, HT-V5). As a 
negative control, we probed for 
Actin protein and found no 
enrichment by HT-RBD (Fig. 
3.18). These results demonstrate that the Pum RBD associates with Pop2. The fact that 
the association was maintained in the presence of RNases indicates that RNA does not 
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mediate the interaction. Together with the data demonstrating that the RBD promotes 
deadenylation, the interaction with Pop2 suggests that the Pum RBD may recruit the 
deadenylase to the target mRNA to enhance deadenylation. 
3.3.2.2 A poly(A) tail is necessary for repression by the Pum RNA binding domain 
The observation that the RBD of Pum 
accelerated deadenylation indicated that poly(A) 
dependent regulation may be the mechanism by 
which it represses protein expression. If so, then 
repression should depend on the presence of a 
poly(A) tail. To test this idea, we compared Pum 
mediated repression of a reporter bearing a 
poly(A) tail to one that lacks poly(A). To create a 
non-adenylated 3’ end, the cleavage/poly-
adenylation elements of the RnLuc 3xPRE 
reporter were replaced by a Histone Stem Loop (HSL), which is processed by a unique 
3’ end formation pathway (Marzluff et al. 2008) (Fig. 3.19). Consistent with earlier 
observations, full-length Pum repressed the RnLuc 3xPRE pA reporter by 79% and the 
Pum RBD repressed by 19% (Fig. 3.20, 3xPRE pA: Pum FL and Pum RBD). In contrast, 
repression of the non-adenylated 
RnLuc 3xPRE HSL reporter by Pum 
FL was diminished to 36% (Fig. 3.20, 
3xPRE HSL).  Strikingly, the RBD 
was unable to repress an HSL 
reporter (Fig. 3.20, 3xPRE HSL: Pum 
RBD) and instead promoted 
expression – the basis of this effect 
is currently unknown. We conclude 
that the 3’ poly(A) tail is necessary for 
repression by the Pum RBD. 
Consistent with this result, 
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repression by full-length Pum is reduced in the absence of a poly(A) tail, reflecting the 
loss of repression by its RBD. The remaining poly(A) independent repressive activity of 
full-length Pum likely emanates from the N-terminal repression domains (Weidmann and 
Goldstrohm 2012). 
The requirement of the poly(A) tail for repression can be interpreted in several 
ways. Pum RBD could repress by promoting shortening of the poly(A) tail, thereby 
reducing translation and/or mRNA stability. Alternatively, Pum RBD could interfere with 
the function of poly(A) binding protein (pAbp), which coats the poly(A) tail and promotes 
translation initiation. To distinguish between these models, we created a new reporter 
mRNA with a non-adenylated HSL 3’ end and an internal poly(A) tract (Fig. 3.19, RnLuc 
3xPRE A20 HSL). The internal poly(A) tract is 20 nucleotides long, which is sufficient to 
bind at least one molecule of pAbp (Kuhn and Wahle 2004). Importantly, because 
deadenylases are 3’ exoribonucleases that do not degrade internal poly(A) tracts 
(Goldstrohm and Wickens 2008), the RnLuc 3xPRE A20 HSL mRNA is not subject to 
deadenylation. Pum FL repressed the RnLuc 3xPRE A20 HSL mRNA by 66%, which is 
similar in magnitude to RnLuc 3xPRE pA with a normal 3’ poly(A) tail (Fig. 3.20). Pum 
RBD repressed RnLuc 3xPRE A20 HSL by 39%, demonstrating that the internal poly(A) 
tract restored and strengthened repression (Fig. 3.20). We conclude that Pum RBD 
repression depends on the presence of poly(A). These results suggest that RBD 
mediated repression may require co-occupancy of the mRNA by Pum RBD and pAbp.  
We also considered the possibility that poly(A) could promote repression by 
facilitating RNA-binding by Pum, perhaps mediated by pAbp. If so, then strengthening 
binding of Pum to the RNA should overcome 
the poly(A) requirement. Pum binds to the 
PRE with a dissociation constant in the low 
nanomolar range (Zamore et al. 1997; Zamore 
et al. 1999). To strengthen this interaction, we 
utilized a modified MS2 coat protein and 
binding site interaction with an order of 
magnitude stronger binding (Lim et al. 1994; 
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Johansson et al. 1998). Two reporters were 
used in this analysis: RnLuc MS2 pA, with a 3’ 
poly(A) tail generated using efficient 
cleavage/poly-adenylation elements, and the 
RnLuc MS2 HSL reporter, with a non-
adenylated 3’ end generated by the HSL (Fig. 
3.21). The results corroborate those described 
for the 3xPRE reporter. When tethered, Pum FL 
repressed the RnLuc MS2 HSL reporter less 
efficiently (41%) than the RnLuc MS2 pA 
reporter (64%) (Fig. 3.21). Importantly, tethered 
Pum RBD repressed the poly-adenylated reporter by 38% whereas repression of the HSL 
reporter was completely alleviated (Fig. 3.22) and, as observed for the 3xPRE HSL 
reporter, Pum RBD slightly enhanced expression of RnLuc MS2 HSL. We conclude that 
poly(A), in the form of a 3’ tail or an internal poly(A) tract, is 
necessary for repression by the Pum RBD and contributes 
to the full magnitude of repression by the full-length Pum 
protein. Moreover, strengthening the association of Pum 
RBD with the mRNA did not lessen the poly(A) 
dependence, suggesting that poly(A) functions beyond 
facilitating the RBD-mRNA interaction. 
3.3.2.3 Poly(A) binding protein is necessary for 
repression by Drosophila and human PUF RNA 
binding domains 
Having found that poly(A) is necessary for 
repression by the Pum RBD, we wished to determine if this 
property is mediated by pAbp. To do so, we depleted pAbp 
using RNAi. Depletion of epitope-tagged pAbp protein was 
confirmed by western blotting (Fig. 3.23). In addition, using 
qRT-PCR, we measured an 84% decrease of endogenous 
pAbp mRNA relative to the negative control RNAi. Next, we 
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confirmed that depletion of pAbp reduced poly(A) stimulated translation. Indeed, poly-
adenylated Renilla luciferase reporter expression was reduced by 40% relative to non-
targeting control RNAi (Fig. 3.23, RnLuc pA), consistent with pAbp’s general role in 
promoting translation. Importantly, reporter luciferase activity remained more than three 
orders of magnitude above background, permitting measurement of Pum activity in 
subsequent experiments. As an additional control, we measured the effect of pAbp 
depletion on a non-adenylated RnLuc HSL reporter. Knockdown of pAbp did not reduce 
luciferase activity (Fig. 3.23, RnLuc HSL), consistent with the fact that HSL translation 
does not utilize pAbp (Marzluff et al. 2008). 
To evaluate the role of pAbp in Pum repression, we 
first took advantage of the ability of the Pum RBD to 
repress the RnLuc 3xPRE A20 HSL mRNA, which bears 
an internal A20 tract and a non-adenylated 3’ end (Fig. 
3.19). This reporter permits analysis of the effect of pAbp 
independent of potential interplay with deadenylation. As 
shown in Fig. 3.24, the Pum RBD repressed the RnLuc 
3xPRE A20 HSL by 46% in the control sample. When 
pAbp was depleted, repression was substantially 
diminished to 11% (Fig. 3.24). This residual repression 
may result from incomplete pAbp depletion. We conclude 
that poly(A) tract dependent repression by Pum RBD 
requires pAbp. 
We next evaluated the roles of Pop2 and Ccr4 deadenylases and pAbp by 
depleting each protein using RNAi and measuring the effect on repression of the RnLuc 
3xPRE pA reporter. Simultaneous knockdown of Pop2 and Ccr4 did not prevent 
repression by full-length Pum, but the activity was reduced from 74% to 64% (Fig. 3.25). 
In contrast, depletion of Pop2 and Ccr4 did not alleviate repression by the RBD, indeed it 
was slightly enhanced (Fig. 3.25). Note that we confirmed efficient depletion of Pop2 and 
Ccr4 proteins by these dsRNAs, which blocked deadenylation (Fig. 3.16 and 3.17). We 
conclude that deadenylation is not required for Pum RBD mediated repression; despite 
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the fact the RBD accelerates 
deadenylation dependent on Pop2 and 
Ccr4 deadenylases (Fig. 3.15 - 3.18).  
When pAbp was knocked down, 
Pum RBD repression of RnLuc 3xPRE pA 
decreased from 32% to 14% (Fig. 3.25); 
therefore, pAbp plays an important role in 
RBD mediated repression of poly-
adenylated mRNA, in agreement with the 
internal poly(A) tract data (Fig. 3.24). In 
contrast, Pum FL repression was largely 
unaffected (Fig. 3.25), highlighting a 
pAbp-independent function of N-terminal 
repression domains of Pum that we 
previously characterized (Weidmann and 
Goldstrohm 2012). It is important to note that the 
general effect of pAbp depletion (Fig. 3.23) did 
not prevent measurement of Pum mediated 
repression because the experimental design 
measures repression within each RNAi condition 
(e.g. repression by wild-type Pum RBD 
measured relative to the mutR7 negative control 
within pAbp depleted cells). 
To further analyze the role of pAbp in Pum 
repression, we used the tethered function 
approach. When fused to MS2, Pum FL and 
Pum RBD repress the RnLuc MS2 pA reporter to 
a degree comparable to their effect on the RnLuc 
3xPRE, 67% and 32%, respectively (Fig. 3.26), 
consistent with our previous analysis 
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(Weidmann and Goldstrohm 2012). Knockdown of pAbp reduced Pum FL repression from 
67% to 38%, whereas repression by the Pum RBD was 
entirely lost (Fig. 3.26). In fact, without pAbp, the RBD slightly 
stimulated reporter protein expression (Fig. 3.26) to a degree 
similar to the RBD’s effect on HSL reporters (Fig. 3.20 and 
3.22). Western blotting confirmed that expression of tethered 
constructs was unaffected by pAbp knockdown (Fig. 3.26). 
Interestingly, repression by tethered Pum FL and RBD is 
more sensitive to pAbp depletion. The results confirm that 
repression by the Pum RBD depends on pAbp, whereas the 
N-terminal repression domains in full length Pum can repress 
independent of this cofactor.  
The finding that pAbp was necessary for repression by the RBD of Drosophila Pum 
suggested that pAbp may also be involved in repression by the conserved RBD of human 
PUFs. To test this idea, we performed RNAi to 
deplete the human pAbp ortholog, PABPC1, 
from HEK293 cells. Efficient knockdown of 
epitope-tagged PABPC1 was confirmed by 
western blotting (Fig. 3.27). A co-expressed 
Halotag protein, included as an internal control, 
was not affected by RNAi depletion of PABPC1 
(Fig. 3.27). To specifically detect RBD mediated 
repression, we utilized the 3xPRE UGG reporter 
(Fig. 3.1) to measure repression activity of 
PUM2 RBD with altered RNA binding 
specificity, fused to Halotag (Fig. 3.28, HT-
PUM2 RBD-R6as). A mutant version of the 
reporter, RnLuc 3xPREmt, wherein the PREs 
were mutated to eliminate PUM2 binding and 
repression (Van Etten et al. 2012), was included 
as a negative control. We observed that PUM2 
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RBD R6as repressed RnLuc 3xPRE UGG by 42% in cells transfected with non-targeting 
control siRNA (Fig. 3.28, NTC). In contrast, PABPC1 depletion substantially reduced 
PUM2 RBD R6as repression to 16% (Fig. 3.28). Importantly, PABPC1 depletion did not 
affect expression of HT-PUM2 RBD R6as (Fig. 3.28). We conclude that PABPC1 is 
required for repression by human PUM2 RBD. Taken together, our data demonstrate that 
poly(A) binding protein plays a conserved role in repression by the RBD of Drosophila 
and human PUFs.  
3.3.2.4 The Pum RNA binding domain associates with pAbp 
 The functional connection between 
the RBD and pAbp prompted us to search for 
a physical association between these two 
proteins. To test this idea, we fused the Pum 
RBD to Halotag and a V5 epitope (HT-RBD-
V5) and co-expressed this protein in D.mel-2 
cells with either myc-tagged pAbp or, as a 
negative control, myc-tagged Lsm11. As a 
negative control, Lsm11 and pAbp were also 
co-expressed in cells with V5-tagged 
Halotag. Cell extracts were treated with 
RNases to degrade RNA that might bridge 
the two proteins. Halotag proteins were 
captured and bound complexes were eluted 
using TEV protease. Western blotting with 
anti-V5 antibody shows that HT-V5 and HT-
RBD-V5 expressed efficiently in D.mel-2 
cells, and an equivalent amount of RBD was 
cleaved off of the resin in both Lsm11 and 
pAbp samples (Fig. 3.29, lanes 6 and 8). pAbp copurified with HT-RBD-V5, but not HT 
control (Fig. 3.29, compare lane 8 to lane 7). The Lsm11 control protein did not associate 
with HT or HT-RBD-V5, demonstrating specificity (Fig. 3.29, lanes 5 and 6). These results 
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reveal that the Pum RBD associates with pAbp independent of RNA, providing a physical 
link between the Pum RBD and its cofactor.  
3.3.2.5 The Pum RNA binding domain does not displace pAbp from a target 
mRNA 
Based on our results showing that pAbp is necessary for poly(A) dependent 
repression by the Pum RBD and that Pum interacts with pAbp, we hypothesized that Pum 
may promote repression by interfering with pAbp’s ability to promote translation. One 
potential mechanism could be that Pum displaces pAbp from the poly(A) tail of a target 
mRNA. To test the hypothesis, we measured the effect of wild-type and mutant Pum RBD 
on the association of pAbp with the RnLuc 3xPRE mRNA. To do so, FLAG-tagged pAbp 
was immunoprecipitated, RNA was purified from the eluate, and pAbp-associated mRNA 
was then detected by northern blotting. We first validated this RNA co-
immunoprecipitation assay by co-expressing FLAG-tagged pAbp with RnLuc reporters 
bearing different 3’ ends including a normal poly(A) tail, an HSL, or an internal 20 
Adenosine tract terminating in a HSL (A20 HSL). As negative controls, mock anti-FLAG 
immunoprecipitations were also performed from cells that expressed each reporter but 
not FLAG-pAbp (Fig. 3.30). Immunoprecipitation of FLAG-pAbp was confirmed by 
western blot (Fig. 3.30). As expected, poly-adenylated RnLuc mRNA was substantially 
enriched by pAbp, with 
44-fold enrichment 
relative to the mock 
eluate (Fig. 3.30). 
Importantly, the HSL 
reporter was not 
enriched; however, the 
introduction of the 
internal Adenosine tract 
(A20 HSL) conferred 
pAbp enrichment (Fig. 
3.30). This control 
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validates our ability to specifically enrich for pAbp associated mRNAs. 
 Using this RNA immunoprecipitation assay, we then tested whether the Pum RBD 
affects the association of pAbp with the PRE-containing reporter mRNA. Three replicate 
FLAG-pAbp immunoprecipitations were performed from cells that co-expressed either the 
RnLuc 3xPRE pA (Fig. 3.31) or the RnLuc 3xPRE A20 HSL (Fig. 3.32) mRNAs along with 
either wild-type or mutant Pum RBD. Inputs and FLAG eluates were assayed by northern 
blotting and FLAG-pAbp enrichment was confirmed via western blotting (Fig. 3.31 and 
3.32). RnLuc 3xPRE pA and RnLuc 3xPRE A20 HSL mRNAs were enriched by 25-30 
fold in the FLAG-pAbp eluates but not in mock eluates. We also performed luciferase 
assays on these samples to verify that RBD mediated repression is effective under these 
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conditions (i.e. that expression of FLAG-
pAbp does not alter repression) (Fig. 
3.33). Consistent with the results in Figure 
3.20, the RBD repressed the 3xPRE pA 
reporter by 17% and repression of the 
3xPRE A20 HSL reporter was slightly 
enhanced at 29% (Fig. 3.33). Importantly, 
wild-type Pum RBD did not significantly 
change the level of enrichment of the 
RnLuc 3xPRE pA and RnLuc 3xPRE A20 
HSL mRNAs in FLAG-pAbp eluates (Fig. 
3.34). We conclude that the RBD does not 
displace pAbp from an mRNA to elicit 
repression. Instead, the data suggest that the RBD-pAbp interaction antagonizes the 
ability of the poly(A)-bound pAbp to enhance translation.  
3.4 Discussion 
Drosophila and human PUF proteins 
possess multiple domains that 
contribute to repression of protein 
expression from target mRNAs 
(Weidmann and Goldstrohm 2012). For 
example, Drosophila Pum has four 
repression domains that can function 
autonomously including the RBD and 
three repression domains located in the 
amino-terminus (Weidmann and 
Goldstrohm 2012). The current 
challenge is to dissect how each 
repression domain acts to inhibit 
translation and/or promote mRNA degradation. In this study, we focused on the 
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mechanism of repression elicited by the evolutionarily conserved RBD. First, we 
evaluated two mechanisms proposed to account for RBD mediated repression including 
inhibition of translation elongation by a PUF-Argonaute-eEF1A ternary complex and 
acceleration of deadenylation achieved via recruitment of Pop2-Ccr4 deadenylases. 
Biochemical data led to a model wherein the PUF RBD forms a complex with 
Argonaute that in turn binds eEF1A (Friend et al. 2012). Our analysis represents the first 
evaluation of this model in Drosophila and human cells. Our results confirm that human 
PUMs associate with Argonaute and reveal that the PUF-Argonaute interaction is 
conserved by Drosophila Pum. However, we found that mutations in conserved sites 
reported to inactivate PUF-Argonaute binding in vitro did not eliminate the PUF-Argonaute 
association of Drosophila and human PUFs. Moreover, these mutations had no effect on 
PUF repression in cells. In these contexts, multiple PUF-Argonaute contacts, or other 
protein partners, may compliment the binding sites that were identified in vitro.  
Our functional data indicate that the interaction of Drosophila and human PUFs 
with Argonautes is not essential for repression in cells.  First, we identified truncations of 
the RBD that eliminated the association with Argonaute but retained repressive activity. 
Multiple regions outside of the reported Argonaute binding site were found to be 
necessary for the PUF-Argonaute interaction. However, when tethered to mRNA, an RBD 
truncation (deletion of PUF repeats 7 and 8) that did not associate with Argonaute was 
still fully active for repression. Second, RNAi depletion of Argonautes did not alleviate 
repression by Drosophila Pum or human PUMs, nor did mutations reported to prevent 
binding to eEF1A. These observations held true for target mRNAs with a minimal 3’UTR 
with PRE elements and for a target mRNA that contains the 3’UTR of the natural Pum 
target mRNA, Hunchback. Taken together, this evidence indicates that the PUF-
Argonaute-eEF1A complex does not play an essential role in the mechanism of 
repression by Drosophila Pum or human PUFs. Notwithstanding, it remains possible that 
the PUF-Argonaute-eEF1A complex could contribute to regulation of particular target 
mRNAs in specific contexts. An intriguing possibility is that a PUF-Argonaute interaction 
could participate in combinatorial control of target mRNAs regulated by both PUFs and 
microRNAs. Interestingly, human and Drosophila PUMs were recently reported to 
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collaborate with microRNA mediated repression (Kedde et al. 2010; Miles et al. 2012). If 
true, we would anticipate that collaborative repression would be dependent on the major 
effector protein of microRNA mediated repression, GW182 (Tritschler et al. 2010). 
Notably, we depleted GW182 from Drosophila cells and saw no effect on repression by 
the Pum RBD (data not shown). Our interpretation of this result is qualified by the fact 
that the reporters used in the present study are not predicted to be regulated by 
microRNAs, and the observations by Friend et al. were reported to be microRNA 
independent (Friend et al. 2012). Thus, future studies are necessary to address whether 
the PUF-Argonaute interaction might participate in combinatorial control. 
Multiple studies indicate that deadenylation plays a role in PUF RBD mediated 
repression. For example, PUF repression correlates with deadenylation of target mRNAs 
(Ahringer et al. 1992; Wreden et al. 1997; Olivas and Parker 2000; Goldstrohm et al. 
2006). Our data and previous work demonstrate that the conserved RBD of yeast, C. 
elegans, Drosophila, and human PUFs interact with the Pop2 subunit of the Pop2-Ccr4 
deadenylase complex (Goldstrohm et al. 2006; Hook et al. 2007; Kadyrova et al. 2007; 
Suh et al. 2009; Van Etten et al. 2012). In this study, we showed that Pop2 copurifies with 
the RBD of Pum. Genetic analysis in yeast demonstrated that PUF mediated 
deadenylation depends on Pop2 and Ccr4, and the yeast Puf4 protein requires Pop2 and 
Ccr4 to repress protein expression (Goldstrohm et al. 2006; Goldstrohm et al. 2007; Hook 
et al. 2007). PUF regulated deadenylation could be reconstituted with purified PUF RBD 
and Pop2-Ccr4 deadenylase complex (Goldstrohm et al. 2006; Goldstrohm et al. 2007; 
Hook et al. 2007). Furthermore, human PUFs interact with multiple isoforms of Pop2 and 
Ccr4 deadenylases and their ability to repress is diminished when deadenylation is 
blocked (Van Etten et al. 2012). These findings all supported a model in which the RBD 
of PUF proteins recruits the deadenylases to target mRNAs , thereby promoting poly(A) 
tail shortening. This effect results in diminished translational output and subsequently can 
lead to mRNA decay. Indeed, we show here that the Pum RBD promotes deadenylation 
and requires the poly(A) tail to repress. Consistent with this model, we showed that 
deadenylation of the Pum target mRNA was fully dependent on Pop2 and Ccr4 
deadenylases. 
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Surprisingly, we found that repression by Drosophila Pum RBD persists when 
Pop2 and Ccr4 are depleted by RNAi. Depletion of the deadenylases caused only a minor 
reduction in repression by full-length Pum. Further, while poly(A) is necessary for Pum 
repression, this requirement can be fulfilled by an internal poly(A) tract that is not 
susceptible to deadenylation. Therefore, deadenylation is not a primary mechanism of 
repression by Drosophila Pum RBD. We hypothesize that deadenylation may be a 
secondary effect and may serve to increase efficiency or reinforce the regulatory switch 
by diverting the repressed mRNA to the decay pathway. 
If deadenylation is not the primary mechanism, then what is the trigger of Pum 
RBD mediated repression?  Our analysis revealed that repressive activity of the RBD is 
fully dependent on the presence of poly(A), whether at the 3’ end or as an internal poly(A) 
tract, in the PRE containing target mRNA. This led us to test the role of the poly(A) binding 
protein, pAbp. Indeed, we found that pAbp was necessary for RBD mediated repression 
in vivo. We also identified a physical link between Pum and pAbp. Biochemical evidence 
further supports the importance of pAbp in PUF repression. Using a translationally active 
yeast extract, the pAbp ortholog, Pab1p, was shown to participate in translational 
inhibition by the RBD of yeast Puf5 (Chritton and Wickens 2011). In this same yeast 
extract, the RBD of C. elegans FBF also inhibited translation in a Pab1p dependent 
manner (Chritton and Wickens 2011). In addition, pAbp co-localizes with PUFs in 
ribonucleoprotein granules in rat neurons (Vessey et al. 2010). Together with our in vivo 
evidence, these findings suggest that the involvement of pAbp in repression by PUFs may 
be an evolutionarily conserved feature. In support of this, we found that RNAi depletion 
of PABPC1 reduced repression by human PUM2 RBD in HEK293 cells. Future in vivo 
analysis of the importance of pAbp orthologs in repression by other PUF proteins will be 
necessary to confirm this prediction. 
Poly(A) binding protein enhances translation, making it an opportune target for 
negative regulators of protein expression (Tritschler et al. 2010; Brook et al. 2012). For 
instance, the translational inhibitor PAIP2 (poly-adenosine binding protein interaction 
protein 2), the sequence specific repressors Musashi, and the micro-RNA Induced 
Silencing Complex (miRISC) component GW182 have all been shown to bind pAbp 
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orthologs (Khaleghpour et al. 2001; Karim et al. 2006; Kawahara et al. 2008; Fabian et 
al. 2009). Binding of PAIP2, Musashi, or GW182 to pAbp disrupts its interaction with the 
5’ cap-bound eIF4F complex, resulting in reduced translation efficiency (Khaleghpour et 
al. 2001; Karim et al. 2006; Duncan et al. 2009; Moretti et al. 2012; Zekri et al. 2013). 
Together with SXL, the RNA binding protein UNR also targets pAbp but reduces 
translation by an alternate mechanism; UNR interferes with ribosome recruitment by the 
assembled initiation factors (Duncan et al. 2009). PAIP2 and miRISC also repress by 
displacing PABPC1 from the poly(A) tail (Karim et al. 2006; Duncan et al. 2009; Moretti 
et al. 2012; Zekri et al. 2013). In the case of miRISC, displacement of PABPC1 is thought 
to lead to subsequent deadenylation, mediated by miRISC recruitment of the Ccr4-Pop2 
deadenylase complex (Moretti et al. 2012; Zekri et al. 2013). Drawing on these examples, 
we consider potential mechanisms for pAbp dependent repression by Pum. Pum did not 
displace pAbp from the target mRNA, distinguishing the mechanism of repression from 
that of miRISC or PAIP2. Alternatively, Pum interaction with pAbp may interfere with pAbp 
binding to eIF4G. We note that our attempts to detect association of eIF4G with Pum RBD 
have been unsuccessful. Supporting this model, Chritton and Wickens showed that the 
Pab1-eIF4G interaction is required for repression by yeast Puf5 in vitro (Chritton and 
Wickens 2011). As a result, Pum would disrupt the “closed loop” contacts between 5’ cap 
bound eIF4F and poly(A) bound pAbp, resulting in diminished translation initiation. It is 
also possible that the pAbp-eIF4G interaction remains unaffected by the PUF-pAbp 
complex. In this scenario, Pum RBD would act like SXL-UNR, interacting with pAbp to 
block ribosome recruitment. Future detailed mechanistic analysis of Pum regulated 
translation will be necessary to distinguish these models. 
While we focused on poly(A) dependent repression by the RBD in the present 
study, our data emphasize that additional mechanisms of PUF repression exist. Full-
length Drosophila and human PUFs retain repressive activity, albeit reduced in 
magnitude, which is independent of poly(A), pAbp, and Pop2-Ccr4 (Chagnovich and 
Lehmann 2001; Van Etten et al. 2012). Our previous work showed that the Pum RBD is 
one of four repression domains in Pum and that the amino-terminus of fruit fly and human 
PUFs exhibit robust repressive activity (Weidmann and Goldstrohm 2012). These 
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observations argue that additional mechanisms of repression, elicited by the amino-
terminal repression domains of Pum, PUM1, and PUM2, remain to be identified. 
Based on conservation of the RBD throughout eukaryotes, it was originally 
suspected that members of the PUF family may repress by the same means (Wickens et 
al. 2002; Spassov and Jurecic 2003). Indeed, enhancement of mRNA decay by the RBD 
via recruitment of deadenylases is a conserved feature, though the contribution to the 
magnitude of repression appears to differ between PUFs in different organisms 
(Goldstrohm et al. 2006; Hook et al. 2007; Blewett and Goldstrohm 2012; Van Etten et al. 
2012). While repression by Drosophila Pum is largely unaffected by depletion of 
deadenylases, repression by human PUM1 was substantially reduced by deadenylase 
depletion and by over-expression of a dominant negative deadenylase (Van Etten et al. 
2012). Additional evidence comes from analysis of yeast PUFs. Both Puf4 and Puf5 
accelerate deadenylation, and repression by Puf4 depends on Pop2 and Ccr4 
(Goldstrohm et al. 2006; Hook et al. 2007; Blewett and Goldstrohm 2012). In contrast, 
while Puf5 does promote poly(A) shortening, it can circumvent deadenylation by recruiting 
the Eap1 protein to enhance decapping of the target mRNA (Blewett and Goldstrohm 
2012). Thus, an emerging principle is that individual PUFs can have different corepressor 
requirements and dominant repressive mechanisms. Analysis of yeast Puf6 lends 
additional support as Puf6 was shown to uniquely target eIF5B to inhibit translation (Deng 
et al. 2008). 
Beyond the RBD, PUF proteins from organisms such as yeast and C. elegans 
differ substantially at the amino acid level from those found in insects and vertebrates 
(Spassov and Jurecic 2003; Weidmann and Goldstrohm 2012). The divergent polypeptide 
sequences of different PUF proteins may confer unique regulatory functions. Further 
adding to the regulatory potential, PUFs from insects and vertebrates have evolved 
multiple repressive domains, each of which can act independently (Weidmann and 
Goldstrohm 2012). Thus, individual PUFs may assemble distinct regulatory complexes 
depending on the context in vivo. We anticipate that members of this ancient protein 
family have evolved strategies of regulation that remain to be revealed, with the pAbp and 
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poly(A) dependent mechanism of the RBD contributing to the maximal efficiency of 
repression. 
3.5 Materials and Methods 
Plasmids. Plasmids used in this study included pAc5.1 FFluc, pAc5.1 RnLuc, 
pAc5.1 RnLuc 3xPRE, pIZ Pum FL, pIZ Pum FL mutR7, pIZ Pum RBD, and pIZ Pum 
RBD mutR7, all of which were previously described in Chapter 2 (Weidmann and 
Goldstrohm 2012). The PRE sequences were derived from the natural Pum target mRNA, 
Hunchback (Murata and Wharton, 1995; Zamore et al., 1999; Zamore et al., 1997). The 
pAc5.1 RnLuc Hb 3’UTR reporter was created by inserting the 3’ untranslated region of 
the Drosophila Hunchback mRNA (NM_169233.2 ) into the XhoI and NotI restriction sites 
downstream of Renilla luciferase coding sequence in pAc5.1 RnLuc vector. The Hb 
3’UTR was amplified from Drosophila genomic DNA using the following primers (Hb 
sequence underlined, restriction sites in bold): 
 
Hb 3’UTR Forward:  
5’-GCAGCTCGAGGTTCCCCATCACCATCACCTTG 
 
Hb 3’UTR Reverse:  
5’-CACCGCGGCCGCAATTTGACTTTGGACTGTTGGTATTGTTTG 
 
The pIZ PUM1 plasmid, expressing human PUM1, was previously described (Van 
Etten et al. 2012). Mutant versions of Drosophila Pum (NP_001262403.1), reported to 
inhibit binding to Argonaute or eEF1A (Friend et al. 2012) were created by site-directed 
mutagenesis with the following primers (mutations in bold):  
 
Pum T1137E Forward:  
5’-CCAACAGAAGTTGGAGCGGGCCGAGGCCGCCGAGAAGCAAATGG 
 
Pum T1137E Reverse:   
5’-CCATTTGCTTCTCGGCGGCCTCGGCCCGCTCCAACTTCTGTTGG 
103 
 
 
Pum F1251R Forward:   
5’-GGACCCCGTGGCGCTGCAGCGCATCATCAATGCTTTCAAGGGTCAGG  
 
Pum F1251R Reverse:   
5’-CCTGACCCTTGAAAGCATTGATGATGCGCTGCAGCGCCACGGGGTCC  
 
The psiCheck1-based RnLuc 3xPRE, RnLuc 3xPRE UGG, and RnLuc 3xPREmt 
reporter plasmids; the pGL4.13 FFLuc internal control; and the pFN21A-based 
expression vectors for Halotag, Halotag human CNOT6L, or Halotag versions of human 
PUM1 and PUM2 R6SYE derivatives were previously described (Van Etten et al. 2012). 
For pFN21A PUM2 RBD R6as, aa705-1050 of human PUM2 (NP_056132.1) was cloned 
into the flexi sites of pFN21A (Promega) and R6as (N921S, Q925E) was generated via 
site directed mutagenesis as in Van Etten et al., 2012. Human PUF mutants were created 
based on the mutations reported to abrogate binding to Argonautes or eEF1A (Friend et 
al. 2012), by site directed mutagenesis of PUM1 (NP_001018494.1) and PUM2 
(NP_056132.1) using the following primers:  
 
PUM1 T874E Forward:   
5’-GCTCAAACTGGAGCGTGCCGAACCAGCTGAGCGCCAGC  
 
PUM1 T874E Reverse:  
5’-GCTGGCGCTCAGCTGGTTCGGCACGCTCCAGTTTCAGC  
 
PUM1 F990R Forward:   
5’-GTGTACAGCCCCAGTCTTTGCAACGTATCATCGATGCGTTTAAGGGACAGG  
 
PUM1 F990R Reverse:   
5’-CCTGTCCCTTAAACGCATCGATGATACGTTGCAAAGACTGGGGCTGTACAC  
 
PUM2 T752E Forward:   
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5’-CATACAGCAAAAACTAGAGAGAGCTGAACCAGCTGAGCGACAGATGG  
 
PUM2 T752E Reverse:   
5’-CCATCTGTCGCTCAGCTGGTTCAGCTCTCTCTAGTTTTTGCTGTATG 
 
PUM2 F866R Forward:   
5’-GTGTTCAGCCACAGTCACTACAGCGCATCATTGATGCTTTCAAGGGACAAG  
 
PUM2 F866R Reverse:   
5’-CTTGTCCCTTGAAAGCATCAATGATGCGCTGTAGTGACTGTGGCTGAACAC  
 
For FLAG immunoprecipitation in HEK293 cells, the coding sequence for human 
AGO1 (NP_036331.1) was inserted with an N-terminal 3xFLAG tag into the pF5A vector 
(Promega) to create pF5A N3xFLAG AGO1. pFN21A PABPC1 was generated by 
inserting the coding sequence of human pAbp, PABPC1 (NP_002559.2) into the flexi 
sites of pFN21A (Promega). For Halotag pulldown assays, the Halotag coding sequence 
from pFN18A (Promega), a C-terminal TEV cleavage site, and the Sgf1 restriction site 
were inserted into the pIZ V5-His A vector (Invitrogen) to create the HT control. Drosophila 
Pum was then inserted in frame and C-terminal to Halotag and a TEV protease cleavage 
site. For HT-RBD, containing amino acids 1091-1533, the N-terminus of Pum (aa1-1090) 
was deleted via inverse PCR. The pIZ myc-Lsm11 (NP_610522.1) vector and the empty 
pUB myc and pUB FLAG vectors (Ubiquitin 63E promoter, SV40 poly(A) site, and pUC19 
backbone) were provided by Dr. Eric Wagner. pUB myc-pAbp was generated by inserting 
the coding sequence of Drosophila pAbp (NP_725750.1) into the pUB vector downstream 
of the myc tag, and pIZ myc-Pop2 and pIZ myc-Ccr4 were generated by inserting the 
coding sequences of Drosophila Pop2 (NP_648538.1) or Drosophila twin (NP_732966.1) 
with an N-terminal myc tag into pIZ. pUB FLAG-Ago1 and pUB FLAG-Ago2 were created 
by inserting the coding sequence of Drosophila Ago1 (NP_001246314.1) and Drosophila 
Ago2 (NP_730054.1) into the pUB FLAG vector downstream and in frame with the FLAG 
tag. For the tethered function assays, the pAc5.1 RnLuc 2xMS2 reporter, pIZ MS2-Pum 
FL, and pIZ MS2-RBD (aa1091-1533) was previously described in Chapter 2 (Weidmann 
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and Goldstrohm 2012). To create truncations of the Pum RBD, fused to MS2, inverse 
PCR was used with pIZ MS2-RBD to delete aa1427-1533 (pIZ MS2-RBDΔC) and 
subsequently aa1330-1426 (pIZ MS2-RBDΔR7-8), aa1222-1294 (pIZ MS2-RBDΔR4-5), 
or aa1091-1186 (pIZ MS2-RBDΔR1-2). For the HSL reporters, a histone stem loop (HSL) 
and a histone downstream element (HDE) were inserted in place of the SV40 
cleavage/poly-adenylation element to create pAc5.1 RnLuc HSL, pAc5.1 RnLuc 3xPRE 
HSL, and pAc5.1 RnLuc MS2 HSL (Weidmann and Goldstrohm 2012). The sequence 
added is as follows, with HSL and Histone downstream element underlined: 5’-
GGTCCTTTTCAGGACCACAAACCAGATTCAATGAGATAAAATTTTCTGTT. Inverse 
PCR was performed to insert 20 Adenosines upstream of the HSL to create the pAc5.1 
RnLuc A20 HSL and pAc5.1 RnLuc 3xPRE A20 HSL reporters. 
 
Cell Culture. D.mel-2 cells (Invitrogen) were cultured in Sf-900 III serum-free 
medium (Invitrogen) with 50 Units/mL penicillin and 50 µg/mL streptomycin using 
standard cell culture techniques. Cells were grown at 28°C. HEK293 cells were cultured 
as previously described (Van Etten et al. 2012). 
 
Transfections. Transfections were performed as previously described for D.mel-
2 cells (Chapter 2, Weidmann and Goldstrohm 2012) and HEK293 cells (Van Etten et al. 
2012). When transfections were performed for transcription shutoff experiments, 
Effectene (QIAGEN) reagents were scaled up to 20 mL total volume in a T-150 flask: 4.55 
ng FFLuc, 9.1 ng RnLuc, 3636 ng pIZ vector, 818 µl EC buffer, 29.1 µl Enhancer, 36.36 
µl Effectene, 14.6 mL D.mel-2 cells (1.5x106 cells/mL), and 5.4 mL Sf900III media. To 
inhibit transcription, Actinomycin D (Sigma) was added at 5 µg/mL final concentration, 48 
hours post-transfection. Aliquots of cells at each indicated time point were removed, 
pelleted at 1000 x g for 3 minutes, and frozen at -80°C until RNA isolation.  For 
experiments with RnLuc 3xPRE HSL and RnLuc 3xPRE A20 HSL reporters, 50 ng and 
20 ng of the indicated reporter, respectively, was transfected per well of a 6-well plate, to 
ensure comparable levels of expression to pA reporters. To compare the effect of pAbp 
depletion on RnLuc pA and RnLuc HSL, 50ng of the indicated RnLuc plasmid and 400ng 
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of empty pIZ vector was transfected into 6-wells treated with either control or pAbp 
dsRNA. 
In the siRNA experiment assessing PABPC1 knockdown efficiency, FuGENE HD 
(Promega) was used to transfect 80 ng pFN21A PABPC1 and 20 ng pFN21A Halotag 
control into 96-wells treated with siRNAs. In experiments testing the effect of siRNA-
mediated depletion of PABPC1 on repression activity of HT-PUM2 RBD R6as, FuGENE 
HD was used to transfect 5 ng pGL4.13 FFLuc, 10 ng psiCheck1 RnLuc 3xPRE UGG or 
RnLuc 3xPRE ACA, and 85 ng pFN21A PUM2 RBD R6as into 20,000 cells in each well 
of a 96-well plate.  
 
RNA Interference. As previously described, double-stranded RNAs (dsRNAs) 
were in vitro transcribed for RNAi including: non-targeting control (NTC) LacZ, PumN, 
Pop2, and Ccr4 (Van Etten et al. 2012; Weidmann and Goldstrohm 2012). The following 
primers were used to generate templates for production of Argonaute and pAbp dsRNAs, 
with T7 promoter sequence underlined and gene specific regions bolded:   
 
AGO1 Forward:  
5’-GGATCCTAATACGACTCACTATAGGCCAATCACTTCCAGGTGACAATGC 
 
AGO1 Reverse:  
5’-GGATCCTAATACGACTCACTATAGGCCACTGCGAGGGCCTTACG 
 
AGO2 Forward:  
5’-GGATCCTAATACGACTCACTATAGGGGATGGAGCAACTCAGGTGGC 
 
AGO2 Reverse:  
5’-GGATCCTAATACGACTCACTATAGGGAGGAATAATCACAATTGCCAGATCG  
 
pAbp Forward:  
5’-GGATCCTAATACGACTCACTATAGGGCGTATGCAGCAGCTGGGACAG 
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pAbp Reverse:  
5’-GGATCCTAATACGACTCACTATAGGCCTTGCAATTGCTGTGGAATTGGC.  
 
Corresponding regions were amplified via PCR from D.mel-2 cDNA and dsRNA 
was transcribed in vitro and purified as previously described (Van Etten et al. 2012; 
Weidmann and Goldstrohm 2012). For knockdown, cells in one well of a 6-well plate, with 
total volume 1.6 mL, was treated with 6 µg of each dsRNA for 5 minutes before 
transfection. For knockdown during transcription shutoff assays, 20 mL total volume was 
treated with 60 µg of each dsRNA for 5 minutes before transfection. 
For RNAi in HEK293 cells, depletion of PABPC1 was performed through the use 
of On-target Plus Smartpool siRNA (L-019598-00) or a Non Targeting Control siRNA 
(Dharmacon). Twenty thousand HEK293 cells were plated per well of a 96 well plate in 
antibiotic free medium. 24 hours later the cells were transfected with 10 fmol of siRNA 
using Dharmafect 1 (Dharmacon) according to the manufacturer’s protocol.  Forty-eight 
hours after siRNA treatment, cells were transfected with reporters and expression 
vectors. Forty-eight hours post-transfection, luciferase assays to measure RnLuc and 
FFLuc activities were performed and cell lysates were prepared for western blot analysis. 
Alignments. Alignments of the PUF RNA binding domain were performed using 
the open source bioinformatics software Jalview 2.8 (www.jalview.org) using the MafftWS 
alignment (Waterhouse et al. 2009). 
 
Luciferase Assays. Luciferase assays were performed as previously described 
using dual glo assay (Promega) (Van Etten et al. 2012; Weidmann and Goldstrohm 2012). 
A relative response ratio (RRR), from RnLuc signal/FFLuc signal, is calculated for each 
sample. The ratio is normalized to the control (set to 100). Percent repression is derived 
from the equation 100*(1-(RRRWT/RRRNegative Control)), where RRRWT is from a sample 
transfected with an active regulator and RRRNegative Control comes from a sample 
transfected with an equivalent amount of an inactive negative control. Inactive controls 
for Pum FL and Pum RBD were created by mutating the RNA recognition amino acids in 
the 7th PUF repeat, which prevents RNA binding and repression, to create pIZ Pum FL 
mutR7 and pIZ Pum RBD mutR7 plasmids (Weidmann and Goldstrohm 2012). Empty pIZ 
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vector was used as the inactive control for human PUM1 in Drosophila cells. The control 
for tethered function experiments was the MS2 expression vector, pIZ MS2 (Weidmann 
and Goldstrohm 2012). For the RnLuc Hb 3’UTR reporter, fold change reporter 
expression was calculated as RRRRNAi/RRRNTC, where RRRRNAi is from sample treated 
with targeting dsRNAs and RRRNTC is from sample treated with non-targeting control 
dsRNAs. 
To measure repression by altered specificity human PUMs in HEK293 cells, the 
pFN21A Halotag expression vector served as a negative control and percent repression 
was calculated as previously described (Van Etten et al. 2012). For RNAi depletion of 
PABPC1 in HEK293, percent repression of RnLuc 3xPRE UGG reporter was calculated 
relative to the negative control reporter, RnLuc 3xPREmt, as previously described (Van 
Etten et al. 2012). 
 Immunoprecipitation. For FLAG immunoprecipitations from HEK293 cell, 3 mLs 
of 200,000 cells/mL were transfected. Mock samples were transfected using Fugene HD 
with 3 µg of Halotag prey plasmids (HT, HT-PUM2, HT-PUM2 T752E, and HT-CNOT6L), 
while FLAG-AGO1 samples were transfected with 750 ng pF5A FLAG-HsAGO1 bait and 
2.25 µg of Halotag prey plasmids. Forty-eight hours post-transfection, cell pellets were 
resuspended in 500 µl lysis buffer containing 0.5% Igepal CA-630 (USB), 50 mM Tris-HCl 
(pH 8.0), 0.5 mM EDTA, 2mM MgCl2, and 150 mM NaCl. Protease inhibitors were also 
added to final concentrations of 1 mM phenylmethylsulfonyl fluoride [PMSF], 10 µg/ml 
aprotinin, 10 µg/ml pepstatin, and 10 µg/ml leupeptin. Lysates were passed through a 25 
gauge needle 5 times and were then cleared at 16,000 x g for ten minutes at 4°C. Cleared 
lysates were treated with final concentrations of 20 U/mL RNase ONE (Promega), 8 
µg/mL RNase A (Fermentas), and 500 nM HaloTag TMR ligand (Promega). A portion was 
kept as the input. The extract was then bound to 10 µl bed volume of EZview Red Anti-
FLAG M2 affinity resin (Sigma) (equilibrated with lysis buffer and blocked for 30 minutes 
at 4°C with 500 µg/ml BSA). Binding proceeded for 12 hours at 4°C. Beads were washed 
1 time in 1 ml lysis buffer and three times in lysis buffer lacking detergent with 500 mM 
NaCl. Beads were resuspended in 30 µl elution buffer containing 50 mM Tris-HCl pH 8.0, 
150 mM NaCl, 0.5 mM EDTA, and 2 mM MgCl2. To elute bound complexes, 3xFLAG 
peptide (Sigma) was added to 150 ng/µl. Elution proceeded with end-over-end rotation 
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for 30 minutes at 4°C. Eluates were separated from the resin using a Micro Bio-spin 
column (Bio-Rad). 
For FLAG immunoprecipitations from D.mel-2 cells, 2 mLs of 1.5 million cells/mL 
were transfected (Effectene) with 300 ng of MS2-V5 prey plasmids (RBD, RBDΔC, 
RBDΔR7-8, RBDΔR4-5, RBDΔR1-2), 50 ng FLAG-Dm Ago2 bait and 50 ng myc-Lsm11 
negative control. Immunoprecipitation proceeded similar to the above protocol with minor 
differences. Each cell pellet was lysed in 300 µL lysis buffer containing 0.5% Igepal CA-
630 (USB), 50 mM Tris-HCl (pH 8.0), 2 mM EDTA, 150 mM NaCl. Protease inhibitors 
were also added to final concentrations of 2 mM phenylmethylsulfonyl fluoride [PMSF], 
20 µg/ml aprotinin, 20 µg/ml pepstatin, and 20 µg/ml leupeptin. Lysates were treated with 
50 U/mL RNase ONE and 10 µg/mL RNase A. After binding, the resin was washed 3 
times in lysis buffer and 3 times in lysis buffer lacking detergent. Beads were eluted for 
24 hours at 4°C in 50 µl elution buffer containing 50 mM Tris pH 8.0, 300 nM NaCl, 2 mM 
EDTA, and 300 ng/µl of 3xFLAG peptide.  
 FLAG-pAbp RNA Immunoprecipitation. The FLAG-pAbp RNA 
immunoprecipitations (RNA-IP) in D.mel-2 cells followed the FLAG immunoprecipitation 
described above with the following key differences. For control in Figure 9A, 2 mLs of 
D.mel-2 cells at 1.5 million cells/mL were transfected with 100 ng of RnLuc reporter 
plasmids (pA, HSL, A20 HSL) and 50 ng of either empty pUB vector or FLAG-pAbp. In 
the RNA-IPs with the Pum RBD, Reporter plasmids (20 ng RnLuc 3xPRE pA or 30 ng 
RnLuc 3xPRE A20 HSL) were co-transfected with 50 ng of either pUB vector or FLAG-
pAbp and 350 ng of either RBD mutR7 or RBD plasmids. The RNA-IP lysis buffer 
consisted of 50 mM Tris pH 8.0, 150 mM NaCl, 2 mM EDTA, protease inhibitors, 0.2% 
Igepal CA-630 (USB), and 200 U/mL RNasin. In addition, beads were washed 1 time in 
lysis buffer and 3 times in lysis buffer with reduced detergent (0.01%). No elution with 
3xFLAG peptide was performed; input lysates and IP pellets were directly subjected to 
Trizol RNA purification or SDS elution. 
 Halotag Pull-down Assays. For pull-down assays, 300 ng bait plasmid (pIZ 
Halotag alone or pIZ Halotag-Pum RBD aa1091-1533 was cotransfected with 100 ng prey 
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plasmid (pIZ myc-Lsm11, pIZ myc-Pop2, or pUB myc-pAbp) into 1 well of a 6-well plate 
for each bait-prey combination. For pull-down of Ago2 by HT-RBD, 300 ng of pIZ Halotag-
PumRBD or pIZ Halotag-PumRBD T1137E bait, 50 ng of pUB FLAG-Ago2 prey, and 50 
ng of pUB myc-Lsm11 control were cotransfected into one 6-well. Two milliliters of 
transfected cells were pelleted at 1000 x g for 3 minutes and washed twice in phosphate 
buffered saline (PBS). Pellets were resuspended in 300 µl lysis buffer containing 0.5% 
Igepal CA-630 (USB), 50 mM Tris-HCl (pH 8.0), 2 mM EDTA, and 150 mM NaCl. Protease 
inhibitors were also added to final concentrations of 2 mM phenylmethylsulfonyl fluoride 
[PMSF], 20 µg/ml aprotinin, 20 µg/ml pepstatin, and 20 µg/ml leupeptin. Lysates were 
passed through a 25 gauge needle 5 times and incubated at 4°C for one hour. Lysates 
were then cleared at 16,000 x g for fifteen minutes at 4°C. A portion of the resulting 
supernatant was kept as the input. The extract was then bound to 20 µl bed volume of 
Halolink beads (Promega) (equilibrated with lysis buffer and blocked for 30 minutes at 
4°C with 500 µg/ml BSA). During the binding, 100 units/ml RNase ONE (Promega) and 
10 µg/ml RNase A was added to degrade RNA. Binding proceeded for 24 hours at 4°C. 
Beads were washed three times in 1 ml lysis buffer and three times in lysis buffer lacking 
detergent with increased NaCl (300 nM NaCl for Ago2, 750 nM NaCl for pAbp). Beads 
were resuspended in 30 µl elution buffer containing 50 mM Tris-HCl pH 8.0 and 300 mM 
NaCl. To cleave Halotag fusions, thereby eluting bound complexes, 5 units of AcTEV 
protease (Invitrogen) was added and incubated for 12 hours at 4°C. Eluates were 
separated from the Halolink beads using a Micro Bio-spin column (Bio-Rad).  
 
Western blotting. Western blotting from luciferase assay samples was performed 
as previously described in Chapter 2 (Weidmann and Goldstrohm 2012). For Western 
blotting of Halotag pull-downs, input samples were diluted ten-fold in Elution Buffer and 
were separated along with TEV elutions via SDS-polyacrylamide (12%) gel 
electrophoresis and proteins were transferred onto Immobilon-P membranes (Millipore). 
All membranes were probed with either V5 monoclonal antibody (Invitrogen), c-myc 
(9E10) antibody (provided by Dr. Eric Wagner), anti-HaloTag monoclonal antibody 
(Promega), or monoclonal anti-FLAG M2 antibody (Sigma). Secondary detection was 
performed using horseradish peroxidase conjugated goat anti-mouse IgG (Thermo 
111 
 
Scientific). Signals were detected using Immobilon western chemiluminescent substrate 
(Millipore) and autoradiography film. 
 
Fluorescent labeling and visualization of Halotag protein constructs. Protein 
extracts from HEK293 cells expressing Halotag fusions were harvested from each well of 
a 96-well plate in 20 µl of lysis buffer (0.5% Igepal CA-630 [USB], 50 mM Tris-HCl [pH 
8.0], 0.5 mM EDTA, 2 mM MgCl2, 150 mM NaCl) with 1 x Protease Inhibitor cocktail 
(Promega) and mixed with 900 nM Halotag TMR Ligand (Promega) for 30 min on ice, 
protected from light. For labeling of FLAG IPs, refer to FLAG IP methods. After labeling, 
extracts were separated via SDS polyacrylamide (12%) gel electrophoresis and detected 
by fluorescence imaging with a Typhoon Trio imager (GE Healthcare).  
 
RNA isolation. For isolation of RNA, 4 ml of transfected D.mel-2 cells were 
centrifuged at 1,000 x g for 3 minutes, washed twice in PBS, and RNA was purified from 
cell pellets using Maxwell 16 LEV SimplyRNA tissue kit and the Maxwell 16 instrument 
(Promega). Total RNA preparations were utilized for Northern blotting or cDNA 
preparation. For pAbp RNA-IP experiments, Trizol reagent (Ambion) was used for RNA 
purification according to manufacturer’s protocols. 
 
Northern analysis. Northern blotting was performed as previously described 
(Blewett and Goldstrohm 2012). RNA was separated in a denaturing 0.85% agarose 
MOPS/formaldehyde gel. RNAs were transferred to Immobilon NY+ membrane 
(Millipore). Membranes were then UV-crosslinked and probed for the RNAs indicated. For 
RnLuc reporter, a 32P body-labeled, antisense RNA probe was created by in vitro 
transcription. The following primers were used to amplify templates for creation of RnLuc 
RNA probes. The T7 promoter sequence is underlined and gene specific regions are 
bolded. 
 
RnLuc forward primer: 5’-GCCCGTGGCTAGATGCATCATCC 
 
RnLuc reverse primer:  
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5’-GGATCCTAATACGACTCACTATAGGGCGGACAATCTGGACGACGTCGG. 
 
For detection of RnLuc reporter for poly(A) tail analysis, primers included the  
 
RnLuc 3’ forward primer: 5’-GGGCGAGGTTAGACGGCCTACCCT 
 
RnLuc 3’ reverse primer:  
5’-GGATCCTAATACGACTCACTATAGGGCGGCCAGCGGCCTTGG. 
 
The 7SL RNA was detected on northern blots using a 32P 5’ end-labeled DNA oligo with 
the following sequence. 
7SL Probe:  
5’-CACCCCTGGCCCGGTTCATCCCTCCTTAGCCAACCTGAATGCCACGG. 
Northern blots of poly(A) tail length, including RNase H cleavage, were performed 
as previously described (Blewett and Goldstrohm 2012). Total RNA, 20 μg, was annealed 
to a cleavage oligo specific to the RnLuc reporter. The oligo used for RNase H cleavage 
bore the sequence 5’-CCTTGAATGGCTCCAGGTA. Oligo dT cleaved control reactions 
contained 5 μg of oligo dT15 (IDT). Two units of RNase H (NEB) were added to each 
reaction. RNAs were cleaved 1 hour at 37 °C, then precipitated with 0.3 M Sodium 
Acetate, and 3 volumes 100% ethanol for 1 hour at -20°C. RNAs were pelleted, washed 
with 70% ethanol, and resuspended in denaturing RNA loading buffer. RNAs were 
separated in 5% polyacrylamide, 7 M urea gels with 0.5 X Tris-Borate EDTA running 
buffer. Electrophoretic transfer to Immobilon NY+ was performed with TransBlot (Bio-
Rad) for 1 hour at 60 Volts. Membranes were then probed as described above. Blots were 
visualized using a Typhoon Trio (GE) phosphorimager and quantitated using ImageQuant 
software (GE). 
 
cDNA preparation and qPCR. For measurement of endogenous mRNA 
knockdown, RNAs were primed with random hexamers (IDT) for synthesis of cDNAs 
using GoScript reverse transcriptase (Promega). The final concentration of RNA in these 
reactions was 500 µg/mL. To measure endogenous mRNA levels, quantitative PCR 
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(qPCR) was performed on 5 µl of cDNA product in a 50 µl reaction using 100 nM of gene 
specific primers and GoTaq qPCR master mix (Promega) as described previously 
(Weidmann and Goldstrohm 2012). Standard negative control reactions were performed 
without reverse transcriptase. Differences in mRNA levels were calculated using the 
ΔΔCT method. CT values were measured and normalized to the internal control Rpl32 
mRNA to generate ΔCT. ΔΔCT was derived relative to the non-targeting control ΔCT (Livak 
and Schmittgen 2001; Schmittgen and Livak 2008). qPCR primers for Pop2 and Ccr4 
were previously published (Van Etten et al. 2012). The qPCR primer sequences for 
additional Drosophila genes are as follows: 
 
Rpl32 Forward: 5’-GCCCAAGGGTATCGACAACAG 
Rpl32 Reverse: 5’-GCACGTTGTGCACCAGGAAC 
Ago1 Forward: 5’-CCAGATGCGTCGCAAGTATCG 
Ago1 Reverse: 5’-CGGGTAGCGCAATTTCATGC 
Ago2 Forward: 5’-GTGAGCGACGGCCAGTTTCC 
Ago2 Reverse: 5’-GAACTTGTTCGATGTCGTTACGTCG 
pAbp Forward: 5’-CGTCGCTCGTTGGGCTATGC 
pAbp Reverse: 5’-GCGACGAAGAGAAGGATCACGC 
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CHAPTER 4 
 
PUMILIO ENHANCEMENT BY NANOS 
 
4.1 Abstract 
Drosophila Pumilio and Nanos proteins function together to control diverse 
developmental processes, germline stem cell maintenance, and neurological functions 
including memory formation. Pumilio belongs to a conserved eukaryotic family of RNA 
binding proteins that bind with high affinity and specificity to Pumilio Response Elements 
(PREs), consequently inhibiting protein synthesis. Nanos belongs to a conserved family 
of tandem zinc finger proteins. Together they are implicated in mRNA localization, 
translational inhibition, and decay. We found that Nanos robustly stimulated Pumilio-
mediated repression by two mechanisms. First, Nanos directly stimulates the RNA 
binding activity of Pumilio. Nanos binds to Pumilio and increases the affinity of Pumilio for 
PRE containing RNA. In fact, Nanos stimulates Pumilio binding to RNAs that are not 
normally bound by Pumilio. This effect is mirrored in cells; Nanos stimulates Pumilio-
dependent repression of mRNAs bearing weak/degenerate PREs. Therefore, Nanos 
expands the repertoire of Pumilio target mRNAs. Second, we discovered that Nanos 
possesses a repression domain that synergistically promotes repression with Pumilio. 
The Nanos repression domain (NRD) can function independently of Pumilio when 
tethered to a reporter mRNA. Depletion of previously proposed corepressors Brain 
Tumor, Ccr4-Not deadenylase, or Cup do not affect NRD function. Together, these data 
reveal a new mechanism of Nanos repression that contributes to combinatorial control by 
Pumilio. We propose that Nanos augments the spatiotemporal control of mRNAs by 
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Pumilio; Nanos specifies how tightly Pumilio binds mRNA and tunes the level of 
repression.  
4.2 Introduction 
 
Drosophila melanogaster Pumilio (Pum) and Caenorhabditis elegans Fem-3 
Binding Factor (FBF) are the founding members of the family of RNA binding proteins 
(RBPs) known as PUFs (Wickens et al. 2002). PUFs throughout eukaryotes each contain 
a series of eight repeated helical motifs that make up the conserved PUF RNA binding 
domain (RBD). Unique among RBPs, each PUF repeat specifies recognition of a single 
nucleotide and can act as part of a modular array (Wang et al. 2002; Miller et al. 2008; 
Wang et al. 2009). Working together, repeats of PUF RBDs bind tightly to specific 8-10 
nucleotide regulatory sequences within mRNAs to promote post-transcriptional regulation 
of expression (Zamore et al. 1997; Wang et al. 2002; Miller and Olivas 2011). In this way, 
PUFs control integral processes like embryonic development, germline maintenance, and 
neurological function (Nusslein-Volhard et al. 1987; Zhang et al. 1997; Forbes and 
Lehmann 1998; Asaoka-Taguchi et al. 1999; Dubnau et al. 2003; Mee et al. 2004; Ye et 
al. 2004).  
The sequence of PUF binding sites is largely conserved among eukaryotes. PUFs 
most similar to Drosophila Pum, like the human PUF proteins PUM1 and PUM2, associate 
strongly with the RNA sequence UGUAHAUA (Gerber et al. 2004; Gerber et al. 2006; 
Galgano et al. 2008; Morris et al. 2008; Hafner et al. 2010). Though Pum binds this 
sequence independently, regulation of targets in vivo requires the partner protein Nanos 
(Nos) (Barker et al. 1992; Forbes and Lehmann 1998; Muraro et al. 2008). This is true for 
multiple targets identified in vivo: including the regulation of the sodium channel Paralytic 
(Para) in the nervous system, the cell cycle regulator Cyclin B (CycB) in the germline, and 
the anterior morphogen Hunchback (Hb) in the early embryo. Nos was proposed to be 
necessary to recruit both the Brain Tumor (Brat) protein and the Ccr4-Not deadenylase 
complex to cause translational inhibition (Cho et al. 2006; Kadyrova et al. 2007). 
However, our group has demonstrated Nos independent repression in cells by multiple 
autonomous repression domains within Pum (Chapters 2 and 3) (Weidmann and 
121 
 
Goldstrohm 2012; Weidmann et al. 2014). While the addition of Nos could enhance Pum 
repression, the mechanism by which Nos does so is unclear.  
Nos proteins contain tandem Zinc fingers (ZnF) that coordinate metal ions using 
a combination of cysteine and histidine amino acids (CCHC) (Curtis et al. 1997). Nos 
proteins are reported to bind RNA with low affinity and no specificity in vitro (Curtis et al. 
1997; Hashimoto et al. 2010). Mutant nos embryos resemble pum mutants, lacking 
abdominal segmentation due to loss of Hb regulation. Expression of Nos proteins with 
mutations that abrogate zinc binding by either ZnF (C315Y, C354Y) or truncations 
missing portions of the Nos N-terminus or C-terminus cannot rescue mutant nos 
embryos (Curtis et al. 1997). Pum and Nos have been demonstrated to interact in an 
RNA dependent manner through co-immunoprecipitation experiments and yeast three-
hybrid assays (Sonoda and Wharton 1999; Edwards et al. 2001). The Xenopus Nanos 
homolog, Xcat2, can pull down Xenopus Pumilio from embryo extracts, and Human 
PUM2 and NOS1 are also purported to interact through the PUF RBD (Nakahata et al. 
2001; Jaruzelska et al. 2003). Mutations in Pum that block Nos recruitment have been 
identified (Edwards et al. 2001). One such mutation, F1367S, prevents Nos dependent 
enhancement of Pum repression in cells (Chapter 2) (Weidmann and Goldstrohm 
2012). The details of this Pum-Nos interaction are unknown. The evidence of Nos RNA 
binding and the conserved interaction of Nos homologues with PUF RBDs might 
suggest a role for Nos in stimulating Pum binding to RNA.  
Features of Pum regulation in vivo hint at a role for Nos in Pum PRE complex 
formation. The presence of Nos exclusively in the developing embryo posterior restricts 
Pum repression of the Hunchback mRNA to this location. This results in localized 
expression of Hb protein in the anterior and subsequently proper abdominal segmentation 
(Lehmann and Nusslein-Volhard 1987; Irish et al. 1989; Wharton and Struhl 1991; Murata 
and Wharton 1995; Wreden et al. 1997; Chagnovich and Lehmann 2001; Cho et al. 2006). 
The Hb mRNA contains two perfect Pum response elements (PREs) of the forms 
UGUAUAUA and UGUACAUA. In cells, mRNA reporters bearing these elements can be 
repressed simply by expressing more Pum (Weidmann and Goldstrohm 2012). For some 
reason, the level of Pum in embryos is insufficient without Nos. Ectopic expression of Nos 
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in the embryo anterior extends the repression of Hb and also permits Pum regulation of 
the Bicoid (Bcd) mRNA (Gamberi et al. 2002). The Bcd mRNA contains a near perfect 
PRE with a centrally located Guanine (UGUAGAUA) not normally favored in Pum binding 
sites. More concentrated amounts of Nos are necessary for Pum regulation of the CycB 
mRNA in primordial germ cells and this necessity persists into germline stem cells (Forbes 
and Lehmann 1998; Gilboa and Lehmann 2004). Low amounts of Nos are unable to 
stimulate Pum repression of CycB mRNA in somatic cells (Kadyrova et al. 2007). The 
PRE element within CycB is particularly degenerate, containing extra nucleotides within 
the center (UGUAauuUAUA). How these varying PRE elements augment Nos and Pum 
regulation is unknown. The varying requirements of Nos for each target may underlie 
differences in the affinity of Pum for each PRE. Nos might enhance Pum repression by 
stimulating binding. This could explain why over-expression of Pum can overcome the 
necessity for Nos (Chapter 2, Weidmann and Goldstrohm 2012).  
Multiple models implicate Nos in the recruitment of repression activity to Pum 
complexes. For example, the Brat protein can assemble into a quaternary structure with 
Nos, Pum, and RNA (Edwards et al. 2001; Sonoda and Wharton 2001). Brat’s recruitment 
of 4EHP competes for recognition of the 5’ cap, inhibiting translation. A NOT interacting 
motif (NIM) exits within the N-termini of Nos homologs, but this motif is absent in 
Drosophila Nos (Lai et al. 2011; Bhandari et al. 2014). An interaction between the Not4 
protein and the Nos N-terminus (NosN), identified through a yeast two-hybrid approach, 
is purported to be a link between Pum and NOT in flies (Kadyrova et al. 2007). Binding of 
NosN to the 4E binding protein, Cup, has also been described (Verrotti and Wharton 
2000). Recruitment of any such element to PRE bound Pum would elicit repression, and 
could be responsible for the ability of Nos to enhance Pum. 
We set out to test each model of Nos enhanced Pum repression. First, we created 
a cell based reporter assay that measures the ability of Nos to regulate the Hb 3’UTR. 
We dissected the regions of Nos necessary for this regulation. As with rescue of the nos 
embryo (Curtis et al. 1997), truncation or mutation of the N-terminus, ZnFs, or C-terminus 
of Nos protein diminished repression. However, a minimal construct of the Nos ZnFs and 
the C-terminal extension was sufficient for significant activity. We purified a recombinant 
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form of this truncated protein and tested its ability to form a ternary complex with the Pum 
RBD and RNA in vitro. Through electrophoretic mobility shift assays, we discovered that 
the presence of Nos increased the affinity of Pum RBD for PRE RNA significantly. 
Moreover, Nos enabled RBD binding to RNA it could not bind alone, including RNAs with 
mutations in the conserved PRE. Using the cell based assay, we confirmed that 
expression of Nos conferred repression on mRNAs containing these same PREs. We 
also uncovered a new RNA independent interaction between the Nos N terminus and 
Pum. Finally, using a tethered function approach, we identified a novel repression domain 
within the Nos N-terminus that appears to operate via a mechanism independent of 
previously identified Nos binding partners. 
4.3 Results 
4.3.1 Nanos enhancement of Pumilio Repression 
4.3.1.1 Pumilio dependent Nanos regulation of the Hunchback 3’UTR 
 To recapitulate Nos and Pum mediated repression, we designed mRNA reporters 
using the open reading frame of Renilla luciferase fused to the 3’UTR of Drosophila 
melanogaster Hunchback mRNA (Weidmann et al. 2014) (Fig. 4.1, RnLuc Hb 3’UTR WT). 
To ensure the reporting of Pumilio dependent repression, mRNAs with mutations in one 
or both PRE sites were also generated (Fig. 4.1; mt1, mt2, and mt1-2). As described in 
Chapters 2 and 3, reporters were transfected 
into D.mel-2 cells and Firefly luciferase (FFLuc) 
was co-expressed as a control (Weidmann and 
Goldstrohm 2012; Weidmann et al. 2014). 
Reporter expression is measured as a relative 
response ratio (RRR) of RnLuc to FFLuc 
luminescence. Renilla luciferase activity was 
1.5 higher in cells expressing the Hb 3’UTR mt1-
2 reporter than cells expressing the Hb 3’UTR 
WT reporter, likely resulting from endogenous 
Pumilio repression (data not shown). D.mel-2 cells do not express detectable levels of 
Nos mRNA (Weidmann and Goldstrohm 2012). To measure the effect of Nos on RnLuc 
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Hb 3’UTR reporters, we expressed Nos fused 
to the HaloTag (HT, Promega) protein and 
measured reporter luminescence (Fig. 4.2). 
Cells expressing the HT protein alone were 
used as a normalization for full reporter 
expression (Fig. 4.2). A percent repression 
value can then be calculated with the equation 
100*(1-(RRRRepressor/RRRControl)), wherein the 
repressor is HT-Nos and the control is HT 
alone. By this metric, Nos repressed the 
RnLuc Hb 3’UTR WT reporter by 75% (Fig. 4.2, WT). This repression is similar in 
magnitude to the Nos enhanced Pum 
repression observed on 3xNRE containing 
reporters (Chapter 2) (Weidmann and 
Goldstrohm 2012). Mutation of either PRE site 
resulted in slightly diminished repression (56% 
and 63%, Fig. 4.2, mt1 and mt2). A loss of both 
PRE sites eliminates repression, with 
expression of Nos resulting in a 15% activation 
of RnLuc Hb 3’UTR mt1-2 expression (Fig. 4.2, mt1-2). Expression of HT and HT-Nos 
was confirmed through fluorescence of labeled HT protein (Fig. 4.3). Thus, this assay 
faithfully captures Nos-enhanced Pumilio repression of the Hb 3’UTR.   
Nos is a 401 amino acid (aa) protein that contains a conserved set of tandem 
Cysteine2-Histidine-Cysteine (CCHC) 
zinc fingers (ZnF) (Fig. 4.4, region Z). 
Outside of this ZnF containing region, 
Nos has a 295aa N-terminus and a 
short 26aa C-terminal extension (Fig. 
4.4, regions N and C). We designed a 
set of mutations and truncations of 
Nos to identify regions of the protein 
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necessary for the enhancement of Pum 
repression. To assess the necessity of 
the ZnFs, we compared wild-type Nos 
repression to that of two mutant variants 
known to abrogate metal binding (Curtis 
et al. 1997) (Fig. 4.5, C319Y and 
C354Y). These variants have the first 
critical Cysteine in one of the two ZnFs 
mutated to Tyrosine. Both the C319Y 
and C354Y mutations completely 
blocked repression caused by Nos, as reporter expression levels mirrored that of the HT 
control (Fig. 4.5). Metal binding to both of the ZnF regions is therefore required for Nos to 
stimulate Pum repression. To explore whether other regions of Nos are important for Pum 
enhancement, we also made truncations of Nos lacking the C or N-terminal domains (Fig. 
4.5, NZ and ZC). Removal of the 26aa C-terminal region nearly eliminated repression; full 
length Nos repressed by 79% while the NZ truncation repressed by only 12% (Fig. 4.5, 
NZC and NZ). Removal of the 295aa N-terminus had a more modest effect, retaining 43% 
repression activity (Fig. 4.5, ZC). No separate Nos region could support repression, 
including the ZnF-containing Z region (Fig. 4.5, N, Z, and C). Differences in expression 
could not explain loss of activity, as each Nos 
variant was expressed at similar levels to the 
wild-type (Fig. 4.6). Taken together, these 
findings suggest a role for the N and C 
regions of Nos in Pum enhancement. The 
ZnFs are absolutely critical for function, and 
the C region is necessary for significant 
enhancement. The N region has only a partial role in Pum enhancement. With a region 
of Nos sufficient for induction of Pum repression (ZC), we began investigating possible 
mechanisms of Nos-mediated enhancement. One hypothesis is that Nos affects Pum’s 
ability to bind to RNA.  
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4.3.1.2 Formation of a stable ternary Pumilio-Nanos-PRE complex in vitro 
We aimed to reconstitute the Pum-Nos-
NRE complex using an electrophoretic mobility 
shift assay (EMSA) in order to evaluate whether 
Nos can contribute to Pum RNA binding. To do 
so, we expressed and purified recombinant 
versions of Pum and Nanos. The Pum 
constructs contained only the region necessary 
for Nos enhancement, the RBD. Recombinant 
Nos consisted exclusively of the minimal region 
sufficient for stimulation of repression, ZC (Fig. 
4.7). As controls, we also purified RBD mutants 
which could not associate with Nos (F1367S) or 
could not associate with RNA (mutR7) (Fig. 4.7). In addition, Nos ZC constructs with the 
ZnF mutations C319Y or C354Y were also purified (Fig. 4.7). To track complex formation, 
we mixed a 5’ Cy5 labeled PRE containing RNA with combinations of our purified proteins 
(Fig. 4.8). The labeled RNA contained 26 nucleotides of the original Hb Nanos Response 
Element 2, which contains a perfect PRE sequence (UGUACAUA). The addition of 40 nM 
wild-type Pum RBD resulted in a near complete shift of the PRE RNA (Fig. 4.8, lanes 1-
3). Addition of Nos ZC at a 
concentration equimolar to RBD 
resulted in a consequent super-
shift, suggesting ternary 
complex formation (Fig. 4.8, 
lane 4). We then tested the 
EMSA properties of Nos-binding 
deficient F1367S RBD (Fig. 4.8, 
lanes 5-8). The RBD-PRE 
complex formed readily but no 
super-shift was observed when 
Nos ZC was added (Fig. 4.8, 
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lanes 6-8).  This interaction site on the RBD is thus necessary for ternary complex 
formation in vitro (Fig. 4.8, lane 8) and for Nos enhanced repression in cells (Chapter 2) 
(Weidmann and Goldstrohm 2012). As expected, the mutR7 RNA-binding deficient RBD 
could not shift RNA (Fig. 4.8, lanes 9-12). While Nos can form ternary complexes with 
wild-type RBD and PRE at this concentration, it cannot shift RNA on its own (Fig. 4.8, 
compare lanes 4 and 14 to 12 and 17). Mutations in either Nos ZnF eliminates ternary 
complex formation as well (Fig. 4.8, lanes 15-16). The F1367 interaction with Nos on the 
RBD is necessary for ternary complex formation in vitro (Fig. 4.8, lane 8) and for Nos 
enhanced repression in cells (Chapter 2) (Weidmann and Goldstrohm 2012). The ZnF 
are absolutely required for the assembly of Nos into Pum-PRE (Fig. 4.8, lanes 15-16) and 
for PRE dependent repression in cells (Fig. 4.5). Thus, the conditions in the EMSA are 
consistent with Nos enhanced repression in cells being a result of Pum-Nos complex 
formation. We then asked whether this complex formation affected the Pum RBD’s ability 
to bind RNA. 
4.3.1.3 Nanos increases the affinity of Pumilio for PRE and non-PREs in vitro 
In order to quantitate the effect of Nos on the association of Pum RBD with the 
PRE, we designed a minimal 16nt RNA based 
on the PRE within the Hb NRE2 (Fig. 4.9, 
HbPRE2). To observe HbPRE2 in our EMSA 
assay, we radiolabeled the 5’ nucleotide with 
32P. While keeping the concentration of RNA 
constant, we titrated the amount of Pum RBD 
(0-200 nM) over multiple equilibrium binding 
reactions and observed changes in native gel 
mobility of the RNA (Fig. 4.9). Through 
quantitation of the fraction of RNA bound 
(shifted RNA/total RNA) at each Pum RBD 
concentration, we were able to measure an 
observed dissociation constant (Kd obs) (Fig. 
4.9). Gathering data from replicate EMSAs, 
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the Kd obs was calculated to be 26nM for 
Pum RBD binding to HbPRE2 (Fig. 4.9). We 
then tested whether the presence of Nos might change the Kd obs. Nos has no measurable 
ability to shift RNAs at low concentration, but it can bind to an RBD-RNA complex (Fig. 
4.8). We again performed the RBD titration under identical conditions, except NosZC was 
included at a constant concentration above that of the highest RBD concentration 
(400nM, Fig. 4.10). Only two species of RNA were observed, unbound and ternary 
complex (Fig. 4.10). Importantly, no shift was observed without Pum RBD, even though 
NosZC was present, simplifying interpretation of the EMSA (Fig. 4.10, first lane). With 
NosZC present, the Kd obs was measured at 8.7nM (Fig 4.10). This is a 3-fold increase in 
the affinity of the Pum RBD for HbPRE2 (Fig. 4.11). An increase in Pum’s affinity for RNA 
could facilitate the enhanced repression observed in cells.  
 Because Nos had a significant effect on Pum binding to the HbPRE2, we 
questioned whether a similar effect could be observed on PRE sites derived from other 
mRNA targets. To this end, we generated 16-19nt RNAs based on other PREs from the 
first Hb NRE, the Bcd 3’UTR, and CycB 3’UTR (Fig. 4.12, HbPRE1, BcdPRE, and 
CycBPRE). Surprisingly, none of these PREs were stably bound by the Pum RBD in our 
EMSA conditions and Kd obs values could not be reliably measured (Fig. 4.12, left panels). 
This held true with concentrations of RBD up to 1µM. Remarkably, the addition of NosZC 
resulted in RNA binding close to HbPRE2 affinity (Fig. 4.12, right panels). With NosZC 
included, the Kd obs for HbPRE1, BcdPRE, and CycBPRE were measured at 59.6nM, 
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46.1nM, and 12.0nM, respectively (Fig. 4.12). This enhancement constitutes a range of 
greater than 16-80 fold increases in affinity (Fig. 4.13). Moreover, the observed modified 
affinities match closely with that of HbPRE2, a site that is regulated independently by Pum 
in cells and together with Nos in vivo.  
 
After witnessing such drastic changes in RNA binding, we were curious whether 
Nos could confer Pum binding to non-PRE RNAs. Mutant versions of the HbPRE2 RNAs 
were created harboring moderate to strong changes in the conserved U1G2U3 
trinucleotide: including a U3 to G mutation or U1G2U3 to ACA (Fig. 4.14, HbPRE2 G3 and 
HbPRE2 ACA). These PRE elements do not confer regulation of a reporter by Pum in 
cells (Chapter 2) (Weidmann and Goldstrohm 2012). The HbPRE2 G3 RNA behaved 
similarly to the weak endogenous PREs from Hb NRE1, Bcd, and CycB (Fig. 4.14, top 
panels). Pum RBD alone could not stably bind HbPRE2 G3, but the inclusion of NosZC 
resulted in a Kd obs of 59.9nM (Fig. 4.14). This represents at least a 16-fold change in 
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binding affinity and results in an interaction 
that rivals a real Pum target RNA (Fig. 
4.15). However, NosZC does not confer 
non-specific binding activity to the Pum 
RBD, as no binding of HbPRE2 ACA was observed with or without Nos (Fig. 4.14, bottom 
panels). The EMSAs collectively show that Nos can act as a potent enhancer of Pum 
RNA binding to both strong and weak PREs, relaxing specificity and improving affinity. It 
became important to test whether Nos can confer Pum binding and repression onto 
mRNAs that Pum does not normally target in cells. 
4.3.1.4 Nanos triggers Pumilio repression of weak PREs in cells 
To assess the ability of Nos to stimulate Pum repression of mRNAs containing 
weak PREs, we turned to our cell based reporter assay. To compare the effects of Nos 
on different sequence elements, we generated Renilla reporters bearing minimal 3’UTRs 
that contain each PRE tested in our EMSA binding assays. Outside of the 19-20nt region 
of insertion, each reporter was identical. Reporters were generated with sequences 
including an empty multiple cloning site (RnLuc MCS), HbPRE2, HbPRE1, BcdPRE, 
CycBPRE, HbPRE2 G3, and HbPRE ACA. Each reporter was co-expressed in cells with 
the FFLuc control and a gradient of HT-Nos (Fig. 4.16). The percent repression of each 
Renilla reporter was measured comparing each sample with increasing HT-Nos to a 
reporter alone sample in the same experiment. As an added negative control, the 
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HbPRE2 was also co-
expressed with a gradient of 
HT alone (Fig. 4.16). Across 
the entire expression 
gradient, HT alone had no 
effect on the HbPRE2 
reporter (Fig. 4.16). High 
amounts of transfected HT-
Nos resulted in some 
repression of the MCS 
reporter, however (21% at 200ng, Fig. 4.16). Repression of the HbPRE2 reporter was 
robust, increasing from 12% repression with 1ng of transfected Nos to 68% repression 
with 200ng of transfected Nos (Fig. 4.16). A similar effect was seen with the HbPRE1 
reporter (24% to 73%, Fig. 4.16). The BcdPRE responded more moderately: repressed 
by 7% at 1ng, 29% at 10ng, 57% at 100ng, and 62% at 200ng (Fig. 4.16). Repression of 
the CycBPRE was limited with low transfected Nos (only 6% at 10ng) and only reached 
30% repression at the highest amount (Fig. 4.16). The HbPRE2 G3 reporter behaved 
similarly to CycBPRE, achieving 30% repression at high amounts of transfected Nos (Fig. 
4.16). Finally, repression of the HbPRE2 ACA reporter was also nonexistent at low Nos 
transfection amounts (Fig. 4.16, 1 and 10ng), but was measurable at high transfection 
amounts (Fig. 4.16, 100 and 200ng, 15% and 26%). While the repression of CycBPRE, 
HbPRE2 G3, and HbPRE2 ACA is only slightly enhanced (30%, 29%, and 26%) when 
compared to MCS (22%), these differences are statistically significant (p < 0.001). We 
conclude that Nos can confer Pum repression to reporters with PRE elements 
proportional to Pum-RNA binding affinity.  
4.3.1.5 Identification of a novel Nanos-Pumilio interaction 
The reason why deletion of the Nos N-terminus could moderately impede the 
enhancement of Pum repression in cells (Fig. 4.5) while the ZC was entirely sufficient for 
the enhancement of Pum RNA binding (Fig. 4.9 - 4.15) was unclear. The N-terminus of 
Nos could have varying roles: it could assist in Pum-Nos complex formation, it may 
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augment and improve the enhancement of RNA binding, or it may assist in recruitment of 
factors necessary for translational repression. To assess the role of the N-terminus in 
Pum complex assembly, we employed a co-immunoprecipitation approach from cells. As 
bait, we created a vector for expression of 3xFLAG-tagged Pum (FLAG-Pum). As prey, 
vectors expressing an HT control, HT-Nos, HT-NosN, or HT-NosZC were used. Each 
prey was co-transfected into cells with either FLAG-Pum or a mock empty expression 
vector. After allowing time to 
express each protein, cells were 
lysed and treated with RNases 1 
and A. Pum protein complexes 
were purified with anti-FLAG 
beads (Fig. 4.17). Bait and prey 
proteins were expressed at 
similar levels in each sample (Fig. 
4.17, Input). HT-Nos and HT-
NosN were both enriched by the FLAG IP exclusively in samples expressing FLAG-Pum 
(Fig. 4.17, FLAG IP). Importantly, the HT negative control was not enriched by FLAG IP 
in either mock or FLAG-Pum expressing samples (Fig. 4.17, FLAG IP HT). The HT-
NosZC construct was also not enriched by FLAG IP in either sample, supporting the idea 
that the interaction between NosZC and Pum may be RNA dependent. Together, these 
results suggest that the Nos N-terminus is responsible for maintaining an RNA 
independent association with Pum in cells. This novel interaction may be partially 
responsible for the loss of repression observed when the Nos N-terminus is deleted. 
Additionally, the Nos N-terminus may also contribute repression activity to the complex, 
as has been reported previously (Kadyrova et al. 2007). Nos homologs also have been 
reported to maintain N-terminal derived repression activity (Lai et al. 2011; Bhandari et 
al. 2014). 
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4.3.2 A Pumilio independent Nanos repression 
4.3.2.1 Tethered function identifies a repression domain in Nanos 
To confirm whether Nos possesses 
intrinsic repression capacity independent of 
Pum, we turned to the tethered function 
assay (Chapter 2 and 3) (Coller and Wickens 
2002). We created plasmids expressing 
fusions of Nos regions to the phage MS2 coat 
protein, which binds a specific RNA stem loop 
structure (Fig. 4.18). We co-expressed these 
fusions with a Renilla luciferase reporter 
bearing two MS2 binding sites in its mRNA 3’UTR (Fig. 4.18, RnLuc 2xMS2). Using FFLuc 
as the transfection control, we used 
luminescence output to quantify RRR for a 
series of tethered Nos mutants and 
truncations much like in Fig. 4.5: constructs 
included tethered NZC, C354Y, NZ, ZC, N, 
and Z. Expression ratios were normalized 
to samples expressing the MS2 coat 
protein alone (set to 100). Compared to the 
MS2 control, tethered full length Nos 
repressed 69% (Fig. 4.19, NZC). Tethered 
Nos repression does not require both ZnFs, 
as the tethered C354Y mutant was able to 
repress by a similar amount (60%, Fig. 
4.19, C354Y). The C-terminal extension was also dispensable; tethered NZ repressed 
67% (Fig. 4.19, NZ). Conversely, deletion of the Nos N-terminus abrogated tethered 
repression (12%, Fig. 4.19, ZC). Moreover, tethering the Nos N-terminus alone was 
sufficient for near full repression activity (63%, Fig. 4.19, N). Very minimal activity was 
observed when Z alone was tethered (7%, Fig. 4.19, Z).  Together, these results indicate 
a role for the Nos N-terminus in inhibiting mRNA expression.  
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4.3.2.2 RNAi depletion of existing partners do not affect Nanos repression 
Pum dependent and independent mechanisms of Nos have been proposed 
previously through interactions with Pum and other partners (Verrotti and Wharton 2000; 
Sonoda and Wharton 2001; Cho et al. 2006; Kadyrova et al. 2007; Lai et al. 2011; 
Bhandari et al. 2014). The tethered Nos activity we observed thus could be derived from 
one of these sources: Pum, Brat, Ccr4-
Not, or the 4E binding protein Cup. To 
evaluate the necessity of these 
proteins in tethered Nos repression, 
we applied dsRNA interference of each 
gene to the tethered function assay 
(Fig. 4.20). Before transfection of 
reporters and tethered NosN, cells 
were incubated with dsRNA 
complementary to endogenous 
mRNAs. As a control, dsRNA targeting 
the absent LacZ gene was used. With 
control dsRNAi, tethered NosN repressed by 64%, mirroring the normal level of activity 
seen in Fig. 4.19 (Fig. 4.20, Control). Depletion of either Pum or Brat did not impede 
repression (70% and 74%, Fig. 4.20, Pum and Brat). Depletion of either the Pop2 and 
Ccr4 deadenylases or the Not1 deadenylase complex scaffolding protein led to a slight 
impairment of repression (60% and 53%, Fig. 4.20, Pop2 + Ccr4 and Not1). Lastly, 
knockdown of Cup had no effect on NosN activity (67%, Fig. 4.20, Cup). Depletion of the 
Pum, Brat, Pop2, and Ccr4 proteins utilizing these dsRNAs has been verified previously 
(Chapter 2 and 3) (Weidmann and Goldstrohm 2012; Weidmann et al. 2014). Knockdown 
of each endogenous mRNA was validated by qRTPCR from each experiment. The 
mRNAs encoding Pum, Brat, Pop2, Ccr4, Not1, and Cup were depleted by 75%, 78%, 
39%, 93%, 84%, and 88%, respectively. The data suggest that the tethered Nos N-
terminus may operate via a novel mechanism, as depletion of factors necessary for other 
Nos mediated deadenylation and translational repression does not relieve activity. This 
repression may contribute to the enhancement of Pum repression by Nos.  
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4.4 Discussion 
4.4.1 Multiple domains of Nanos are necessary for enhanced Pum repression 
 
Drosophila Nanos is required for Pum-mediated repression of multiple mRNAs in 
vivo (Barker et al. 1992; Wreden et al. 1997; Forbes and Lehmann 1998; Asaoka-Taguchi 
et al. 1999; Sonoda and Wharton 1999; Gilboa and Lehmann 2004; Ye et al. 2004; 
Kadyrova et al. 2007; Muraro et al. 2008). Pum binding and Nos recruitment to the targets 
Hunchback, Paralytic, and Cyclin B are crucial for development, motor function, and 
fertility, respectively. However, Pum causes translational repression, accelerates 
deadenylation, and limits target mRNA levels all in the absence of Nos (Chapters 2 and 
3, Weidmann and Goldstrohm 2012; Weidmann et al. 2014). If Nos is not necessary for 
Pum activity, why is Nos required in vivo? We evaluated two hypotheses: 1) Nos could 
enhance Pum RNA binding, restricting where Pum could engage its targets and 2) Nos 
may recruit additional activity that permits full repression by Pum.  
D.mel-2 cells, which do not express detectable levels of Nos, were a perfect 
system to test what effect Nos had on Pum-dependent repression. We created a reporter 
mRNA bearing the 3’UTR of the Pum target Hunchback, whose regulation depends on 
Nos in vivo. The number of Pum binding sites in the Hb 3’UTR and the amount of Nos 
protein confers a precise level of regulation upon the Hunchback transcript during embryo 
development (Wharton and Struhl 1991). Our results in D.mel-2 cells fully recapitulated 
Hb regulation; Nos expression blocked translation of our reporter in a manner dependent 
on Pum binding sites. One Pum binding site was sufficient for repression, but the 
presence of both was slightly more inhibitory than either alone. With Nos-Pum regulation 
accurately reconstituted in cells, we sought to dissect what regions of Nos were important 
for activity. 
Nos has a 295 amino acid (aa) N-terminus and a short 26aa C-terminal extension 
that flank an 80aa region including tandem zinc fingers (ZnFs). One of the first nos mutant 
alleles identified was nosL7, which expresses a protein with an in-frame deletion of 7 
amino acids (aa376-382, ITMEDAI) in the Nos C-terminal extension (Lehmann 1988). 
The nosL7 allele results in a loss of function; embryos generated from nosL7 flies are small, 
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lack abdominal segments, and are ultimately inviable (Lehmann 1988). This deletion in 
Nos precludes formation of a Pum-Nos-RNA complex as measured by multiple binding 
assays, including yeast three-hybrid and in vitro pull-down (Wharton et al. 1998, Sonoda 
and Wharton 1999). We observed that deletion of the Nos C-terminal extension, which 
includes the ITMEDAI sequence, significantly impairs Nos repression of an Hb 3’UTR 
reporter in Drosophila cells. We speculate that this region of Nos serves as a binding site 
for Pum; without this interaction, Nos cannot enhance Pum repression. 
The defining characteristic of the Nanos family of proteins is their tandem CCHC 
type ZnFs (Curtis et al. 1997). These ZnFs are conserved from flies to humans and are 
purported to confer non-specific RNA binding to Nos and its homologs (Curtis et al. 1997; 
Hashimoto et al. 2010). Interruption of metal coordination by either Nos ZnF results in 
abdominal segmentation and fertility defects in flies similar to other pum and nos mutants 
(Curtis et al. 1997). We observed that mutations in these ZnFs (C319Y and C354Y) also 
completely blocked Nos stimulated repression of the Hb 3’UTR reporter. Thus, the ZnFs 
and C-terminal extension of the Nos protein are critical to Pum enhancement in cells and 
likely underlie effects observed in vivo. If the C-terminal extension is necessary for Pum 
interaction, perhaps the RNA binding capacity of the ZnFs is important for enhancement.  
The N-terminus of Nos is not highly conserved and its role in translational 
repression is unknown. Injection of RNAs expressing Nos proteins lacking the N-terminus 
cannot rescue the nos phenotype, suggesting that this region plays a role in Nos 
dependent regulation (Curtis et al. 1997). In D.mel-2 cells, we observed that truncation of 
the Nos N-terminus cuts repression of the Hb 3’UTR reporter in half. The Nos N-terminus, 
therefore, contributes activity to the more crucial ZnFs and C-terminal extension. It is 
important to understand how each region contributes to Pum repression. 
4.4.2 Nanos enhances Pum repression by increasing affinity for RNA 
 
Reports of Nos RNA binding dependent on Zinc coordination and the observation 
that Nos stimulates Pum repression through the RBD led us to question whether Nos 
might affect Pum’s affinity for RNA. The observed Nos RNA binding was very weak and 
nonspecific, but it might contribute in a combinatorial fashion to Pum’s specific sequence 
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recognition. To test this, we expressed and purified recombinant variants of the Pum RBD 
and the Nos ZC region and directly assessed their ability to bind RNA through 
electrophoretic mobility shift assays. As expected, the Pum RBD bound the HbPRE2 RNA 
readily; yet we did not observe RNA binding by NosZC even at µM concentrations. 
However, when Nos was added together with RBD and PRE, a ternary complex of Pum, 
Nos, and RNA was observed. Mutation of either Nos ZnF (C315Y or C354Y) prevented 
ternary complex formation. The F1367S mutation in the Pum RBD also obviated complex 
formation, consistent with past reports of impaired Nos association and synergistic 
repression (Edwards et al. 2001, Weidmann and Goldstrohm 2012). These results favor 
a model of Pum dependent recruitment of Nos to RNA.  Does the ternary complex mediate 
recruitment of factors that inhibit protein synthesis or does the association with Nos 
change Pum’s affinity for RNA? Either mechanism could be responsible for Pum 
enhancement. 
The C. elegans PUF protein FBF-2 is an example where association with other 
partners into a ternary complex affects RNA binding and protein recruitment. Germline 
development defective 3 (GLD-3) and the cytoplasmic polyadenylation element binding 
protein (CPEB), CPB-1, compete for interaction with FBF-2 (Menichelli et al. 2013). GLD-
3 behaves like Nos; GLD-3 cannot associate with RNA alone, but will assemble in a 
ternary complex with RNA and FBF-2 (Wu et al. 2013). GLD-3’s association with FBF-2 
did not affect RNA affinity, it was only recruited to the RNA by FBF-2. CPB-1 can bind 
RNA by itself, but in complex with FBF-2 it alters PUF specificity in vitro for the nucleotides 
flanking the PUF binding site (Campbell et al. 2012a). Additionally, like Nos, CPB-1 
increases the affinity of FBF-2 for certain mRNA sequences, including C. elegans Cyclin 
B (CYB-1) (Menichelli et al. 2013). An interaction between a human PUF and a human 
CPEB, PUM2 and CPEB3, is also conserved (Campbell et al. 2012b). The interactions of 
GLD-3 and CPB-1 are maintained through a binding site on FBF-2 analogous to the Nos 
interaction region on the Pum RBD: both sites exist between the seventh and eight repeat 
of the PUF RBD. Competing interactions of CPB-1 and GLD-3 could determine whether 
FBF-2 requires specific flanking nucleotides in the RNA binding site to interact and 
repress. Nos may operate through a similar mechanism. Mutations in the four nucleotides 
upstream of the Hb PRE result in a loss of proper regulation in vivo (Wharton et al. 1998). 
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Nanos may confer added specificity through its own direct interaction with these 
nucleotides. We measured the Pum RBD’s affinity for the PRE in the presence or absence 
of Nos. By itself, the RBD’s affinity for PRE RNA was strong; we observed a Kd of 26 nM. 
When we measured the assembly of the same amount of RBD and RNA into ternary 
complex with Nos, the association was even stronger (8 nM). GLD-3 does not affect RNA 
binding by FBF-2 (Wu et al. 2013). CPB-1 can increase FBF-2 affinity for a weak CYB-1 
PRE about 5-fold and slightly alters specificity (Menichelli et al. 2013). Nos can actually 
increase the Pum RBD’s affinity for even a strong PRE site. 
The ability of Nos to significantly enhance Pum binding to a perfect PRE RNA was 
striking. We wondered whether Nos could assist retention of Pum on sites which are more 
weakly associated, perhaps shifting the specificity even more so than CPB-1 does to FBF-
2. We sampled RNAs of varying PRE “strength” derived from multiple Pum targets or 
created through mutation of the HbPRE2 RNA. Of the RNAs tested, only the HbPRE2 
RNA could stably associate with the Pum RBD alone. To our surprise, even the PRE 
sequence derived from the first Hb mRNA NRE (HbPRE1) was not bound with high 
affinity. Upon closer inspection, we attribute this to an ability of the HbPRE1 16mer to 
form stem loops or self-dimers under our binding conditions; 8 of 16 nucleotides in 
HbPRE1 can base pair with a ΔG of -6.3 kcal/mol. Nonetheless, this RNA was readily 
incorporated into the Pum-Nos-PRE ternary complex, highlighting the improvement of 
Pum-RNA affinity. The BcdPRE, CycBPRE, and an HbPRE2 mutant (U3 to G3) behaved 
similarly. None were bound by the Pum RBD alone, but the presence of Nos mediated 
strong incorporation into the ternary complex. In fact, only the HbPRE2 triple mutant 
(HbPRE ACA) did not respond to the addition of Nos. These results show that Nos 
significantly improves Pum RNA binding and can cause greater than 80-fold increases in 
affinity for weak PRE sites. This will substantially expand the number of Pum targets in 
vivo in addition to greatly enhancing Pum repression activity.  
We then asked whether each PRE element tested in vitro could confer Nos 
enhanced Pum repression on a reporter mRNA. The results corroborated our own in vitro 
analyses and validate observations in vivo. The perfect PRE sites, HbPRE1 and HbPRE2, 
were significantly repressed even with small amounts of Nos expression, much like Hb 
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regulation in the embryo posterior. The BcdPRE, which contains a central G residue 
normally absent in PREs (UGUAGAUA), conferred a moderate amount of repression. In 
the embryo, Bcd mRNA repression is observed in the anterior upon ectopic expression 
of Nos (Gamberi et al. 2002). Repression of the CycBPRE reporter required larger 
amounts of transfected Nos, mirroring the requirement for concentrated Nos protein in 
pole cells where CycB translation is repressed (Kadyrova et al. 2007). Mutation of U3 to 
G in the HbPRE2 reporter resulted in behavior resembling the CycB PRE. Surprisingly, 
even the strong mutant HbPRE2 ACA, where the conserved U1G2U3 triplet has been 
changed to ACA, was slightly repressed by high amounts of transfected Nos. High 
amounts of Nos also resulted in repression of a reporter without any PREs in the 3’UTR, 
but this repression was significantly reduced compared to those containing PREs. We 
attribute this background to degenerate PRE-like sites intrinsic to the reporter coding 
sequence (CDS). The Paralytic mRNA is regulated through such a CDS intrinsic site 
(Muraro et al. 2008).   
As measured via EMSAs, weak PREs could be bound with similar affinity to strong 
PREs when Nos was present. In cells, the level of repression is proportional to the Nos-
Pum-RNA affinity. The HbPRE2 is bound most strongly by Pum and Nanos and can be 
repressed by adding small amounts of Nos in cells. The CycBPRE or G3 PRE were only 
bound by Pum when Nos was present, and are only repressed when large amounts of 
Nanos are expressed. The ACA PRE mutant is not bound in vitro by Pum even when Nos 
is present, and it is repressed more weakly than other PRE reporters at high amounts of 
Nos expression. Thus, the level of Nos determines what affinity is necessary for a PRE 
to be bound and, to a certain extent, the magnitude of repression. 
4.4.3 The Nanos N-terminus contains a novel Pum interaction domain 
 
If RNA binding enhancement, which occurs through the Nos ZC regions, was 
sufficient for Pum enhancement, why does removal of the Nos N-terminus affect 
repression? The Nos N-terminus could be performing multiple roles, including reinforcing 
the Pum-Nos interaction or recruiting other factors which might aid in repression. To 
directly test the former hypothesis, we performed Co-IPs of Pum and Nanos. We were 
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surprised to find an RNA independent association of the two proteins, as this has not 
been observed previously. Using truncations of the Nos protein, we further dissected the 
region of Nos necessary for this interaction. The Nos N-terminus was necessary and 
sufficient for RNA independent association with Pum. Interactions between the PUF RBD 
and Nanos homologues have been observed by our group in vitro and by other groups 
using yeast hybrid assays and pulldown experiments with proteins from flies, frogs, and 
humans (Sonoda and Wharton 1999; Edwards et al. 2001; Nakahata et al. 2001; 
Jaruzelska et al. 2003). These interactions all depend on regions of Nos encompassing 
regions Z and C. We speculate that the novel association between Pum and the Nos-N 
terminus, coupled to the interaction of NosZC and the Pum RBD, might assist in Pum-
Nos-RNA complex formation. This model might explain the partial loss of Nos mediated 
repression when the N-terminus is excluded. Further experiments are necessary to 
determine whether this interaction is direct and to identify what regions of Pumilio are 
required. 
4.4.4 The Nanos N-terminus contains a Pum independent repression domain 
  The Nos N-terminus may serve another role by recruiting factors that enhance 
repression function rather than RNA binding. To evaluate the ability of each Nos domain 
to repress protein expression, we used the MS2 tethering assay to link Nos directly to an 
mRNA reporter. This method of Nos recruitment resulted in robust repression of the 
2xMS2 reporter, much like the effect of untethered Nos expression on RnLuc Hb 3’UTR. 
However, similar mutations and truncations of tethered Nos had vastly different outcomes 
on reporter expression. Mutation or deletion of Nos Z and C had no effect on repression 
by tethered Nos. In fact, the Nos N-terminus was sufficient for near complete activity. 
There are many candidates for factors that might underlie the activity of this newly 
identified Nos repression domain (NRD); Pum, Brat, the NOT complex, and Cup have all 
been reported to bind Nos and function in translational regulation or mRNA decay. To 
assess which factors might contribute to NRD activity, we performed RNAi depletion of 
each. Only depletion of NOT complex components caused a minor reduction of 
repression. This suggests that the Nos N-terminus may be able to recruit an as yet 
unidentified translational regulator. This model could explain why the N terminus of Nos 
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is necessary for full repression of the Hb 3’UTR reporter in cells. Recruitment of the 
unknown factor by the NRD may contribute to the enhancement of Pum repression in 
vivo. 
4.4.5 Implications and future directions 
In summary, we have characterized two new mechanisms of Pum repression 
enhancement by Nos. Nos improves the binding affinity of the Pum RBD for RNA targets 
through assembly of a ternary complex. This strengthens binding to the PRE consensus 
and can also confer binding on non-canonical Pum targets. This ability of Nos extends to 
the enhancement of Pum repression of PRE and non-PRE containing reporter mRNAs in 
cells. A newly identified Pum interaction 
with the Nos N terminus may aid in 
ternary complex formation. Further, the 
Nos N-terminus contains an effective 
repression domain that remains active 
when other known Nos partners are 
depleted. Together, enhanced RNA 
binding and the recruitment of new 
repression activity could increase the 
magnitude of Pum repression and 
expand the breadth of Pum mRNA 
targets (Fig 4.21). 
How do these findings inform the biology of Pum and Nos proteins? Nos, through 
N-terminal and C-terminal interactions, shifts Pum from a partially inactive state to a fully 
active state. Nos does so through enhancement of RNA binding and the addition of 
repression. For the Hunchback RNA, this results in posterior specific Pum binding and 
repression, resulting in proper embryonic development. In the developing pole cells and 
germline stem cells, high concentrations of Nos confer Pum regulation on the weak PREs 
of Cyclin B mRNA. This prevents premature differentiation of the germline and ultimately 
maintains asymmetric stem cell division. In the nervous system, Nos could be localized 
in specific synaptic regions to control plasticity at the neuromuscular junction through 
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regulation of the sodium channel, Paralytic. The Paralytic mRNA has a PRE within its 
CDS, and Nos enhanced RNA binding may be required for Pum to access this site.  
It is unclear whether Nos and Pum homologs interact synergistically like the fly 
proteins. PUFs are present throughout eukaryotes, while NOS proteins are conserved 
among metazoans. Germline regulation by PUFs and NOS proteins is a common feature 
(Jaruzelska et al. 2003, Lai et al. 2011, Nakahata et al. 2001), while only PUFs are 
implicated in the regulation of the mammalian nervous system (Driscoll et al. 2013, 
Vessey et al. 2010). Loss of the retinoblastoma tumor suppressor results in increased 
expression of Nos in flies and NOS in human cells, and consequently repression of mRNA 
targets containing PREs (Miles et al. 2014). Only the ZnFs of Nos and NOS proteins are 
highly conserved, yet the Nos N and C-terminal regions are both important for optimal 
enhancement of Pum repression. Additionally, the sequence between repeats 7 and 8 of 
the Pum RBD thought to interact with Nanos only exists in flying insects. Because 
mammalian PUFs and NOS proteins are reported to interact, the nature of their 
association must be distinct from Nos and Pum. The N-termini of NOS proteins from fish, 
amphibian, and mammals contain a motif that interacts with the NOT1 subunit of the 
CCR4-NOT deadenylase complex and tethering this domain to mRNA is sufficient to 
cause translational repression (Bhandari et al. 2014, Lai et al. 2011). The Drosophila Nos 
N-terminus does not contain this motif yet is capable of translational repression 
independent of the NOT complex. The interaction and enhancement mechanism of PUFs 
and NOS proteins might have changed, but the functional outcomes may remain. 
Whether or not mammalian NOS proteins are capable of enhancing PUF RNA binding is 
unknown. 
The remaining questions are mechanistic in nature. How is the Pum-Nos complex 
assembled and how does this impart strengthened RNA binding? More quantitative 
analyses are required to assess the contributions of Nos to kon and koff rates of Pum RNA 
binding. It remains unclear whether Nos facilitates complex formation through a transient 
interaction with RNA or by changing the Pum RBD’s ability to engage RNA, putatively 
through binding induced structural changes. Looking at the big picture, can Nos or 
proteins like Nos confer changes in the identities of Pum targeted RNAs transcriptome-
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wide? Are the mRNAs targeted by Pum alone distinct from those bound when Nos is 
present? New approaches leveraging next generation sequencing technologies would 
inform what these changes might be. Lastly, what role does the Nos N-terminus play in 
the enhancement of RNA binding, if any? Importantly, what is/are the mechanism(s) of 
the NRD? Understanding the effects of the NRD on mRNA deadenylation, decay, and 
translation would inform what components are necessary for repression. Does the 
availability of each repression mechanism control the ultimate fate of an mRNA target? 
Depending on the collection of co-repressors available, Pum repression might lead to 
transcript silencing and storage, deadenylation and decay, or even activation of 
expression. Understanding how Nos modulates Pum repression remains integral to 
revealing how all PUF proteins might be regulated.  
4.5 Materials and Methods 
Plasmids. Plasmids used in this study included pAc5.1 FFluc, pAc5.1 RnLuc Hb 
3’UTR, pAc5.1 RnLuc 2xMS2, pIZ HT, and the empty pUB 3xFLAG vector (mock 
transfections of Fig. 4.17), all of which were previously described in Chapters 2 and 3 
(Weidmann and Goldstrohm 2012; Weidmann et al. 2014). The described changes to the 
RnLuc Hb 3’UTR reporter plasmid (UGU – ACA for each PRE) to create pAc5.1 RnLuc 
Hb 3’UTR m1, mt2, and mut1-2 were generated using inverse PCR. The pIZ HT-Nanos 
expression vector was created by inserting the coding DNA sequence of Drosophila 
Nanos protein (NP_001262723.1) into the XbaI restriction site of pIZ HT in frame with an 
upstream HaloTag coding sequence and TEV cleavage site and downstream V5 epitope 
and His6 elements. Importantly, we found that the Nanos sequence amplified from whole 
fly cDNA was that of Nanos isoform B, which lacks the 19 amino acid sequence aa14-
VGVANPPSLAQSGKIFQLQ-32 present in the N-terminus of full length Nos isoform A 
(NP_476658.1). This sequence was not present in any constructs presented here and is 
thus unnecessary for all activities mentioned. However, the amino acid positions noted in 
the text correspond to Nos isoform A. This was meant to prevent confusion in reporting 
of the originally identified Cysteine mutations (C319Y and C354Y, which are C300Y and 
C335Y in isoform B) and domain separations. The C319Y and C354Y mutations were 
generated via Quickchange site directed mutagenesis, while the following truncations 
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were generated with inverse PCR: NZ includes aa1-373, ZC includes aa289-401, N 
includes aa1-294, Z includes aa289-373, and C includes aa374-401. 
Bacterial expression vectors for expression of recombinant Pum and Nos were 
created with the pFN18K vector (Promega), which allows fusion of an N-terminal HaloTag 
to a protein of interest for purification. Sequence encoding the RNA binding domain of 
Pum (aa 1091-1426 of NP_001262403.1) was inserted into pFN18K via the Flexi® 
Cloning System (Promega) to create the Pumilio RBD WT vector. Quickchange site 
directed mutagenesis was used to generate the F1367S RBD mutant and the RBD mutR7 
(S1342A N1343A E1346A) vectors. An identical approach was applied to create pFN18K 
NosZC and the C319Y and C354Y mutant vectors. A triple FLAG-tag was added with 
inverse PCR into the pFN18K Pumilio RBD such that the epitope would be incorporated 
at the N-terminus of the purified and eluted protein. Similarly, a V5 sequence was added 
to pFN18K NosZC such that the final protein included a C-terminal epitope.  
Reporters used for Nos enhancement of Pum repression with varying PRE 
elements were all made based on the pAc5.1 RnLuc plasmid. Two changes were made 
to generate the pAc5.4 RnLuc base vector (RnLuc MCS in Fig. 4.16). First, a second 
cleavage and polyadenylation element intrinsic to the pAc5.1 vector was removed via 
inverse PCR, leaving only the strong SV40 element included in the original Renilla vector 
sequence. Second, a sequence within the RnLuc ORF that produced a near PUF site in 
the mRNA was synonymously mutated to eliminate possible background. The pAc5.4 
RnLuc MCS vector contains a 3’UTR sequence between the stop codon and the SV40 
cleavage and polyadenylation signal of the form: 
 
(XhoI and NotI restriction sites in bold, insertion site is underlined) 
5’TTCTAGGCGATCGCTCGAGCCCGGGAATTCGTTTAAACCTAGAGCGGCCGCTGG
CCGC 
 
To generate each pAc5.4 reporter, complementary DNA oligos (IDT) bearing wild 
type and mutant PRE elements from endogenous Pum targets were inserted into the XhoI 
and Not1 restriction sites of the pAc5.4 RnLuc MCS reporter. The oligos used are as 
follows: 
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(Restriction site overhangs in bold, PRE sequences underlined, mutations lowercase) 
 
HbPRE2 Forward:  
5’-TCGACGAAAATTGTACATAAGCC 
 
HbPRE2 Reverse:  
5’-GGCCGGCTTATGTACAATTTTCG 
 
HbPRE2 G3 Forward:  
5’-TCGACGAAAATTGgACATAAGCC 
 
HbPRE2 G3 Reverse:  
5’-GGCCGGCTTATGTcCAATTTTCG 
 
HbPRE2 ACA Forward:  
5’-TCGACGAAAATacaACATAAGCC 
 
HbPRE2 ACA Reverse:  
5’-GGCCGGCTTATGTtgtATTTTCG 
 
HbPRE1 Forward:  
5’-TCGACCAGAATTGTATATATTCG 
 
HbPRE1 Reverse:  
5’-GGCCCGAATATATACAATTCTGG 
 
 
BcdPRE Forward:  
5’-TCGAAAGTGATTGTAGATATCTA 
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BcdPRE Reverse:  
5’-GGCCTAGATATCTACAATCACTT 
 
CycBPRE Forward:  
5’-TCGAGACTATTTGTAATTTATATC 
 
CycBPRE Reverse:  
5’-GGCCGATATAAATTACAAATAGTC 
 
The FLAG-Pum vector used for co-immunoprecipitation of Nos and Nos 
truncations was generated by PCR amplification of full length Pumilio sequence including 
V5 and His6 tags from the pIZ Pumilio vector (Chapter 2) (Weidmann and Goldstrohm 
2012) and insertion into the pUB FLAG vector. The pIZ MS2-Nanos plasmid was achieved 
through insertion of Nanos sequence in frame between the upstream MS2 coat protein 
and the downstream V5 His6 using KpnI and XbaI restriction sites. As with pIZ HT-Nos 
vectors, a combination of Quickchange site directed mutagenesis and inverse PCR was 
employed to generate MS2-Nos C354Y, MS2-NZ, MS2-ZC, MS2-NosN, and MS2-NosZ. 
  
Cell Culture. D.mel-2 cells (Invitrogen) were cultured in Sf-900 III serum-free 
medium (Invitrogen) with 50 Units/mL penicillin and 50 µg/mL streptomycin using 
standard cell culture techniques. Cells were grown at 28°C. 
 
Transfections. Transfections were performed very closely to previously described 
for D.mel-2 cells (Chapters 2 and 3) (Weidmann and Goldstrohm 2012; Weidmann et al. 
2014). Each Effectene (QIAGEN) 6-well transfection was composed of 5ng FFLuc control 
plasmid, 10ng of RnLuc plasmid, 200ng total of expression vector, 43-44µl of EC buffer, 
1.6µl of enhancer, 2µl of Effectene, 300µl of new sf900 III media, and 1.6mL of D.mel-2 
cells (1M/mL). For untethered Nos experiments where mass was not indicated, 10ng of 
Nos expression vector was balanced to 200ng total with empty pIZ vector. For every Nos 
transfection gradient, pIZ was also used to balance total expression vector to 200ng. 
When using MS2 tethered Nos, 50ng was the standard amount. For transfections used 
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in Co-Immunoprecipitation of FLAG-Pum and HT-Nos, the transfections included 100ng 
of pUB plasmid bait, 300ng of pIZ-HT prey, 92µl of EC buffer, 3.2µl of enhancer, 4µl of 
Effectene, 300µl of new sf900 III media, and 1.6mL of D.mel-2 cells (1.5M/mL). 
 
RNA Interference. As previously described, double-stranded RNAs (dsRNAs) 
were in vitro transcribed for RNAi including: non-targeting control (NTC) LacZ, Pum, Brat, 
Pop2, and Ccr4 (Van Etten et al. 2012; Weidmann and Goldstrohm 2012; Weidmann et 
al. 2014). The following primers were used to generate templates for production of Not1 
and Cup dsRNAs, with T7 promoter sequence underlined and gene specific regions 
bolded:   
 
Not1 Forward:  
5’-GGATCCTAATACGACTCACTATAGGCTTTACGCTCAGTTGCTGCAGGACC 
 
Not1 Reverse:  
5’-GGATCCTAATACGACTCACTATAGGCAAAGCAATCGCCTGAGTTCCCAC 
 
Cup Forward:  
5’-GGATCCTAATACGACTCACTATAGGGTACCACAATGGCAAGTCGCAGC 
 
Cup Reverse:  
5’-GGATCCTAATACGACTCACTATAGGACGTTTCTCGCTCTGTTTCGCC 
 
Corresponding regions were amplified via PCR from D.mel-2 cDNA and dsRNA 
was transcribed in vitro and purified as previously described (Van Etten et al. 2012; 
Weidmann and Goldstrohm 2012; Weidmann et al. 2014). For knockdown, cells in one 
well of a 6-well plate, with total volume 1.6 mL, was treated with 6 µg of each dsRNA for 
5 minutes before transfection.  
 
Luciferase Assays. Luciferase assays were performed as previously described 
using dual glo assay (Promega) (Chapters 2 and 3) (Weidmann and Goldstrohm 2012; 
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Weidmann et al. 2014). A relative response ratio (RRR), from RnLuc signal/FFLuc signal, 
is calculated for each sample. The ratio is normalized to the control (set to 100). Percent 
repression is derived from the equation 100*(1-(RRRWT/RRRNegative Control)), where RRRWT 
is from a sample transfected with an active regulator and RRRNegative Control comes from a 
sample transfected with an equivalent amount of an inactive negative control. The pIZ-
HT vector was used as the inactive control for HT-Nos constructs. The control for tethered 
function experiments was the MS2 expression vector, pIZ MS2.  
 
 Immunoprecipitation. For FLAG immunoprecipitations from D.mel-2 cells, two 
duplicate 6-wells of 2 mLs of 1.5 million cells/mL were transfected (Effectene) with 300 
ng of pIZ HT prey plasmids (HT control, HT-Nanos, HT-N, or HT-ZC) and 100 ng bait 
(empty pUB or FLAG-Pum). Forty-eight hours post-transfection, the 4mL of transfections 
were pelleted for 3 minutes at 1000xg and lysed in 250 µL lysis buffer containing 0.2% 
Igepal CA-630 (USB), 50 mM Tris-HCl (pH 8.0), 5mM MgCl2, and 150 mM NaCl. Protease 
inhibitors were added to final concentrations of 2 mM phenylmethylsulfonyl fluoride 
[PMSF], 20 µg/ml aprotinin, 20 µg/ml pepstatin, and 20 µg/ml leupeptin. RNase ONE and 
RNase A were also added to 50 U/mL and 10 µg/mL, respectively. Lysates were passed 
through a 25 gauge needle 5x before incubation on ice for 1 hour. Lysates were cleared 
by centrifugation at 16,000xg for 2 minutes. Lysates were then diluted 4-fold into buffer 
containing 50 mM Tris-HCl (pH 8.0), 5mM MgCl2, and 150 mM NaCl. A portion of this 
diluted lysate (40µl) was saved as input. FLAG containing complexes were precipitated 
from remaining volume using 20µl M2 Affinity Resin (Sigma) that had been washed three 
times in lysis dilution buffer. Complexes were bound four 24 hours at 4°C. After binding, 
the resin was washed a total of 9 times in  1mL wash buffer (50 mM Tris-HCl (pH 8.0), 
5mM MgCl2, and 300 mM NaCl) with a decreasing amount of detergent (3x with 0.5% 
Igepal CA-630, 3x with 0.2%, and 3x with 0.05%). Beads were eluted for 24 hours at 4°C 
in 50 µl elution buffer containing 50 mM Tris pH 8.0, 300 nM NaCl, 5 mM MgCl, 0.05% 
Igepal CA-630 and 300 ng/µl of 3xFLAG peptide.  
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 Bacterial Expression and Purification of Recombinant Protein. KRX bacterial 
cells (Promega) were transformed with pFN18K plasmids, plated on LB media with 
kanamycin, and grown at 37C. A single colony was moved into 25mL of liquid culture 
with agitation at 37C for 16 hours. 10mL of this culture was diluted into 750mL of 2xYT 
media with 25µg/mL Kanamycin and 2mM MgSO4 and incubated at 37C with shaking. 
When the culture reached OD600 of 0.7-0.9, cells were induced by adding 5mL of 20% 
Rhamnose (0.1% final) and grown at 37C for 3 hours. Cells were pelleted at 7000xg for 
10 minutes, washed in 30mL of Bug Wash (50 mM Tris-HCl, pH 8.0, 10% Sucrose) and 
pelleted again.  
Pellets were resuspended in 25mL binding buffer including 50mM Tris-HCl pH 8.0, 
0.5mM EDTA, 2mM MgCl2, 150mM NaCl, 1mM DTT, 0.05% Igepal CA-630, 1 mM PMSF, 
10 µg/ml aprotinin, 10 µg/ml pepstatin, and 10 µg/ml leupeptin. To lyse cells, lysozyme 
was added to a final concentration of 0.5mg/mL and cells were incubated at 4°C for 30 
minutes with gentle rocking. MgCl2 was then increased to 7mM concentration and DNase 
I (Roche) was added to 10µg/mL before continuing incubation for another 20 minutes. 
Lysates were cleared at 50,000xg for 30 min at 4C. HaloTag containing proteins were 
bound with 500µl of pre-washed HaloLink Resin (Promega) for 24 hours at 4°C. Beads 
were washed 3 times with Wash Buffer (50mM Tris-HCl pH 8.0, 0.5mM EDTA, 2mM 
MgCl2, 1M NaCl, 1mM DTT, 0.5% Igepal CA-630) and 3 times with Elution Buffer (50mM 
Tris-HCl, pH 7.6, 150mM NaCl, 1mM DTT, 20% Glycerol). After washing, beads were 
resuspended in 400µl of Elution Buffer with 30U of AcTEV protease (Invitrogen) and 
cleavage proceeded for 24 hours at 4°C. After removal of beads, the concentration of 
cleaved protein was measured compared to BSA standards through SDS-polyacrylamide 
(4-20%) gel electrophoresis and subsequent Coomassie staining. 
Fluorescent and Radioactive Electrophoretic Mobility Shift Assays. All RNA binding 
reactions were performed in RNA Binding Buffer (50mM Tris-HCl pH 7.6, 150mM NaCl, 
2mM DTT, 2µg/mL BSA, 0.01% Igepal CA-630, 0.02% Bromophenol Blue, 20% Glycerol). 
Reactions were left to equilibrate for 3 hours at 4°C. A 5% native polyacrylamide TBE 
mini-PROTEAN gel (BIO-RAD) was pre-run for 3 hours at 50V before loading 5µl of each 
sample. Gels were run at 50V for 2-2.25 hours at 4°C. For fluorescent EMSAs, RNA was 
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imaged immediately via fluorescence imaging with a Typhoon Trio imager (GE 
Healthcare). For the fluorescent EMSAs, the concentration of target RNA was held 
constant at 1nM, while the concentrations of Pum RBD and Nos ZC are as noted in Figure 
4.8. The fluorescent RNA target used contained the following sequence (the PRE element 
is underlined): 
Cy5 Nanos Response Element RNA 
5’-Cy5-rUUGUUGUCGAAAAUUGUACAUAAGCC 
For the Kd obs measurements, radioactive RNA oligos were used at a constant 
concentration of 300pM. RNAs were labeled with 32P at their 5’ ends using T4 DNA Ligase 
(NEB) with ATP [λ-32P] (Perkin-Elmer). RNA oligos (IDT) used included the following (with 
PRE elements underlined and mutations in lowercase bold): 
 
HbPRE2 RNA:  
5’-rAAAUUGUACAUAAGCC 
 
HbPRE2 G3 RNA:  
5’-rAAAUUGgACAUAAGCC 
 
HbPRE2 ACA RNA:  
5’-rAAAUacaACAUAAGCC 
HbPRE1 Forward:  
5’-rGAAUUGUAUAUAUUCG 
 
BcdPRE Forward:  
5’-rUGAUUGUAGAUAUCUA 
 
CycBPRE Forward:  
5’-rUAUUUGUAAUUUAUAUC 
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 Replicate EMSAs (N = 3) were performed for each RNA to calculate Kd obs. For 
HbPRE2 RNA, the concentration of NosZC in the +NosZC EMSAs was held constant at 
400nM while the gradient of Pum RBD concentrations included 0nM, 0.2nM, 0.5nM, 1nM, 
2nM, 5nM, 10nM, 20nM, 50nM, 75nM, 100nM, 150nM, and 200nM. For all other RNAs 
tested, the +NosZC condition held NosZC concentration at 1µM while Pum RBD 
concentration gradient included 0nM, 2nM, 5nM, 10nM, 20nM, 50nM, 100nM, 200nM, 
300nM, 400nM, 500nM, 750nM, and 1000nM. Gels containing radioactive RNAs were 
dried at 70°C for 30 minutes and vacuum affixed to Whatman paper. The radioactive gels 
were then exposed to a storage phosphor screen for 16 hours. The signal on the screen 
was captured with a Typhoon Trio imager (GE Healthcare) and subsequently quantified 
using ImageQuant TL Software (GE Healthcare). Fraction bound values were plotted 
against RBD concentration for multiple EMSAs and Kd obs was calculated via nonlinear 
regression analysis within the GraphPad Prism software (GraphPad Software, Inc.). 
Western blotting. Western blotting from luciferase assay samples was performed 
as previously described in Chapters 2 and 3 (Weidmann and Goldstrohm 2012; 
Weidmann et al. 2014). Proteins were separated via SDS-polyacrylamide (4-20%) gel 
electrophoresis and transferred onto Immobilon-P membranes (Millipore). All membranes 
were probed with either V5 monoclonal antibody (Invitrogen) or monoclonal anti-FLAG 
M2 antibody (Sigma). Secondary detection was performed using horseradish peroxidase 
conjugated goat anti-mouse IgG (Thermo Scientific). Signals were detected using 
Immobilon western chemiluminescent substrate (Millipore) and autoradiography film. 
 
Fluorescent labeling and visualization of Halotag protein constructs. Protein 
extracts from D.mel-2 cells expressing HaloTag fusions were incubated with 100nM 
HaloTag TMR Ligand (Promega) for 30 min on ice, protected from light. After labeling, 
extracts were separated via SDS polyacrylamide (4-20%) gel electrophoresis and 
detected by fluorescence imaging with a Typhoon Trio imager (GE Healthcare).  
 
cDNA preparation and qPCR. For measurement of endogenous mRNA 
knockdown, RNAs were primed with random hexamers (IDT) for synthesis of cDNAs 
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using GoScript reverse transcriptase (Promega). The final concentration of RNA in these 
reactions was 200 µg/mL. To measure endogenous mRNA levels, quantitative PCR 
(qPCR) was performed on 5 µl of cDNA product in a 50 µl reaction using 100 nM of gene 
specific primers and GoTaq qPCR master mix (Promega) as described previously in 
Chapters 2 and 3 (Weidmann and Goldstrohm 2012; Weidmann et al. 2014). Standard 
negative control reactions were performed without reverse transcriptase. Differences in 
mRNA levels were calculated using the ΔΔCt method. Ct values were measured and 
normalized to the internal control Rpl32 mRNA to generate ΔCt. ΔΔCt was derived relative 
to the non-targeting control ΔCT (Livak and Schmittgen 2001; Schmittgen and Livak 
2008). qPCR primers for Rpl32, Pum, Brat, Pop2, and Ccr4 were previously published 
(Van Etten et al. 2012; Weidmann and Goldstrohm 2012; Weidmann et al. 2014) The 
qPCR primer sequences for additional Drosophila genes are as follows: 
 
Not1 Forward: 5’- CTTTAACTCGAGCAGCGACTACAGC 
Not1 Reverse: 5’- CTGGTTCTGTTGCGTGTACAGTGC  
 
Cup Forward: 5’- CTGAAGGCGATCCTCGGCC 
Cup Reverse: 5’- CGATCCATGTCCGTCAAGCG 
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CHAPTER 5 
 
CONCLUSIONS  
 
5.1 Summary of Thesis 
 
5.1.1 Repression and regulatory domains of Pumilio 
This dissertation expands the understanding of how PUF proteins work to control 
the flow of genetic information. My findings elucidate combinatorial control of mRNA 
regulation by the multifunctional RNA binding proteins Nanos and Pumilio. This work has 
focused on molecular mechanisms, but the results apply to the important biological 
processes directed by PUF post-transcriptional regulation. Contributions to the field 
include elucidation of regions of PUFs necessary for activity, a novel means of regulating 
PUF activity, new factors involved in PUF mediated repression, and, in the case of Nanos, 
how partner proteins can influence the outcome of PUF control through RNA binding 
enhancement and accessory repression recruitment. 
My first major finding addressed the existing model of Drosophila Pumilio (Pum) 
repression. Nanos (Nos), and sometimes Brain Tumor, are necessary for Pum mediated 
repression of important mRNAs throughout the fly life cycle. The existing model 
suggested that Pum was only necessary for RNA binding, and the partners Nos and Brain 
Tumor recruited factors necessary for translational repression. I developed and optimized 
a cell-based luciferase reporter assay that measures Pum repression. I observed that 
while Nos could stimulate Pum repression, both Nos and Brain tumor were dispensable 
for Pum’s activity (Chapter 2). Additionally, the RNA binding domain (RBD) of Pum was 
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not sufficient for full repression. Instead, a combination of four repression domains, 
including three N-terminal regions and the RBD, were necessary for complete activity. 
Each domain could repress 
independently when tethered directly 
to an mRNA. The ability of PUF N-
terminal domains to repress was 
conserved in human PUM1 and 
PUM2 as well. My work discovered 
these multiple sources of repression 
activity and revealed how Pum can 
use multiple mechanisms to achieve 
target inhibition (Fig. 5.1).  
Another important discovery 
was made during the analysis of the 
Pum N-terminus: two conserved regulatory motifs that differentially modulate repression 
domain function. One domain, PCMb (Pumilio conserved motif B), could completely block 
the activity of two Pum repression domains. Another region, PCMa (Pumilio conserved 
motif A), counteracts inhibition by PCMb. The PCMa region was also somewhat modular, 
as it could be fused in a non-native conformation to restore repression to the inhibited 
PCMb-RD3 construct. This was the first demonstration of auto-regulatory domains within 
the Pum N-terminus (Fig. 5.2). 
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5.1.2 Mechanisms of mRNA repression by the PUF RNA binding domain 
My work has also clarified a portion of Pum’s Nanos independent repression 
mechanism (Chapter 3). I first evaluated a model of repression wherein the PUF RBD 
bound to Argonaute proteins to interfere with translation elongation through eEF1A. While 
I confirmed the association of PUF RBDs (fly and human) with Argonautes, I showed that 
the interaction was not integral to PUF function. Depletion of Argonaute proteins or 
elimination of Argonaute-RBD binding did not affect repression by the PUF RBD. Instead, 
I confirmed the conserved role of deadenylation in RBD activity. I showed that the Pum 
RBD could accelerate deadenylation of an mRNA target. This deadenylation was 
dependent upon the Ccr4-Not deadenylase complex. Homologs of the NOT complex 
subunit, Pop2, interact directly with PUF proteins in eukaryotes ranging from yeast to 
humans. RBD mediated deadenylation acceleration is likely a conserved mechanism of 
all PUF proteins. 
However, further experiments revealed that deadenylation was a consequence of 
Pum RBD repression, not a prerequisite. RBD activity did depend on the presence of a 
poly(A) tail, however, as it was unable to repress an mRNA that terminated with a Histone 
stem loop. This could be overcome by insertion of a poly(A) tract within the 3’UTR. I found 
that this was due to the RBD’s reliance on the poly(A) binding protein, pAbp, for 
translational inhibition. The RBD binds pAbp and prevents its ability to stimulate 
translation. Unlike other regulators, the RBD does not exclude pAbp from poly(A) RNA, it 
merely blocks pAbp’s ability to promote initiation. I saw that repression by a human PUF 
protein was also impaired by depletion of the human pAbp homolog, PABPC1. This is 
evidence of a conserved mechanism of translational inhibition by PUF RBDs. One 
important caveat: the N-terminal Pum repression domains do not require pAbp or poly(A) 
and operate through an as yet unknown mechanism. This allows Pum to control gene 
expression in different contexts where one pathway may or may not be available. 
5.1.3 Pumilio enhancement by Nanos 
My work has also led to a new interpretation of the role that Nos plays in Pum 
repression. Nos is certainly necessary for regulation of specific Pum mRNA targets in 
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vivo, but my experiments offer a new explanation for this requirement beyond a simple 
co-recruitment model (Chapter 4). Pum can repress without Nos, but the addition of 
Nanos stimulates Pum activity. Using my cell based assay, I was able to identify regions 
of Nanos sufficient for Pum enhancement. The Nos zinc fingers and C-terminal extension 
(ZC) were most important, but the Nos N-terminus also contributed. I tested whether Nos 
had any effect on the binding of RNA by the Pum RBD. The Nos ZC region improved the 
affinity of the RBD for an RNA containing the Pum Response Element (PRE) in vitro. In 
fact, Nos ZC permitted the Pum RBD to bind to RNAs with weak PRE sites that the Pum 
RBD could not bind to alone. Thus, 
Nos enhances Pum RNA binding. 
The expression of Nos in cells 
could also confer Pum repression 
on mRNA reporters bearing 
degenerate or mutant PRE sites. 
This enhancement of RNA binding 
is likely why Nos is required in vivo 
for Pum repression; the localization 
of Nos determines where Pum will 
bind RNAs. For example, this 
explains why Pum repression of the Hunchback mRNA is restricted to the posterior where 
Nanos is expressed. It also may underlie why high concentrations of Nanos are necessary 
in the pole cells to regulate through the Cyclin B PRE, a highly degenerate binding site. 
These observations also suggest that Pum, with the help of Nos, could bind an entirely 
new set of mRNA targets without canonical PREs (Fig. 5.3). 
Lastly, I uncovered new roles for the Nos N-terminus that could contribute to Pum 
enhancement. First, the Nanos N-terminus is responsible for an RNA independent 
association with Pum. This could reinforce formation of a Pum-Nos-RNA complex or 
assist in the recruitment of Pum co-repressors. Second, I found that tethering the Nos N-
terminus can lead to Pum-independent repression. Depletion of other proposed Nanos 
partners (Brat, Not, or Cup) did not impede activity, suggesting a novel mechanism of 
repression. Nos might recruit additional repression activities to the complex to ensure 
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target inhibition. The mechanism of repression utilized by Pum and Nanos N-termini 
remain to be elucidated in detail. 
5.2 Future Directions 
5.2.1 How do the N-terminal repression domains work? 
While my work has made significant strides in understanding PUF activity, it has 
also generated new lines of inquiry. Importantly, through what mechanisms do the N-
terminal Pum repression domains (RDs) exert their function? Their sequence is not very 
conserved, although both Drosophila and human PUFs maintain repression domains in 
their N-termini. A conserved structure may be important for function. However, based on 
sequence analysis and structure prediction, the RD sequences appear to be highly 
disordered and of low complexity. For instance, the Pum RDs contain multiple regions of 
poly-glutamine thought to confer prion-like aggregation (Salazar et al. 2010). These 
domains also mediate assembly into distinct aggregate foci. Mammalian Pumilio 2 
(Pum2) exists in Ribonucleoprotein (RNP) particles localized in dendrites and also 
assembles into larger aggregate stress granules (Vessey et al. 2006). Stress granules 
and another type of RNP granule, processing bodies, are thought to be sites of mRNA 
storage and perhaps direct mRNA turnover through coordination of decay factors (Decker 
and Parker 2012). Preliminary experiments with further truncations of each RD have not 
clarified what is necessary. Multiple motifs within each repression domain, including those 
without poly-glutamine, seem to contribute to full activity. 
Our lab has pursued multiple approaches to identify partners involved in activity: 
including a limited RNAi screen, a yeast 2-hybrid approach, and mass spectrometry. We 
have identified putative interactors, but no factor necessary for repression was identified. 
A genome-wide RNAi screen could identify factors involved in function, but the reporter 
assay must be adapted for this procedure. Likely candidates might include enhancers of 
decapping, translation initiation factors, or ribosomal components. Refinements in the 
mass spectrometry approach might also be helpful. This could include purification of RNA 
bound complexes rather than immunoprecipitation of the protein domains alone. Such an 
approach might enrich for active Pum complexes rather than all factors which can bind or 
regulate. Microscopy would be useful to test whether each RD changes the localization 
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of mRNA targets. If the RDs truly aggregate in granules, this should be easy to observe. 
Alternatively, the Pum RDs may have some amount of activity towards RNA on their own, 
possibly nucleolytic or RNA binding. In vitro assays could address whether the RDs bind 
and or degrade RNA molecules. A necessity for this approach would require new methods 
of purifying these domains. Similar approaches will be useful in describing the 
mechanism(s) of the Nanos repression domain as well. 
5.2.2 What is the purpose and mechanism of autoregulation? 
Analysis of the Pum N-terminus revealed the existence of auto-regulatory domains 
PCMa and PCMb. These regions are more conserved than the repression domains 
themselves and are arrayed in a similar fashion in fly and human PUFs. How do these 
auto-regulatory domains operate? Work describing the fly phosphoproteome revealed 
that region PCMa is highly phosphorylated (Zhai et al. 2008). This post-translational 
modification may act as a switch between active and inactive RDs. The modification state 
of PCMa might determine whether PCMb plays an inhibitory role. Upon 
kinase/phosphatase activity on PCMa, PCMb could shift its regulatory state. Mutational 
analysis of each phosphorylated site in PCMa would be necessary to confirm their role in 
regulation. How PCMa and PCMb modulate the RDs is also unclear. There is no current 
evidence that PCMb can act to inhibit RD2 or RD3 in cells when it is not physically fused, 
however PCMa added in trans has a limited ability to block PCMb inhibition. PCMb may 
inhibit recruitment of co-repressors through a change in localization or through 
modifications of local structure. PCMa might counteract this activity through association 
with PCMb. We have initiated in vitro binding assays meant to identify direct interactions 
between PCMa and PCMb. Microscopy approaches could delineate a mechanism of 
differential localization from one of dynamic structure. Tethering PCMb to each RD might 
drastically change its position in the cell. Structural characterization of the RDs alone and 
fused to each regulatory motif could highlight how a switch might occur. It is also possible 
that Nos might interact with these motifs, although new in vitro interaction and functional 
assays would need to be developed to separate other mechanisms of Nos enhancement 
from PCMa/b modulation. 
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5.2.3 Towards a complete mechanism of PUF RBD mediated repression 
My work contributes mechanistic insight to conserved mechanisms of PUF RBD 
repression. While Argonautes were not necessary for RBD activity, poly(A) and pAbp 
were required. Multiple reports suggest a link between PUFs and small RNA mediated 
repression (Kedde et al. 2010; Friend et al. 2012; Miles et al. 2012). These events may 
be mRNA specific and underlie co-regulation by PUFs and RISCs in particular contexts. 
The use of poly(A) binding proteins to inhibit translation appears to be a mechanism 
conserved from yeast PUFs to human PUFs (Chritton and Wickens 2011; Weidmann et 
al. 2014). Since the RBD does not evict pAbp from mRNA, it is unclear how exactly 
translation inhibition is achieved. The RBD and pAbp interact in an RNA independent 
manner, but the nature of this interaction has not been fully described. Is the interaction 
direct? Does pAbp binding to the RBD exclude eIF4G from binding to pAbp? A 
combination of recombinant pull-downs and RNA-immunoprecipitation experiments might 
address these questions. 
A surprising feature of RBD regulation was the lack of a requirement for the Ccr4-
Not deadenylase complex. PUF RBDs throughout eukaryotes maintain direct interactions 
with the Pop2 deadenylase subunit. Indeed, my work confirmed that the RBD accelerates 
Ccr4-Not dependent deadenylation. However, this activity was not required. Instead, it 
appears that deadenylation is a consequence of pAbp directed translational inhibition. 
Depletion of pAbp eliminated reporter deadenylation. This was an unexpected result, as 
the presence of pAbp is thought to prevent deadenylation by Ccr4-Not. However, the 
Ccr4-Not complex can be recruited by pAbp through accessory proteins (Ezzeddine et al. 
2007). It is possible that RBD binding initiates a conformational change in pAbp that 
results in a shift from being protective to promoting degradation. What allows 
deadenylation to proceed? Pop2 and the RBD also interact independent of RNA, yet 
deadenylation is not accelerated unless pAbp dependent translational inhibition has 
occurred. Perhaps the RBD-pAbp interaction occludes the pAbp-poly(A) interface without 
fully evicting pAbp from the RBD bound complex. A better understanding of the RBD-
pAbp-Pop2 interaction is necessary to test this hypothesis. 
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5.2.4 What is the nature of RNA binding and repression enhancement by Nanos? 
The most intriguing finding was that of the role of Nanos in enhancing Pum RNA 
binding. The interaction between Pum, Nos, and RNA has been known for many years. 
However, the formation of the complex could only be inferred indirectly from pull-downs 
and yeast hybrid assays (Sonoda and Wharton 1999; Edwards et al. 2001). I was excited 
to demonstrate the ternary complex with purified proteins and native EMSA. It was 
proposed that Pum had to bind Nos to confer repression onto its targets through 
recruitment of the Ccr4-Not complex (Kadyrova et al. 2007). Instead, I found that Nos has 
a large effect on the RBD’s ability to bind to RNA. Strikingly, Nos conferred Pum binding 
in vitro and repression in cells to RNAs with degenerate Pum response elements. How 
can Nanos do this? Three hypotheses remain to be tested: 1) Nanos could be transiently 
interacting with RNA and orienting the PRE for binding by the RBD, 2) Nanos might bind 
the RBD and encourage a conformation with higher RNA affinity, or 3) RBD binding to a 
PRE provides a platform for Nos binding, which subsequently locks the RBD in place. 
While EMSA has proven useful for generating relative Kd measurements, it has been 
difficult to infer actual rates. More precise approaches would assist in the determination 
of kon and koff values. A stopped-flow approach might be able to capture a relatively fast 
kon. Single molecule approaches with fluorescently labeled proteins and immobilized RNA 
could also be appropriate for monitoring the kinetics of complex formation. Alternatively, 
structural information on this complex could deliver insight into how the association of 
Nanos changes Pum’s engagement with mRNA.  
Lastly, because the effect of Nanos is so drastic in vitro and in cells, it is important 
to evaluate our assumptions about what a Pum target really is. If proteins like Nanos can 
significantly change the affinity of PUFs and putatively relax their specificity, there may 
be a novel subset of mRNAs that PUFs regulate. One might ask whether the presence of 
Nanos can significantly change what targets PUM binds transcriptome-wide. Advanced 
sequencing technology will allow measurement of changes in PUM binding and regulation 
globally. Are targets of Pum alone distinct from targets of the Pum-Nos complex? High 
throughput sequencing coupled to cross-linking and immunoprecipitation (HITS-CLIP) or 
Photoactivatable ribonucleoside cross-linking and immunoprecipitation (PAR-CLIP) are 
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both techniques that might assess whether Nos simply expands the list of Pum targets by 
relaxing specificity or actually changes Pum targets by altering specificity. Experiments in 
vivo reveal that mutations in nucleotides upstream of the Hunchback PRE impair Nos-
Pum-RNA complex formation and Hunchback regulation (Wharton et al. 1998). This site 
might be bound by Nos and thus determine the altered specificity of the Nos-Pum complex 
compared to Pum alone. This could be quickly tested in vitro using the established EMSA 
protocol for ternary complex formation. Additionally, a systematic evolution of ligands by 
exponential enrichment (SELEX) approach might also be appropriate to screen for 
changes in the RNAs that Pum-Nos might prefer. 
 In conclusion, my work has moved the field of PUF regulation forward on many 
fronts. This dissertation has answered many questions and raised many more. It lays the 
foundation for future studies of the mechanisms of PUF regulation, and it informs how 
PUFs might be controlled within the biological processes they operate. 
5.3 References 
 
Decker CJ, Parker R. 2012. P-bodies and stress granules: possible roles in the control of 
translation and mRNA degradation. Cold Spring Harbor perspectives in biology 4: 
a012286. 
 
Chritton JJ, Wickens M. 2011. A role for the poly(A)-binding protein Pab1p in PUF protein-
mediated repression. The Journal of biological chemistry 286: 33268-33278. 
 
Edwards TA, Pyle SE, Wharton RP, Aggarwal AK. 2001. Structure of Pumilio reveals 
similarity between RNA and peptide binding motifs. Cell 105: 281-289. 
 
Ezzeddine N, Chang TC, Zhu W, Yamashita A, Chen CY, Zhong Z, Yamashita Y, Zheng 
D, Shyu AB. 2007. Human TOB, an antiproliferative transcription factor, is a 
poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA 
deadenylation. Molecular and cellular biology 27: 7791-7801. 
 
Friend K, Campbell ZT, Cooke A, Kroll-Conner P, Wickens MP, Kimble J. 2012. A 
conserved PUF-Ago-eEF1A complex attenuates translation elongation. Nature 
structural & molecular biology 19: 176-183. 
 
Kadyrova LY, Habara Y, Lee TH, Wharton RP. 2007. Translational control of maternal 
Cyclin B mRNA by Nanos in the Drosophila germline. Development 134: 1519-
1527. 
 
167 
 
Kedde M, van Kouwenhove M, Zwart W, Oude Vrielink JA, Elkon R, Agami R. 2010. A 
Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-
222 accessibility. Nat Cell Biol 12: 1014-1020. 
 
Miles WO, Tschop K, Herr A, Ji JY, Dyson NJ. 2012. Pumilio facilitates miRNA regulation 
of the E2F3 oncogene. Genes & development 26: 356-368. 
 
Salazar AM, Silverman EJ, Menon KP, Zinn K. 2010. Regulation of synaptic Pumilio 
function by an aggregation-prone domain. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 30: 515-522. 
 
Sonoda J, Wharton RP. 1999. Recruitment of Nanos to hunchback mRNA by Pumilio. 
Genes & development 13: 2704-2712. 
 
Vessey JP, Vaccani A, Xie Y, Dahm R, Karra D, Kiebler MA, Macchi P. 2006. Dendritic 
localization of the translational repressor Pumilio 2 and its contribution to dendritic 
stress granules. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 26: 6496-6508. 
 
Weidmann CA, Raynard NA, Blewett NH, Van Etten J, Goldstrohm AC. 2014. The RNA 
binding domain of Pumilio antagonizes poly-adenosine binding protein and 
accelerates deadenylation. Rna 20: 1298-1319. 
 
Wharton RP, Sonoda J, Lee T, Patterson M, Murata Y. 1998. The Pumilio RNA-binding 
domain is also a translational regulator. Mol Cell 1: 863-872. 
 
Zhai B, Villen J, Beausoleil SA, Mintseris J, Gygi SP. 2008. Phosphoproteome analysis 
of Drosophila melanogaster embryos. J Proteome Res 7: 1675-1682. 
 
 
 
 
 
 
 
 
 
 
 
